热点在线丨珀莱雅: 珀莱雅化妆品股份有限公司2022年年度报告(英文版)

来源:证券之星 2023-04-20 17:36:08
<p>                             Annual Report 2022</p><p>Stock Code: 603605                                            Stock Abbreviation: Proya</p><p>Bond Code: 113634                            Bond Abbreviation : Proya Convertible Bond</p><p style="text-align: center"><img style="display:block;margin:auto;" width="450" src="http://www.xcctv.cn/uploadfile/2022/0610/20220610100822639.jpg" /></br>【资料图】</p><p>                     Proya Cosmetics Co., Ltd.</p><p>                       Annual Report 2022</p><p>                                            Annual Report 2022</p><p>                                         Important Notes</p><p>I.     The Board of Directors, Board of Supervisors, directors, supervisors and senior management</p><p>       of the Company warrant that the content of the Annual Report is authentic, accurate and</p><p>       complete, free from false records, misleading statements and major omissions, and shall be</p><p>       jointly and severally liable therefore.</p><p>II.    All directors of the Company attended the meeting of the Board of Directors.</p><p>III.   Pan-China Certified Public Accountants (Special General Partnership) has issued a standard</p><p>       unqualified audit report to the Company.</p><p>IV.    HOU Juncheng, chairman of the Company, and WANG Li, CFO of the Company and Head</p><p>       of Accounting Department, represent and warrant that the financial report in the Annual</p><p>       Report is authentic, accurate and complete.</p><p>V.      The profit distribution plan or capital reserve capitalization plan for the Reporting Period</p><p>        approved by the Board of Directors</p><p>Based on the total share capital as of the record date on which equity distribution is implemented, the</p><p>Company proposes to distribute to all shareholders registered a cash dividend of RMB8.7 (tax inclusive)</p><p>per 10 shares, and convert the capital reserve into share capital in the proportion of 4 shares for every 10</p><p>shares held, but give no bonus shares. Based on the total share capital of 283,519,469 shares on December</p><p>inclusive) and a total of 113,407,788 shares will be converted.</p><p>In case of a change in the Company"s total share capital due to the conversion of convertible bonds before</p><p>the record date for equity distribution, the Company maintain the said distribution and conversation ratios</p><p>and yet adjust the total distribution and conversion amounts.</p><p>VI.     Disclosure of risks involved in forward-looking statements</p><p>√ Applicable □ Not applicable</p><p>Any future plan, development strategy and other descriptions contained in the forward-looking statements</p><p>herein shall not be deemed as the Company"s substantial commitments to investors. Investors should note</p><p>that investment involves risks.</p><p>VII.   Whether there is any non-operating capital occupation by a controlling shareholder and</p><p>       other related parties</p><p>No</p><p>VIII. Whether there is any external guarantee provided in violation of specified decision-making</p><p>      procedures</p><p>No</p><p>                                            Annual Report 2022</p><p>IX.    Whether the majority of the directors are unable to warrant the authenticity, accuracy and</p><p>       completeness of the Annual Report disclosed by the Company</p><p>No</p><p>X.     Major risk tips</p><p>The Company has described the existing risks in details in this Report. Refer to "(IV) Possible risks", "VI.</p><p>Discussion and Analysis of the Company"s Future Development", "Section III Management Discussion</p><p>and Analysis".</p><p>XI.   Other</p><p>□ Applicable √ Not applicable</p><p>                                                          Annual Report 2022</p><p>                                                              Contents</p><p>           Financial statements signed and sealed by the Legal Representative, CFO of the Company,</p><p>Documents and person in charge of Accounting Department</p><p>Available Original copy of the audit report stamped by the accounting firm and signed and sealed by</p><p>    for    certified public accountants.</p><p>Inspection Original copies of all documents and announcements of the Company disclosed during the</p><p>           Reporting Period in newspapers designated by China Securities Regulatory Commission.</p><p>                                           Annual Report 2022</p><p>                                     Section I Definitions</p><p>I. Definitions</p><p>In this report, unless the context otherwise requires, the following terms have the following meanings:</p><p> Definition</p><p> Proya Cosmetics, this</p><p>                                 refers to Proya Cosmetics Co., Ltd.</p><p> Company, or the Company</p><p>                                           Huzhou Branch of Proya Cosmetics Co., Ltd., a branch of the</p><p> Huzhou Branch                   refers to</p><p>                                           Company</p><p>                                           Shanghai Branch of Proya Cosmetics Co., Ltd., a branch of the</p><p> Shanghai Branch                 refers to</p><p>                                           Company</p><p>                                           Hangzhou Proya Trade Co., Ltd., a wholly-owned subsidiary</p><p> Proya Trade                     refers to</p><p>                                           of the Company</p><p>                                           Hanna Cosmetics Co., Ltd., a wholly-owned subsidiary of the</p><p> Korea Hanna                     refers to</p><p>                                           Company</p><p>                                           Anya (Huzhou) Cosmetics Co., Ltd., a wholly-owned</p><p> Anya (Huzhou)                   refers to</p><p>                                           subsidiary of Korea Hanna</p><p>                                           Yueqing Laiya Trading Co., Ltd., a wholly-owned subsidiary</p><p> Yueqing Laiya                   refers to</p><p>                                           of the Company</p><p>                                           Huzhou UZERO Trading Co., Ltd., a wholly-owned</p><p> Huzhou UZERO                    refers to</p><p>                                           subsidiary of the Company</p><p>                                           Mijing Siyu (Hangzhou) Cosmetics Co., Ltd., a wholly-owned</p><p> Mijing Siyu (Hangzhou)          refers to</p><p>                                           subsidiary of the Company</p><p>                                           Zhejiang Meiligu Electronic Commerce Co., Ltd., a wholly-</p><p> Meiligu                         refers to</p><p>                                           owned subsidiary of the Company</p><p>                                           Huzhou Chuangdai E-commerce Co., Ltd., a wholly-owned</p><p> Chuangdai Electronics           refers to</p><p>                                           subsidiary of Meiligu</p><p>                                           Hangzhou Boxin Trading Co., Ltd., a wholly-owned</p><p> Hangzhou Boxin                  refers to</p><p>                                           subsidiary of Meiligu</p><p>                                           Hapsode (Hangzhou) Cosmetics Co., Ltd., a wholly-owned</p><p> Hapsode (Hangzhou)              refers to</p><p>                                           subsidiary of the Company</p><p>                                           Hapsode Co., Ltd., a wholly-owned subsidiary of Hapsode</p><p> Korea Hapsode                   refers to</p><p>                                           (Hangzhou)</p><p>                                           Huzhou Hapsode Trading Co., Ltd., a wholly-owned</p><p> Huzhou Hapsode                  refers to</p><p>                                           subsidiary of Hapsode (Hangzhou)</p><p>                                           Danyang Hapsode Cosmetics Trading Co., Ltd., a wholly-</p><p> Danyang Hapsode                 refers to</p><p>                                           owned subsidiary of Hapsode (Hangzhou)</p><p>                                           Hangzhou Proya Commercial Management Co., Ltd., a</p><p> Proya Commercial                refers to</p><p>                                           wholly-owned subsidiary of the Company</p><p>                                           Hangzhou Tiedingxian Catering Management Co., Ltd., a</p><p> Tiedingxian                     refers to</p><p>                                           holding subsidiary of Proya Commercial</p><p>                                           Hangzhou Tielexin Aini Catering Management Co., Ltd., a</p><p> Tielexin Aini                   refers to</p><p>                                           wholly-owned subsidiary of Proya Commercial</p><p>                                           Hangzhou Xiake Bar Catering Management Co., Ltd., a</p><p> Xiake Bar                       refers to</p><p>                                           wholly-owned subsidiary of Proya Commercial</p><p>                                  Annual Report 2022</p><p>                                 Hangzhou Luxiaotie Fitness Co., Ltd., a wholly-owned</p><p>Luxiaotie            refers to</p><p>                                 subsidiary of Proya Commercial</p><p>                                 Hangzhou Donghai Wangchao Catering Management Co.,</p><p>Donghai Wangchao     refers to</p><p>                                 Ltd., a wholly-owned subsidiary of Proya Commercial</p><p>                                 Hong Kong Keshi Trading Co., Ltd., a holding subsidiary of</p><p>Hong Kong Keshi      refers to</p><p>                                 the Company</p><p>                                 Hongkong Xinghuo Industry Limited, a wholly-owned</p><p>Hongkong Xinghuo     refers to</p><p>                                 subsidiary of the Company</p><p>                                 Hong Kong Zhongwen Electronic Commerce Co., Limited, a</p><p>Hong Kong Zhongwen   refers to</p><p>                                 wholly-owned subsidiary of Hongkong Xinghuo</p><p>                                 Hong Kong Xuchen Trading Limited, a wholly-owned</p><p>Hong Kong Xuchen     refers to</p><p>                                 subsidiary of Hongkong Xinghuo</p><p>                                 Proya Europe SARL, a wholly-owned subsidiary of Hongkong</p><p>Proya Luxembourg     refers to</p><p>                                 Xinghuo</p><p>                                 Shanghai Zhongwen Electronic Commerce Co., Ltd., a</p><p>Shanghai Zhongwen    refers to</p><p>                                 wholly-owned subsidiary of the Company</p><p>                                 Huzhou Niuke Technology Co., Ltd., a holding subsidiary of</p><p>Huzhou Niuke         refers to</p><p>                                 the Company</p><p>                                 Hangzhou Wanyan Culture Media Co., Ltd., a wholly-owned</p><p>Hangzhou Wanyan      refers to</p><p>                                 subsidiary of Huzhou Niuke</p><p>                                 Hong Kong Wanyan Electronic Commerce Co., Limited, a</p><p>Hong Kong Wanyan     refers to</p><p>                                 wholly-owned subsidiary of Huzhou Niuke</p><p>                                 Huzhou Younimi Cosmetics Co., Ltd., a wholly-owned</p><p>Huzhou Younimi       refers to</p><p>                                 subsidiary of the Company</p><p>                                 Korea Younimi Cosmetics Co., Ltd., a holding subsidiary of</p><p>Korea Younimi        refers to</p><p>                                 the Company</p><p>                                 Ningbo TIMAGE Cosmetics Co., Ltd., a holding subsidiary of</p><p>Ningbo TIMAGE        refers to</p><p>                                 the Company</p><p>                                 Hangzhou TIMAGE Cosmetics Co., Ltd., a wholly-owned</p><p>Hangzhou TIMAGE      refers to</p><p>                                 subsidiary of Ningbo TIMAGE</p><p>                                 Ningbo Keshi Trading Limited, a holding subsidiary of the</p><p>Ningbo Keshi         refers to</p><p>                                 Company</p><p>                                 Zhejiang Beute Cosmetics Co., Ltd., a wholly-owned</p><p>Zhejiang Beute       refers to</p><p>                                 subsidiary of the Company</p><p>                                 Ningbo Proya Enterprise Consulting Management Co., Ltd., a</p><p>Ningbo Proya         refers to</p><p>                                 wholly-owned subsidiary of the Company</p><p>                                 Zhejiang Qingya Culture Art Communication Co., Ltd., a</p><p>Zhejiang Qingya      refers to</p><p>                                 holding subsidiary of the Company</p><p>                                 Boya (Hong Kong) Investment Management Co., Limited, a</p><p>Boya (Hong Kong)     refers to</p><p>                                 wholly-owned subsidiary of the Company</p><p>Japan OR             refers to   O&R Co., Ltd., a holding subsidiary of Boya (Hong Kong)</p><p>                                 Ningbo Tangyu Trading Co., Ltd., a wholly-owned subsidiary</p><p>Ningbo Tangyu        refers to</p><p>                                 of Japan OR</p><p>                                 Hangzhou Weiluoke Cosmetics Co., Ltd., a wholly-owned</p><p>Hangzhou Weiluoke    refers to</p><p>                                 subsidiary of the Company</p><p>                                          Annual Report 2022</p><p>                                         Hangzhou Yizhuo Culture Media Co., Ltd., a wholly-owned</p><p> Hangzhou Yizhuo             refers to</p><p>                                         subsidiary of the Company</p><p>                                         Hangzhou Oumisi Trading Co., Ltd., a wholly-owned</p><p> Hangzhou Oumisi             refers to</p><p>                                         subsidiary of the Company</p><p>                                         Guangzhou Qianxi Network Technology Co., Ltd., a wholly-</p><p> Guangzhou Qianxi            refers to</p><p>                                         owned subsidiary of the Company</p><p>                                         Proya (Hainan) Cosmetics Co., Ltd., a wholly-owned</p><p> Proya (Hainan)              refers to</p><p>                                         subsidiary of the Company</p><p>                                         Shenggelan (Hangzhou) Cosmetics Co., Ltd., a wholly-owned</p><p> Singuladerm (Hangzhou)      refers to</p><p>                                         subsidiary of the Company</p><p>                                         Xuzhou Laibo Information Technology Co., Ltd., a wholly-</p><p> Xuzhou Laibo                refers to</p><p>                                         owned subsidiary of the Company</p><p>                                         Proya (Zhejiang) Cosmetics Co., Ltd., a wholly-owned</p><p> Proya (Zhejiang)            refers to</p><p>                                         subsidiary of the Company</p><p> CSRC                        refers to   China Securities Regulatory Commission</p><p> SSE                         refers to   Shanghai Stock Exchange</p><p>                                         Pan-China Certified Public Accountants (Special General</p><p> Pan-China                   refers to</p><p>                                         Partnership)</p><p> CSC                         refers to   China Securities Co., Ltd.</p><p> Company Law                 refers to   Company Law of the People"s Republic of China</p><p> Securities Law              refers to   Securities Law of the People"s Republic of China</p><p> Articles of Association     refers to   Articles of Association of Proya Cosmetics Co., Ltd.</p><p> RMB/RMB’0,000               refers to   Renminbi Yuan/Renminbi 10,000 Yuan</p><p> Reporting Period            refers to   January 1, 2022 to December 31, 2022</p><p>            Section II Company Profile and Key Financial Indicators</p><p>I.    Company Information</p><p>Chinese name of the Company                 Proya Cosmetics Co., Ltd.</p><p>Short name of the Company in Chinese        珀莱雅</p><p>English name of the Company                 Proya Cosmetics Co., Ltd.</p><p>Abbreviation of English name of the</p><p>                                            Proya</p><p>Company</p><p>Legal representative of the company         HOU Juncheng</p><p>II.   Contact Details</p><p>                                  Board Secretary                 Securities Affairs Representative</p><p>Name                 WANG Li                                    WANG Xiaoyan</p><p>Mailing address      Xihu District, Hangzhou City, Zhejiang     Road, Xihu District, Hangzhou City,</p><p>                     Province                                   Zhejiang Province</p><p>Telephone            0571-87352850                              0571-87352850</p><p>Fax                  0571-87352813                              0571-87352813</p><p>Email                proyazq@proya.com                          proyazq@proya.com</p><p>                                               Annual Report 2022</p><p>III. General Information</p><p>                                                 No. 588, Xixi Road, Liuxia Street, Xihu District,</p><p>Registered address</p><p>                                                 Hangzhou City, Zhejiang Province</p><p>                                                 For details, please refer to the Announcement on</p><p>                                                 Amending the Articles of Association and Applying for</p><p>Historical changes in the Company"s</p><p>                                                 Changing Business Registration (No.2019-008) disclosed</p><p>registered address</p><p>                                                 by the Company on the designated media on February 27,</p><p>                                                 Proya Building, No. 588 Xixi Road, Xihu District,</p><p>Office address of the Company</p><p>                                                 Hangzhou City, Zhejiang Province</p><p>Postal code of the registered office address     310023</p><p>Company website                                  http://www.proya-group.com</p><p>Email                                            proyazq@proya.com</p><p>IV.   Information Disclosure and Place for Obtaining the Report</p><p>Media for the Company"s information</p><p>                                                 Shanghai Securities News, Securities Times</p><p>disclosure</p><p>CSRC"s designated website for the</p><p>                                                 http://www.sse.com.cn</p><p>Company"s Annual Report disclosure</p><p>The Company"s Annual Report may be               Board of Director"s Office, Proya Building, No. 588 Xixi</p><p>obtained at                                      Road, Xihu District, Hangzhou City, Zhejiang Province</p><p>V.    Stock Information</p><p>                                               Stock Information</p><p>                                                                                       Stock abbreviation</p><p>      Stock class       Stock exchange         Stock abbreviation     Stock code</p><p>                                                                                         before changes</p><p>                        Shanghai Stock</p><p>       A share                                       Proya               603605               None</p><p>                          Exchange</p><p>VI. Other Relevant Information</p><p>                                                    Pan-China Certified Public Accountants (Special</p><p>                     Name</p><p>                                                    General Partnership)</p><p> Auditor of the</p><p>                                                    Block B, China Resources Building, No. 1366,</p><p> Company             Office address</p><p>                                                    Qianjiang Road, Jianggan District, Hangzhou</p><p> (domestic)</p><p>                     Name of the signing</p><p>                                                    YIN Zhibin, WANG Xiaokang</p><p>                     accountant</p><p> Sponsor             Name                           China Securities Co., Ltd.</p><p> performing                                         Room 2203, North Tower, Shanghai Securities</p><p>                     Office address</p><p> continuous                                         Building, No. 528, Pudong South Road, Shanghai</p><p> supervisory         Names of the sponsor"s</p><p>                                                    GE Liang, WANG Zhan</p><p> duty during the     signing representatives</p><p> Reporting           Period of continuous           January 4, 2022 - December 31, 2023</p><p>                                             Annual Report 2022</p><p> Period             supervision</p><p>VII. Major Accounting Data and Financial Indicators for the Past Three Years</p><p>(I) Major Accounting Data</p><p>                                                                             Unit: Yuan Currency: RMB</p><p>   Major accounting                                                       Year-on-year</p><p>          data                                                             change (%)</p><p> Operating revenue         6,385,451,424.00          4,633,150,538.43            37.82 3,752,386,849.02</p><p> Net profit</p><p> attributable to</p><p> shareholders of the</p><p> listed company</p><p> Net profit</p><p> attributable to</p><p> shareholders of the</p><p> listed company net</p><p> of non-recurring</p><p> profit or loss</p><p> Net cash flow from</p><p> operating activities</p><p>                          As of the end of          As of the end of      Year-on-year        As of the end of</p><p> Net assets</p><p> attributable to</p><p> shareholders of the</p><p> listed company</p><p> Total assets              5,778,071,824.19          4,633,049,783.03             24.71       3,636,882,185.29</p><p>(II) Key Financial Indicators</p><p>                                                                           Year-on-year</p><p>      Key financial indicators               2022              2021                                 2020</p><p>                                                                            change (%)</p><p> Basic earnings per share</p><p> (RMB/share)</p><p> Diluted earnings per share</p><p> (RMB/share)</p><p> Basic earnings per share net of</p><p> non-recurring profit and loss                      2.80           2.83              -1.06                 2.34</p><p> (RMB/share)</p><p> Weighted average ROE (%)                                                       Up by 3.70</p><p>                                                                          percentage points</p><p> Weighted average ROE net of                                                    Up by 3.09</p><p> non-recurring profit and loss (%)                                        percentage points</p><p>Explanation on the Company"s major accounting data and financial indicators for the recent three years as</p><p>                                               Annual Report 2022</p><p>  of the end of the Reporting Period</p><p>  □ Applicable √ Not applicable</p><p>  VIII. Differences in Accounting Data under Chinese and International Accounting Standards</p><p>  (I)     Difference in net profit and net assets attributable to shareholders of the listed company in the</p><p>          financial report disclosed in accordance with International accounting standards and Chinese</p><p>          accounting standards</p><p>  □ Applicable √ Not applicable</p><p>  (II) Differences in net profit and net assets attributable to shareholders of the listed company in</p><p>       the financial report disclosed in accordance with International accounting standards and</p><p>       Chinese accounting standards</p><p>  □ Applicable √ Not applicable</p><p>  (III) Description of differences between international and Chinese accounting standards:</p><p>  □ Applicable √ Not applicable</p><p>  IX.      Major Financial Data for 2022 by Quarter</p><p>                                                                                Unit: Yuan  Currency: RMB</p><p>                                Q1                  Q2                         Q3                 Q4</p><p>                         (January - March)     (April - June)         (July - September) (October - December)</p><p>Operating revenue          1,254,357,336.99   1,371,585,907.30          1,336,130,787.67     2,423,377,392.04</p><p>Net           profit</p><p>attributable      to</p><p>shareholders of the</p><p>listed company</p><p>Net           profit</p><p>attributable      to</p><p>shareholders of the</p><p>listed company net</p><p>of non-recurring</p><p>profit and loss</p><p>Net cash flow from</p><p>operating activities</p><p>  Description of differences between quarterly data and disclosed regular report data</p><p>  □ Applicable √ Not applicable</p><p>  X.       Non-recurring Profit and Loss Items and Amounts</p><p>  √ Applicable □ Not applicable</p><p>                                                                                  Unit: Yuan   Currency: RMB</p><p>                                                Amount for           Note (if       Amount for     Amount for</p><p>        Non-recurring profit and loss item</p><p> Gain or loss on disposal of non-current</p><p> assets</p><p> Unauthorized approval, no formal</p><p>                                                   Annual Report 2022</p><p>                                                    Amount for           Note (if      Amount for      Amount for</p><p>    Non-recurring profit and loss item</p><p>approval, or occasional tax refund or</p><p>reduction</p><p>Government grants recognized in profit or</p><p>loss for the current period (excluding</p><p>government grants that are closely related</p><p>to the Company"s business operations and</p><p>gained at a fixed amount or quantity</p><p>according to national standards)</p><p>Capital occupation fees charged to the non-</p><p>financial enterprises and included in profit</p><p>or loss for the current period</p><p>Gains when the investment cost of</p><p>acquiring a subsidiary, an associate and a</p><p>joint venture is less than the fair value of the</p><p>identifiable net assets of the invested entity</p><p>Gains or losses from exchange of non-</p><p>monetary assets</p><p>Gains or losses from entrusting others with</p><p>investment or asset management</p><p>Asset impairment provision accrued for</p><p>force majeure such as natural disasters</p><p>Gains or losses from debt restructuring</p><p>Enterprise restructuring fees, such as</p><p>staffing expenses and integration fees</p><p>Profit and loss of the part exceeding fair</p><p>value generated from transaction with</p><p>unreasonable transaction price</p><p>Current net gains or losses of subsidiaries</p><p>established by business combination</p><p>involving enterprises under common</p><p>control from the beginning of the period to</p><p>the combination date</p><p>Gains or losses on contingencies that have</p><p>no relation with the normal operation of the</p><p>Company</p><p>Gains or losses from change in fair value by</p><p>held-for-trading financial assets, derivative</p><p>financial assets, held-for-trading financial</p><p>liabilities   and      derivative      financial</p><p>liabilities, and investment income from</p><p>disposal of held-for-trading financial</p><p>assets, derivative financial assets, held-for-</p><p>trading financial liabilities, derivative</p><p>                                               Annual Report 2022</p><p>                                                Amount for           Note (if     Amount for      Amount for</p><p>    Non-recurring profit and loss item</p><p>financial liabilities and other debt</p><p>investments, excluding the effective</p><p>hedging businesses related with normal</p><p>operations of the Company</p><p>Reversal of provision for impairment of</p><p>receivables and contract assets individually    2,782,350.76</p><p>tested for impairment</p><p>Gains or losses from outward entrusted</p><p>loaning</p><p>Gains or losses from changes in the fair</p><p>values of Investment real estate that are</p><p>subsequently measured using the fair value</p><p>model</p><p>Impact of a one-time adjustment on current</p><p>profit and loss according to the</p><p>requirements of tax and accounting laws</p><p>and regulations</p><p>Custody fees of entrusted operation</p><p>Other non-operating revenue and expenses</p><p>                                                -2,926,959.81                     -3,078,442.83   -6,810,805.57</p><p>besides the above items</p><p>Other items that conform to the definition</p><p>of non-recurring profit or loss</p><p>Less: Effect of income tax                      3,689,885.55                      1,917,310.27    1,042,102.64</p><p>Effect of minority equity (after tax)           5,802,406.15                      2,314,480.49      688,969.45</p><p>                   Total                       28,886,986.92                      8,026,545.18    6,073,394.19</p><p> The reasons should be explained for the non-recurring profit and loss items defined by the Company</p><p> according to the definition of the Explanatory Announcement No.1 on Information Disclosure for</p><p> Companies Offering Their Securities to the Public: Non-recurring Profit and Loss, and the definition of</p><p> the non-recurring profit and loss items listed in the Explanatory Announcement No.1 on Information</p><p> Disclosure for Companies Offering Their Securities to the Public: Non-recurring Profit and Loss as</p><p> recurring profit and loss items.</p><p> □ Applicable √ Not applicable</p><p> XI. Items Measured at Fair Value</p><p> √ Applicable □ Not applicable</p><p>                                                                               Unit: Yuan    Currency: RMB</p><p>                                                                                        Amount of impact</p><p>          Item            Opening balance      Ending balance         Current change</p><p>                                                                                       on the current profit</p><p>   Receivable                                                                                           0.00</p><p>   financing</p><p>   Other      equity        56,402,400.00       146,402,400.00          90,000,000.00                  0.00</p><p>                                                          Annual Report 2022</p><p>            instrument</p><p>            investments</p><p>                   Total                59,644,400.00      146,402,400.00         86,758,000.00                    0.00</p><p>           XII. Other</p><p>           □ Applicable √ Not applicable</p><p>                            Section III         Management Discussion and Analysis</p><p>           I.    Business Discussion and Analysis</p><p>           RMB6.385 billion operating revenue, up by 37.82% YOY</p><p>           including RMB6.362 billion prime operating revenue, up by 37.69% YOY</p><p>           RMB23 million non-operating revenue</p><p>           Prime operating revenue:</p><p>           (1) By channel</p><p>                                                                                Change in</p><p>                                          Change in         Change in</p><p>                            Amount                                              2020 over      Proportion   Proportion    Proportion</p><p>         Channel           (RMB100                                             the previous     of 2022      of 2021       of 2020</p><p>                                         previous year     previous year</p><p>                            million)                                               year           (%)          (%)           (%)</p><p>                                           YOY (%)           YOY (%)</p><p>                                                                                YOY (%)</p><p>           Direct sales         44.78             59.79             76.16             79.63         70.40       60.66         42.45</p><p> Online    Distribution         13.10             16.79              8.56             34.36         20.58       24.27         27.56</p><p>           Subtotal             57.88             47.50             49.54             58.59         90.98       84.93         70.01</p><p>           Household</p><p>           chemicals</p><p> Offline</p><p>           Others             1.31           -32.32         -30.50         -32.81           2.06        4.19                   7.43</p><p>           Subtotal           5.74           -17.62         -38.03         -23.12           9.02       15.07                  29.99</p><p> Total                       63.62            37.69          23.28          20.26        100.00       100.00                 100.00</p><p>           Note: The percentage of sales from each channel is the proportion of its sales in the prime operating</p><p>           revenue.</p><p>           (2) By brand</p><p>                                                                                Change in</p><p>                                         Change in         Change in</p><p>                           Amount                                               2020 over      Proportion   Proportion     Proportion</p><p>         Brand            (RMB100                                              the previous     of 2022      of 2021        of 2020</p><p>                                        previous year     previous year</p><p>                           million)                                                year           (%)          (%)            (%)</p><p>                                          YOY (%)           YOY (%)</p><p>                                                                                YOY (%)</p><p>           Proya             52.64              37.46              28.25              12.43         82.74        82.87         79.66</p><p>Self-</p><p>           TIMAGE             5.72             132.04             103.48                   -         8.99         5.33             -</p><p>owned</p><p>           OR                 1.26             509.93                  -                   -         1.98            -             -</p><p>brands</p><p>           Hapsode            1.87             188.27                  -                   -         2.94            -             -</p><p>                                                         Annual Report 2022</p><p>          Other</p><p>          brands</p><p>          Subtotal          63.12                40.74            26.63            19.11          99.22          97.05          94.48</p><p>          Cross-</p><p>Agency    border</p><p>brands    agency</p><p>          brands</p><p>Total                       63.62             37.69              23.28             20.26         100.00        100.00         100.00</p><p>          Note: The proportion of sales of each brand is the proportion of its sales in the prime operating revenue;The</p><p>          data of OR and Hapsode is incorporated into that of other brands in 2021 and therebefore, but is separately</p><p>          listed in 2022 and thereafter.</p><p>          (3) By category</p><p>                                  Change in          Change in           Change in 2020</p><p>                    Amount                                                                 Proportion     Proportion     Proportion</p><p>   Category        (RMB100                                                                  of 2022        of 2021        of 2020</p><p>                                 previous year      previous year         previous year</p><p>                    million)                                                                  (%)            (%)            (%)</p><p>                                   YOY (%)            YOY (%)               YOY (%)</p><p>  Skincare</p><p>  (including          54.84              38.56                22.70               11.38        86.20          86.10          86.50</p><p>  cleansing)</p><p>  Make-up</p><p>  cosmetics</p><p>  Body & hair           1.26            509.93                -                 -         1.98             -          -</p><p>  Others                0.00           -100.00          -41.05               0.47         0.00         0.52        1.09</p><p>  Total               63.62               37.69          23.28              20.26       100.00       100.00      100.00</p><p>          Note: The " Body & hair " category is included in the "Skincare (including cleansing)" category before</p><p>          RMB817 million net profit attributable to shareholders of the listed company, up by 41.88% YOY</p><p>          RMB789 million net profit attributable to shareholders of the listed company net of non-recurring profit</p><p>          and loss, up by 38.80% YOY</p><p>                       Indicator                2022          2021           2020                Notes</p><p>                                                                                     Mainly due to the increased</p><p>                                                                                     gross profit margin.</p><p>                                                                                     Mainly due to:</p><p>                                                                                     online direct sales; 2. Hero</p><p>                                                                                     product strategy;</p><p>                                                                                     Mainly due to:</p><p>                                                                                     as Hapsode) and increased</p><p>                                            Annual Report 2022</p><p>                                                                             spending       in     image</p><p>                                                                             promotion.</p><p>Of which: image promotion fee</p><p>rate</p><p>                                                                             Mainly due to:</p><p>                                                                             increased by 67.15% YOY</p><p>                                                                             (an absolute increase of</p><p>                                                                             RMB51.43 million);</p><p>                                                                             R&D expense ratio was</p><p>                                                                             with 3.55% for the same</p><p>                                                                             period last year).</p><p>                                                                             Mainly due to:</p><p>rate (time/year)                                                             2.    Decreased     average</p><p>                                                                             balance      of    accounts</p><p>                                                                             receivable.</p><p>days (days)</p><p>(time/year)</p><p>II. The Company"s Industry Situation during the Reporting Period</p><p>According to the Guidelines for the Industry Classification of Listed Companies by the CSRC, the</p><p>Company falls under chemical raw material and chemical product manufacturing (classification code:</p><p>C26); according to the Industrial Classification for National Economic Activities (GB/T 4754-2017), the</p><p>Company falls under the manufacturing of daily chemical products (C268) and further under the</p><p>manufacturing of cosmetics (C2682).</p><p>According to statistics from the National Bureau of Statistics, in 2022, the total retail sales of consumer</p><p>goods reached RMB43,973.3 billion, down by 0.2% YOY; the total retail sales of cosmetics reached</p><p>RMB393.6 billion, down by 4.5% YOY (covering consumer goods above designated units).</p><p>III. The Company"s Business Operations during the Reporting Period</p><p>(I) Main business</p><p>The Company seeks to build a new domestic cosmetics industry platform, and is primarily engaged in</p><p>R&D, production and sales of cosmetic products. Main brands owned by the Company include Proya,</p><p>TIMAGE, Off&Relax, Hapsode, CORRECTORS, INSBAHA, UZERO and Anya. The Company"s own</p><p>brands have covered fields such as popular skincare, make-up, body & hair, and high-efficiency skincare:</p><p>                                            Annual Report 2022</p><p>(1) Proya, focusing on technology skincare, designed for young white-collar female customers, priced at</p><p>RMB200 to RMB500, sold both online and offline.</p><p>(2) Hapsode, customized for young skin, especially for college students and other young female customers,</p><p>priced at RMB50 to RMB150, sold mainly online.</p><p>TIMAGE, a professional make-up brand with a new Chinese style, priced at RMB150 to RMB300, sold</p><p>online.</p><p>Off&Relax, developed and made in Japan, focusing on scalp care, priced at RMB150 to RMB200, sold</p><p>mainly online.</p><p>CORRECTORS, a high-efficiency skincare brand, priced at RMB260 to RMB600, sold online.</p><p>(II) Business models</p><p>Mainly online sales, supplemented by offline sales.</p><p>Online sales are mainly operated through direct sales and distribution. Direct sales are mainly carried out</p><p>on platforms such as Tmall, TikTok, JD, Kwai, and Pinduoduo. Distribution platforms include Taobao,</p><p>JD, and Vipshop.</p><p>Offline sales are mainly operated through dealers. Channels include cosmetics franchise stores,</p><p>supermarkets, and single-item stores.</p><p>Self-production is the main production model of the Company, supplemented by OEM production. The</p><p>skincare products of the Company are self-produced while make-up products are both self-produced and</p><p>OEM-produced. The Company has self-built skincare and make-up factories.</p><p>Independent R&D is the main R&D model of the Company, supplemented by industry-university-research</p><p>cooperation. The Company has maintained R&D cooperation with front-end research institutions and</p><p>high-quality raw material suppliers including the Institute of Microbiology, Chinese Academy of Sciences,</p><p>Zhejiang University of Technology, BASF China, Ashland China, Royal DSM Shanghai, LIPOTRUE</p><p>S.L., and Shenzhen Siyomicro Bio-tech.</p><p>IV. Analysis of Core Competitiveness during the Reporting Period</p><p>√ Applicable □ Not applicable</p><p>The Company"s core competitiveness is mainly embodied by:</p><p>The Company adheres to the guidance of the 6*N strategy and puts it into practice amid the rapidly</p><p>changing market; consolidates and deepens the refined operation management system highlighting "R&D,</p><p>products, contents, operation"; constructs a self-driven organization featuring "culture-strategy-</p><p>mechanism-talents".</p><p>With a keen insight into consumers" needs, the Company keeps sharpening the strengths of hero products,</p><p>as well as building and improving the matrix of core hero products based on R&D and relying on quick</p><p>response and organizational capabilities.</p><p>The Company has built a self-driven and agile organization to serve brands in the second echelon that</p><p>have taken shape as well as brands under incubation. By building our own MCN team and content</p><p>                                            Annual Report 2022</p><p>marketing team, the Company strengthens the internally circular ecosystem and connects Proya brands</p><p>with the external ecosystem.</p><p>V. Main Operations during the Reporting Period</p><p>Proya:</p><p>During the Reporting Period, Proya continued to deepen the "Hero Product Strategy"; primarily expanded</p><p>and upgraded the categories and efficacy of Elastic Brightening Youth Essence, Ruby Essence, and</p><p>Advanced Original product families; launched Advanced Original Face Cream, Advanced Original Face</p><p>Mask, and other new products; upgraded the Elastic Brightening Youth Activating Eye Cream, the Deep</p><p>Ocean Energy Wrinkless and Firming Moisture Cream, and the Advanced Original Essence to version 2.0,</p><p>which further solidified the mindset of the three product families; continued to explore high-end product</p><p>categories by launching the Inaugurating Nourishing Face Oil. These products give consumers more</p><p>options and better product experiences.</p><p>In 2022, Proya ranked 1st in the essence category, 4th in the mask category, 4th in the eye cream category,</p><p>and 9th in the face cream category on Tmall.</p><p>TIMAGE:</p><p>During the Reporting Period, TIMAGE further completed the deployment of facial make-up product lines,</p><p>and strengthened the impression of a "professional make-up artist" for consumers. Based on the facial</p><p>make-up category, TIMAGE created two segments of "Contour Line" and "Base Make-up". In addition</p><p>to contour, highlighter, and primer, TIMAGE created another six categories including liquid foundation,</p><p>concealer, and setting spray. The large base make-up category was supplemented while maintaining</p><p>advantages in contour lines, so that the base make-up category could establish a wider presence.</p><p>In 2022, the "tri-colored contour palette" and "dual-colored highlighter palette" of TIMAGE maintained</p><p>their advantages in the highlighter category, led the growth for the brand aggressively, improved product</p><p>penetration, and brought a large number of new customers to the brand. The tri-colored contour palette</p><p>ranked 1st in the highlighter category on Tmall. The dual-colored highlighter palette ranked 2nd in the</p><p>highlighter category on Tmall. The face primer ranked 1st in the sun block/primer category on Tmall. The</p><p>newly-launched tri-colored concealer palette ranked 1st in the concealer category on Tmall. The newly-</p><p>launched setting spray ranked top 10 in the setting spray category on Tmall.</p><p>Off&Relax (OR):</p><p>During the Reporting Period, the Company continued to optimize the product structure and facilitated the</p><p>construction of a scalp health care system for the brand.</p><p>Making scalp health a focus for the brand penetrating the market, OR solves users" pain points by rapidly</p><p>building two flagship products "Off&Relax Hot Spring Water SPA Shampoo" and "Off&Relax Hot Spring</p><p>Water Hair Mask". Based on the existing market environment and the characteristics of Japanese brands,</p><p>OR sorts out product selling points, provides various scalp and hair care products for high-net-value</p><p>consumers, who care user experience of cleansing and care products, to satisfy the demands of different</p><p>consumers.</p><p>Hapsode:</p><p>During the Reporting Period, Hapsode focused on building two cleansing products: Amino Acid Crystal</p><p>and Multiple Acids Purely Cleansing Mud Musk. Cleansing products allow the Company to rapidly reach</p><p>                                             Annual Report 2022</p><p>young consumers with oily skin. Also, Hapsode completes the brand and category portfolio by launching</p><p>highly-effective skin cleansing products such as the "Ultra Soothing Facial Mask " and the "Oil Control</p><p>Balanced Serum", builds up a pyramid-typed product system for oily skin, and gradually improves</p><p>consumers" recognition of Hapsode as "an expert for the care of oily skin".</p><p>Proya:</p><p>During the Reporting Period, the Proya brand continuously built its brand around the "spirit of discovery",</p><p>focused on socially important issues such as gender equality, mental health and intimate relationships, and</p><p>created and communicated brand content on issues related to young people"s growth and the target</p><p>audience for long-lasting effects. The Company carried out brand marketing events as follows:</p><p>(1) "Next Stop, Decisive Turn" in January: Proya delivered the hope for the new year with poems and</p><p>gave the audience a beautiful wish for good luck by organizing a subway poetry exhibition.</p><p>(2) "Gender is Not the Borderline, Prejudice is" on Women"s Day in March: Aiming at gender equality</p><p>once again, Proya invited the female soccer WANG Shuang and the Nanxing Hexingtang Lion Dance</p><p>Team to shoot a documentary. Efforts were made to unite with seven brands to continuously strive for "a</p><p>gender equal world" with concrete actions.</p><p>(3) "Visible Only to Moms" on Mother"s Day in May: Proya told the stories of "mothers", who are one of</p><p>the target consumer groups of the brand, to all family members, and invited experts of different fields to</p><p>participate in topic discussions. Differentiated from the "Thank You Mother" topic in the same period, the</p><p>event drummed up more discussions about the "division of household labor and responsibilities".</p><p>(4) "Dare to love, dare not to love" on the Chinese Valentine"s Day in August: Proya worked with</p><p>FUJIFILM and photographers to discuss with consumers the form of self presentation in love in the way</p><p>of pictures and texts. Meanwhile, the Company proposed the brand technology mindset of "A Scientific</p><p>Choice for Skin" while working with the original content platform Zhihu to seek the answer to the question</p><p>"what is the best scientific choice for skin", and better help consumers understand the knowledge of</p><p>scientific skin care so they can choose products more wisely.</p><p>(5) "The Smallest Thing Is Important" in September: Proya advocated for school bullying victims, held</p><p>the attention to the signs of campus bullying that seem "insignificant", and called on the public to realize</p><p>the "multi-faced look" of campus bullying, so as to light up the road ahead for those growing amidst bullies.</p><p>(6) World Mental Health Day in October: Proya continued on the "Echo Project" brand marketing</p><p>campaign, paid sustaining attention to the mental health of young people, and output the brand attitude of</p><p>Proya. Joining hands with Beijing New Sunshine Charity Foundation, Douban, Owspace, Fangsuo</p><p>Commune, The Mind, Xiaoyuzhou Podcast APP, and xinli001.com, Proya presented everyone the</p><p>multiple possibilities of "emotional outlets".</p><p>(7) Pop-up series at 9 stores in 8 cities across China in November: By understanding the youngsters"</p><p>“Coffee & Alcohol Pop Up” mindset, Proya effectively integrated its hero products into a popular lifestyle</p><p>of young people, delivering a young brand image by catering to a lifestyle that better suits young</p><p>consumers.</p><p>TIMAGE:</p><p>During the Reporting Period, TIMAGE comprehensively deepened the brand recognition of "Chinese</p><p>make-up, original beauty" and had a dialog with Chinese female consumers with its unique</p><p>professionalism and aesthetics. By means of cross-border marketing, brand responsibility and care, and</p><p>brand values delivery, TIMAGE carried out the following marketing events:</p><p>                                            Annual Report 2022</p><p>(1) "Unfiltered You" on Women"s Day in March: Photographers were invited to output the opinions of</p><p>"original beauty", speak out for the brand, and interpret the concept of original beauty as female artists.</p><p>Starting from the insight into "filters", the event presents the brand concept and aesthetic tonality of</p><p>original beauty.</p><p>(2) "Witness the Original Beauty" in April: TIMAGE worked with Hippocampus, a professional</p><p>photography organization, to provide ID photo make-up of "original beauty". Hippocampus set up special</p><p>make-up tables at its 180 stores. Large-screen advertisements were launched in 5 major cities and online</p><p>topics were promoted to most searched hashtags to encourage consumers to share their changes in the</p><p>make-up before taking an ID photo over the years.</p><p>(3) "Life is Beautiful" in June: TIMAGE collaborated with the One Way Street Library to start topics.</p><p>Many art workers, music critics, directors, writers, and screenwriters sent articles and photos of their</p><p>experiences to share and output positive content. TIMAGE also produced peripheral sachets and gave</p><p>them to consumers for free.</p><p>(4) "Origin at the Beginning of Autumn" in August: TIMAGE produced a video with three female content</p><p>KOLs to present the life attitude that "It is Never too Late to Do" and encourage everyone to find more</p><p>possibilities in life.</p><p>(5) "You Are Beautiful in Every Single Way" in October: TIMAGE released the first high-quality brand</p><p>promotion film to set the latest visual identity of the brand, complete the full-chain communication loop</p><p>from "original beauty" to "Chinese make-up", and showcase the brand tonality of TIMAGE as well as its</p><p>attitude toward women"s intrinsic growth.</p><p>(6) "See Your Beauty" in December: By producing thank-you letters and peripheral gifts, TIMAGE</p><p>interacted with fans to express its gratitude for the support of fans.</p><p>Proya:</p><p>Online:</p><p>(1) Tmall flagship store</p><p>During the Reporting Period, the Company continued to consolidate the hero product matrix strategy and</p><p>created super-hero products throughout the Internet. Combining factors of consumers, goods, and venues,</p><p>the Company deeply maintains the members and regular customers of stores, improves their possibilities</p><p>of repurchase and per customer transaction, increases the penetration into populations and high-value users</p><p>in tier 1 and tier 2 cities; heightens the ranking in core categories and draws the attention of consumers;</p><p>values the operation of self live-streaming and improves the proportion of self live-streaming. During</p><p>the "6.18" and "11.11" shopping festivals in 2022, the gross merchandise volume (GMV) of Proya</p><p>Flagship Store ranked 5th on Tmall Beauty and 1st among all Chinese products. In 2022, the GMV of</p><p>Proya Flagship Store ranked 4th on Tmall Beauty and 1st among all Chinese products.</p><p>(2) TikTok</p><p>During the Reporting Period, the Company strengthened self live-streaming and multi-matrix account</p><p>operation: increased the consumer maintenance efficiency while stepping up the maintenance of members</p><p>and fans; optimized the product structure, and dramatically increased the proportion of hero products and</p><p>the per customer transaction of stores. During the "6.18" and "11.11" shopping festivals in 2022, Proya</p><p>ranked 1st both on TikTok Beauty and among all Chinese products. In 2022, Proya ranked 3rd on TikTok</p><p>Beauty and 1st among all Chinese products.</p><p>(3) JD</p><p>                                             Annual Report 2022</p><p>During the Reporting Period, the Company deeply implemented the hero product strategy and further</p><p>improved the sales proportion of hero products through efficient operation; improved the experience of</p><p>members, attracted new high-value customers, and increased the repurchase ratio to have a better insight</p><p>into the population and lock target consumers; optimized the quality of advertisement content, expanded</p><p>advertisement channels, and operated various channels in a more refined manner. During the "6.18" and</p><p>"11.11" shopping festivals in 2022, Proya ranked 1st both on JD Beauty and among all Chinese products.</p><p>In 2022, Proya ranked 10th on JD Beauty, and ranked 1st among all Chinese products.</p><p>Offline:</p><p>(1) Household chemicals: Corresponding rating systems are matched for strongly influential areas and</p><p>weekly influential areas of the brand to manage outlets in an targeted and differentiated manner. The</p><p>business logic is now driven by "dynamic sales" instead of "channel policies", so as to optimize bad</p><p>inventory in channels, ensure maximum benefits for retailers, and keep close eyes on the fund, inventory,</p><p>and benefits of retailers.</p><p>(2) Supermarkets: The brand power enables the department store channel to improve existing counters,</p><p>upgrade the image, and enhance the efficiency. The "Coffee & Alcohol Pop Up" initiative is held through</p><p>brand marketing campaigns at 9 stores in 8 cities including Hangzhou, Shenzhen, Ningbo, Suzhou,</p><p>Wenzhou, and Xi"an, so as to reach young target customers, strengthen the communication with the young</p><p>population, and promote the strategic cooperation between the brand and key systems. Also, the</p><p>cooperation with supermarkets is shrunk strategically.</p><p>(1) Organization: The Company continuously improves the organizational structure, opens up the brand</p><p>planning mode that connects both the upper level and the lower level, builds a management mode</p><p>integrating a product and delivery capability-focused "middle platform" and an "agile front", continues to</p><p>deepen the application of digital technologies, and promotes the incubation and growth of new businesses</p><p>through the empowerment of platforms and digitalization.</p><p>(2) Talents: The Company continuously promotes the talent supply chain mechanism for young and</p><p>international talents based on business needs, steps up the introduction of talents for research, development,</p><p>and information application, accurately and rapidly identifies, and efficiently utilizes talents, and gradually</p><p>builds a dynamic, competent and self-driven talent team through the combination of training and practices.</p><p>Through the dual-channel management, the Company improves the talent density, facilitates talent</p><p>development, and builds a talent echelon.</p><p>(3) Mechanism: The Company deepens a performance culture featuring high investment, high</p><p>performance and high returns, improves a performance management system emphasizing targets, process</p><p>and results; flexible utilizes the diversified incentive system covering short-term (quarterly performance</p><p>and project incentives), middle-term (annual performance dividends) and long-term (equity incentives and</p><p>partners) incentives. Also, the Company deepens the application of the project system, builds up a three-</p><p>level project management system consisting of the Company, business divisions, and departments, and</p><p>puts efforts on the end-to-end value chain and internal control projects to continuously hone the</p><p>organization capability.</p><p>During the Reporting Period, the Company took the R&D Innovation Center and the International</p><p>Academy of Sciences as the engine for innovation; improved the R&D of all key stages from raw material</p><p>to finished products, including fundamental research, formula development, physical and chemical</p><p>                                            Annual Report 2022</p><p>analysis, raw material and product efficacy evaluation, etc. The Company continues to push the</p><p>construction of the International Academy of Sciences to conduct the research of skin texture, design</p><p>active substances, and verify their efficacy. The R&D Innovation Center continues to focus on researching</p><p>and developing new skin care and make-up products. Now the Shanghai R&D Center is under construction</p><p>and the Japan R&D Center is under preparation.</p><p>(1) Patents: During the Reporting Period, the Company newly applied for 21 national invention patents,</p><p>licensed invention patents and 17 design patents, totaling 32 patents obtained. As of the end of the</p><p>Reporting Period, the Company had 107 nationally licensed invention patents, 19 utility model patents,</p><p>and 99 design patents, totaling 225 patents obtained.</p><p>(2) Standard releasing: During the Reporting Period, the Company participated the drafting of two newly</p><p>released group standards, namely the TZHCA 017-2022 Hair Growth and Rest Period Quantity Ratio Test</p><p>Method and the T/ZHCA 019-2022 Cosmetics Anti-dandruff Efficacy Test Method. As of the end of the</p><p>Reporting Period, the Company had led or participated in the development of 14 national standards, 3</p><p>industry standards, and 14 group standards.</p><p>(3) Achievements and awards: During the Reporting Period, the Company was granted the following</p><p>honorable titles, including the Hangzhou "Kunpeng" Enterprise, One of the Top Ten Enterprise in China"s</p><p>Light Industry ad Cosmetics Industry, One of the Top 100 Enterprises in Hangzhou Manufacturing</p><p>Industry, Third Prize in National Commercial Technology Advancement Award, Top Ten Make-up</p><p>Brands of Zhejiang in 2021. At the IFSCC International Cosmetic Science Conference, the Company</p><p>presented a number of its scientific achievements.</p><p>(4) Strategic cooperation: During the Reporting Period, the Company deepened the strategic cooperation</p><p>with existing partners, and performed strategic cooperation with Zhejiang Peptites Biotech Co., Ltd.</p><p>(1) Procurement and planning:</p><p>During the Reporting Period, the Company"s supply chain system integrated the data and information from</p><p>various information platforms and timely calculated the demand for raw materials based on the demand</p><p>at the terminal while synchronizing inventory of suppliers, procurement cycle, and logistic information.</p><p>In the end, these information is accurately and agilely transmitted to all departments through the supply</p><p>chain information platform to reach a balance between terminal sales and productivity and provide a back-</p><p>end support for promotions on 6.18 and 11.11.</p><p>The Company has organized multiple training sessions for suppliers in terms of sustainable development,</p><p>actively adopts sustainable packaging, and achieves remarkable effect in reducing plastics, using</p><p>environmentally-friendly materials, and minimizing packaging.</p><p>(2) Production:</p><p>Based on market sales and needs, the Company makes productivity arrangement in advance, adheres to</p><p>lean manufacturing, and keeps improving production efficiency by using automated, intelligent, and</p><p>digital technologies. During the Reporting Period, the Company expanded some workshops, added</p><p>multiple production lines, and enhanced productivity to meet the demands during the 6.18 and 11.11</p><p>shopping festivals. In addition, the Company further strengthened the full-process quality management</p><p>and risk management, regularly held communication meetings of quality experiences for consumers,</p><p>received market feedback as soon as possible, and implemented project-specific management and closed-</p><p>loop tracking.</p><p>During the Reporting Period, the Company completed the "Massive Safety Training For A Million</p><p>Employees" program, allowing all employees to master and grasp laws and regulations related to safe</p><p>                                           Annual Report 2022</p><p>production, enhance their awareness safe production hazards, and improve the safety emergency response</p><p>capability. The Huzhou Factory installed the independent fire control and management platform of the</p><p>provincial fire and rescue corps to systematically manage the fire control work. The Company upgraded</p><p>and renovated the fire-fighting system to control the whole process of smoke exhaust.</p><p>(3) Logistics:</p><p>During the Reporting Period, the Company continued to improve the logistics management system and</p><p>initiated the installation of the automated three-dimensional warehouse equipment. The Company was</p><p>rated as the winner of the "China Logistics Industry Golden Ant Award 2021 and 2022" by the organizing</p><p>committee of the LET-a CeMAT ASIA</p><p>(I) Analysis of main business</p><p>                                                                         Unit: Yuan   Currency: RMB</p><p>                                                                Amount for the</p><p>                                        Amount for the</p><p>             Account                                            same period last    Change ratio (%)</p><p>                                        current period</p><p>                                                                      year</p><p> Operating revenue                        6,385,451,424.00       4,633,150,538.43               37.82</p><p> Operating cost                           1,934,850,203.65       1,554,155,646.61               24.50</p><p> Selling expenses                         2,785,837,352.95       1,991,534,076.73               39.88</p><p> General and administrative</p><p> expenses</p><p> Financial expenses                         -40,996,523.01           -7,484,395.13                447.76</p><p> Research and development</p><p> expenses</p><p> Net cash flow from operating</p><p> activities</p><p> Net cash flow from investing</p><p>                                           -298,215,550.57        -341,823,618.60        Not applicable</p><p> activities</p><p> Net cash flow from financing</p><p>                                            -65,251,320.73         489,615,295.96                -113.33</p><p> activities</p><p>Cause for change in operating revenue: mainly due to increased online sales.</p><p>Cause for change in operating cost: mainly due to increased operating costs resulting from the increase of</p><p>operating revenue.</p><p>Cause for change in sales expenses: In 2022, sales expenses amounted to RMB2.786 billion, accounting</p><p>for 43.63% of the operating revenue (compared with 42.98% for the same period last year). Selling</p><p>expenses increased by RMB794 million or 39.88% YOY, mainly due to an increase of RMB746 million</p><p>or 44.60% YOY in the image promotion expenses in the current period (used for the incubation of new</p><p>brands such as TIMAGE, OR, and brand re-shaping).</p><p>Cause for change in general and administrative expenses: In 2022, administrative expenses amounted to</p><p>RMB327 million, accounting for 5.13% of the operating revenue (compared with 5.12% for the same</p><p>period last year). General and administrative expenses increased by RMB90.31 million or 38.11% YOY,</p><p>mainly due to increased equity incentive expense for restricted shares, employee compensation, and</p><p>service fees.</p><p>Cause for change in financial expenses: The general impact of interest income and foreign exchange gains</p><p>and losses reduced financial expenses by RMB33.51 million.</p><p>                                                Annual Report 2022</p><p>    Cause for change in R&D expenses: In 2022, R&D expenses amounted to RMB128.01 million, an increase</p><p>    of RMB51.43 million YOY, accounting for 2.00% of the operating revenue (compared with 1.65% for the</p><p>    same period last year). In 2022, the parent company"s R&D expense ratio was 4.31% (compared with 3.55%</p><p>    for the same period last year).</p><p>    Cause for change in net cash flow from operating activities: 1. mainly due to the YOY increase in the</p><p>    operating revenue and the increase in cash received from commodity sales; 2. increased payment for goods;</p><p>    Cause for change in net cash flow from investment activities: a YOY increase of RMB44million, mainly</p><p>    due to decreased cash flow from investment activities caused by the disposal of the 52% equity of</p><p>    Shanghai Healthlong Biochemical Technology Co., Ltd in the previous period. The event is not recognized</p><p>    in the current period.</p><p>    Causes for change in net cash flow from financing activities: a YOY decrease of RMB555 million, mainly</p><p>    due to that (1) the cash received from absorbing investment (equity incentive expense for restricted shares)</p><p>    is increased by RMB165 million; (2) the cash received from reclaiming borrowings is decreased by</p><p>    RMB647 million (RMB747million of fund raised in the previous period by issuing the "Proya Convertible</p><p>    Bond"); (3) the cash paid related to financing activities is increased by RMB43 million; (4) the cash paid</p><p>    to distribute dividends, profits, or repay interest is increased by RMB28 million.</p><p>    A detailed description of major changes in the Company"s activities, profit composition or sources of profit</p><p>    during the current period</p><p>    □ Applicable √ Not applicable</p><p>    √ Applicable □ Not applicable</p><p>    For details, see the analysis in "1. Analysis of changes in accounts in the Income Statement and the Cash</p><p>    Flow Statement", "(I) Analysis of main business", "V. Main Operations during the Reporting Period",</p><p>    "Section III Management Discussion and Analysis" of this report.</p><p>    (1).      Main business activities by industry, product, region and sales model</p><p>                                                                               Unit: Yuan      Currency: RMB</p><p>                                        Main business activities by industry</p><p>                                                              Gross      Change in     Change in       Change in</p><p>                                                              profit     operating     operating      gross profit</p><p>   Industry        Operating revenue    Operating cost</p><p>                                                             margin       revenue      cost YOY       margin YOY</p><p>                                                               (%)       YOY (%)          (%)             (%)</p><p>Household                                                                                              Up by 3.32</p><p>chemicals           6,361,763,550.69   1,916,352,535.29          69.88         37.69        24.03      percentage</p><p>industry                                                                                                 points</p><p>                                        Main business activities by product</p><p>                                                             Gross      Change in      Change in       Change in</p><p>                                                             profit      operating     operating      gross profit</p><p>   Product         Operating revenue    Operating cost</p><p>                                                            margin        revenue      cost YOY       margin YOY</p><p>                                                              (%)        YOY (%)          (%)             (%)</p><p>Skincare            5,483,643,868.53   1,616,998,071.19         70.51         38.56         29.68      Up by 2.02</p><p>                                             Annual Report 2022</p><p>(including                                                                                    percentage</p><p>cleansing)                                                                                      points</p><p>                                                                                              Up by 9.16</p><p>Make-up</p><p>cosmetics</p><p>                                                                                                points</p><p>                                                                                              Up by 11.73</p><p>Body & hair       125,659,396.08      47,687,457.85          62.05       509.93      365.92   percentage</p><p>                                                                                                points</p><p>Others                      0.00                0.00              -     -100.00     -100.00</p><p>                                                                                               Up by 3.32</p><p>Total           6,361,763,550.69    1,916,352,535.29         69.88        37.69       24.03    percentage</p><p>                                                                                                 points</p><p>                                     Main business activities by region</p><p>                                                         Gross       Change in    Change in    Change in</p><p>                                                          profit      operating   operating    gross profit</p><p>   Region       Operating revenue    Operating cost</p><p>                                                        margin         revenue    cost YOY    margin YOY</p><p>                                                           (%)        YOY (%)        (%)           (%)</p><p>                                                                                               Up by 0.03</p><p>Northeast</p><p>China</p><p>                                                                                                 points</p><p>                                                                                               Up by 6.61</p><p>North China        69,783,559.44      26,385,241.51          62.19         9.94       -6.42    percentage</p><p>                                                                                                 points</p><p>                                                                                               Up by 8.26</p><p>East China        712,780,874.13     298,564,036.15          58.11         4.34      -12.84    percentage</p><p>                                                                                                 points</p><p>                                                                                               Up by 2.51</p><p>South China        44,924,050.01      18,046,419.43          59.83       -41.91      -45.33    percentage</p><p>                                                                                                 points</p><p>                                                                                              Decreased by</p><p>Central China     149,971,246.18      61,852,910.54          58.76       -15.39      -11.34</p><p>                                                                                               percentage</p><p>                                                                                                 points</p><p>                                                                                               Up by 0.22</p><p>Northwest</p><p>China</p><p>                                                                                                 points</p><p>                                                                                               Up by 1.09</p><p>Southwest</p><p>China</p><p>                                                                                                 points</p><p>                                                                                              Up by 46.97</p><p>Hong Kong</p><p>and overseas</p><p>                                                                                                 points</p><p>                                                                                               Up by 0.90</p><p>Others (e-</p><p>commerce)</p><p>                                                                                                 points</p><p>                                                    Annual Report 2022</p><p>                                                                                                            Up by 3.32</p><p>Total                 6,361,763,550.69     1,916,352,535.29          69.88         37.69         24.03      percentage</p><p>                                                                                                              points</p><p>                                       Main business activities by sales model</p><p>                                                              Gross       Change in         Change in       Change in</p><p>                                                               profit     operating         operating      gross profit</p><p> Sales model         Operating revenue  Operating cost</p><p>                                                              margin       revenue          cost YOY       margin YOY</p><p>                                                                (%)       YOY (%)              (%)             (%)</p><p>                                                                                                            Up by 2.63</p><p>Online                5,788,034,421.87     1,684,190,321.43          70.90         47.50         35.26      percentage</p><p>                                                                                                              points</p><p>                                                                                                            Up by 2.60</p><p>Offline                573,729,128.82        232,162,213.86          59.53        -17.62        -22.60      percentage</p><p>                                                                                                              points</p><p>                                                                                                            Up by 3.32</p><p>Total                 6,361,763,550.69     1,916,352,535.29          69.88         37.69         24.03      percentage</p><p>                                                                                                              points</p><p>        Description of main business activities by industry, product, region and sales model</p><p>        (1) Description of growth in household chemicals: The growth in prime operating revenue this year was</p><p>        mainly due to RMB5.788 billion online sales (accounting for 90.98% of the prime operating revenue), an</p><p>        increase of RMB1.864 billion or 47.50% YOY.</p><p>        (2) Description of growth in make-up cosmetics: mainly due to RMB572 million sales of TIMAGE that</p><p>        falls under the make-up cosmetics category during the Reporting Period, an increase of RMB326million</p><p>        or 132.04% YOY.</p><p>        (3) Description of growth in body and hair: mainly due to RMB126 million sales of OR that falls under</p><p>        the Body & hair category during the Reporting Period, an increase of RMB105 million or 509.93% YOY.</p><p>        (4) Description of growth in others: No income of other categories is reported this year, mainly due to that</p><p>        the Company no longer operated the cross-border brand agency business.</p><p>        (5) Description by region: The sales of other regions declined, except e-commerce, Hong Kong and</p><p>        overseas, East China, and North China, mainly due to a YOY fall in offline sales.</p><p>        (2).   Analysis table of production and sales</p><p>        √ Applicable □ Not applicable</p><p>                                                                             Change in      Change       Change in</p><p>           Major</p><p>                       Unit     Production        Sales        Inventory     production     in sales     inventory</p><p>          products</p><p>                                                                             YOY (%)       YOY (%)       YOY (%)</p><p>         Household</p><p>                       Piece   314,064,556    276,025,390     90,180,032       42.44        27.66          72.95</p><p>         chemicals</p><p>        Description of production and sales</p><p>        The quantities in the above table include self-produced and OEM products, excluding the quantity of</p><p>        products produced through cross-border brand agency.</p><p>        (3).   Performance of major purchase contracts and major sales contracts</p><p>        □ Applicable √ Not applicable</p><p>                                                Annual Report 2022</p><p>   (4).     Cost statement analysis</p><p>                                                                                                    Unit: RMB</p><p>                                           Statement by industry</p><p>                                                                                    Proportio</p><p>                                                  Proportion                          n% in</p><p>                                                   % in total   Amount for the      total cost     YOY       Descri</p><p>                   Cost        Amount for the</p><p> Industry                                           cost for     same period         for the      change     ption</p><p>                composition    current period</p><p>                                                  the current      last year         current     ratio (%)</p><p>                                                  period (%)                          period</p><p>                                                                                       (%)</p><p>               Raw materials                           66.20                            63.18       29.97</p><p>               Labor and</p><p>               manufacturing   107,432,847.50            5.61    81,119,950.03           5.25       32.44</p><p>Household      cost</p><p>chemicals                                                     316,528,909.0</p><p>               Outsourcing     302,956,467.34          15.81                            20.49       -4.29</p><p> industry                                                                 8</p><p>               Freight         237,269,640.00       12.38                               11.09       38.49</p><p>               Subtotal                            100.00                             100.00        24.03</p><p>                                            Statement by product</p><p>                                                                                    Proportio</p><p>                                                  Proportion                        n in total</p><p>                                                    in total    Amount for the       cost for      YOY       Descri</p><p>                   Cost        Amount for the</p><p> Product                                            cost for     same period        the same      change     ption</p><p>                composition    current period</p><p>                                                  the current      last year          period     ratio (%)</p><p>                                                  period (%)                        last year</p><p>                                                                                       (%)</p><p>               Raw materials                           75.97                            73.31       34.39</p><p>               Labor and</p><p>               manufacturing   101,753,659.87            6.29    74,591,026.00           5.98       36.42</p><p>Skincare       cost</p><p>(including                                                       113,127,555.8</p><p>               Outsourcing      92,297,157.26            5.71                            9.07      -18.41</p><p>cleansing)                                                                   1</p><p>               Freight         194,513,686.83          12.03                            11.64       34.08</p><p>               Subtotal                               100.00                          100.00        29.68</p><p>               Raw materials   40,084,933.46           15.93     62,041,264.64          23.55      -35.39</p><p>Make-up</p><p>               Labor and</p><p>cosmetics                        5,679,187.63            2.26        6,528,924.03        2.48      -13.01</p><p>               manufacturing</p><p>                                               Annual Report 2022</p><p>            cost</p><p>            Outsourcing     174,194,228.29            69.21                         64.91        1.88</p><p>            Freight          31,708,656.87            12.60        23,869,561.68     9.06      32.84</p><p>            Subtotal        251,667,006.25           100.00                        100.00       -4.46</p><p>            Raw materials        175,079.76             0.37                   -        -           -</p><p>            Labor and</p><p>            manufacturing                  -            0.00                   -        -           -</p><p>Body &</p><p>            cost</p><p> hair</p><p>            Outsourcing      36,465,081.79            76.46         8,307,839.73    81.17     338.92</p><p>            Freight          11,047,296.30            23.17         1,927,244.65    18.83     473.22</p><p>            Subtotal         47,687,457.85           100.00        10,235,084.38   100.00     365.92</p><p>            Raw materials                -                -                    -        -          -</p><p>            Labor and</p><p>            manufacturing                  -                   -               -        -           -</p><p>Others      cost</p><p>            Outsourcing                    -                   -   24,114,635.62    98.16     -100.00</p><p>            Freight                        -                   -      452,529.45     1.84     -100.00</p><p>            Subtotal                       -                   -   24,567,165.07   100.00     -100.00</p><p> Other explanations</p><p> None</p><p> (5).    Changes in consolidation due to changes in the equity of major subsidiaries during the</p><p>         Reporting Period</p><p> √ Applicable □ Not applicable</p><p> For details, see "VIII. Changes in the Consolidation Scope", "Section X Financial Report".</p><p> (6).    Significant changes or adjustments to the Company"s business activities, products or services</p><p>         during the Reporting Period</p><p> □ Applicable √ Not applicable</p><p> (7).    Major sales customers and major suppliers</p><p> A. The Company"s major customers</p><p> √ Applicable □ Not applicable</p><p> The sales of top five customers amounted to RMB798.31million, accounting for 12.55% of the total annual</p><p> sales; the sales of related parties of such top five customers amounted to RMB0, accounting for 0.00% of</p><p> the total annual sales.</p><p> Circumstances where a single customer contributed to more than 50% of the total sales, top 5 customers</p><p> included a new customer, or the Company relied heavily on a small number of customers during the</p><p> Reporting Period</p><p> □ Applicable √ Not applicable</p><p>                                           Annual Report 2022</p><p>B. The Company"s major suppliers</p><p>√ Applicable □ Not applicable</p><p>The purchase amount of top 5 suppliers amounted to RMB393.25million, accounting for 20.57% of the</p><p>total annual purchase amount; the purchase amount of related parties of such top 5 suppliers amounted to</p><p>RMB0, accounting for 0.00% of the total annual purchase amount.</p><p>Circumstances where a single supplier accounted for more than 50% of the total procurement, top 5</p><p>suppliers included a new supplier, and the Company relied heavily on a small number of suppliers during</p><p>the Reporting Period</p><p>□ Applicable √ Not applicable</p><p>Other explanations</p><p>None</p><p>√ Applicable □ Not applicable</p><p>                                                                                            Unit: RMB</p><p>                                                                   Change for the</p><p>     Expense item          2022                   2021                                Growth rate (%)</p><p>                                                                   current period</p><p>         Selling</p><p>        expenses</p><p>      General and</p><p>     administrative      327,296,749.37        236,988,519.23        90,308,230.14               38.11</p><p>        expenses</p><p>     Research and</p><p>      development        128,009,104.49         76,583,650.83        51,425,453.66               67.15</p><p>        expenses</p><p>       Financial</p><p>                          -40,996,523.01         -7,484,395.13      -33,512,127.88      Not applicable</p><p>        expenses</p><p>(1). Statement of R&D investment</p><p>√ Applicable □ Not applicable</p><p>                                                                                            Unit: RMB</p><p> Expensed R&D investment for the                                                       128,009,104.49</p><p> current period</p><p> Capitalized R&D investment for the                                                               0.00</p><p> current period</p><p> Total R&D investment                                                                  128,009,104.49</p><p> Total R&D investment in operating                                                               2.00</p><p> revenue (%)</p><p> Capitalization of R&D investment (%)                                                             0.00</p><p>(2). Statement of R&D personnel</p><p>√ Applicable □ Not applicable</p><p>                                           Annual Report 2022</p><p>Number of R&D personnel                                                                             229</p><p>Percentage of R&D personnel (%)                                                                    7.21</p><p>                                    Educational background structure</p><p>Educational level                                                           Number of persons</p><p>PhD                                                                                                   4</p><p>Master                                                                                               69</p><p>Bachelor                                                                                            123</p><p>Associate                                                                                            31</p><p>High school and below                                                                                 2</p><p>                                             Age structure</p><p>Age range                                                                   Number of persons</p><p>Under 30 (exclusive)                                                                                100</p><p>(3). Description</p><p>□ Applicable √ Not applicable</p><p>(4). Cause for significant changes in the composition of R&D personnel and the impact on the future</p><p>     development of the Company</p><p>□ Applicable √ Not applicable</p><p>√ Applicable □ Not applicable</p><p>                                                                                             Unit: RMB</p><p>                                       Amount for the</p><p>                   Amount for the                          Growth rate</p><p>      Item                              same period                               Description</p><p>                   current period                             (%)</p><p>                                          last year</p><p>                                                                         Mainly due to:</p><p>                                                                         operating revenue and the</p><p> Net cash flow</p><p>                                                                         increase in cash received from</p><p> from</p><p> operating</p><p> activities</p><p>                                                                         goods;</p><p>                                                                         image promotion fees.</p><p> Net cash flow                                                           Mainly due to the disposal of</p><p> from                                               -         Not        the 52% equity of Shanghai</p><p>                   -298,215,550.57</p><p> investing                             341,823,618.60      applicable    Healthlong        Biochemical</p><p> activities                                                              Technology Co., Ltd. in the</p><p>                                         Annual Report 2022</p><p>                                                                        previous period. The event is</p><p>                                                                        not recognized in the current</p><p>                                                                        period.</p><p>                                                                        Mainly due to:</p><p>                                                                        absorbing investment (equity</p><p>                                                                        incentive      expense      for</p><p>                                                                        restricted shares) is increased</p><p>                                                                        by RMB165 million;</p><p>                                                                        reclaiming borrowings is</p><p>Net cash flow                                                           decreased by RMB647million</p><p>from                                                                    (RMB747million of fund</p><p>                    -65,251,320.73   489,615,295.96           -113.33</p><p>financing                                                               raised for the previous period</p><p>activities                                                              by issuing the "Proya</p><p>                                                                        Convertible Bond");</p><p>                                                                        financing      activities     is</p><p>                                                                        increased by RMB43 million;</p><p>                                                                        dividends, profits, or repay</p><p>                                                                        interest is increased by</p><p>                                                                        RMB28 million.</p><p>Cash received</p><p>from the sale</p><p>of goods and      7,088,465,997.21                             38.17</p><p>the rendering</p><p>of services</p><p>Other      cash</p><p>                                                                        Mainly due to the increased</p><p>received</p><p>                                                                        bank interest and government</p><p>related      to     99,500,140.40     54,614,521.56            82.19</p><p>                                                                        subsidies received in the</p><p>operating</p><p>                                                                        current period.</p><p>activities</p><p>Cash paid for</p><p>                                                                        Mainly due to the expanded</p><p>goods</p><p>purchased         2,241,842,834.78                             38.69</p><p>and services</p><p>                                                                        production.</p><p>received</p><p>Payments of                                                             Mainly due to the expanded</p><p>various types      660,096,624.31    432,668,333.55            52.56    sales scale and the improved</p><p>of taxes                                                                profitability of the Company.</p><p>Other      cash                                                         Mainly due to the expanded</p><p>paid related to                      1,864,985,801.                     sales scale and the increased</p><p>operating                                       02                      payment for image promotion</p><p>activities                                                              expenses.</p><p>                                               Annual Report 2022</p><p> Net       cash</p><p> received from</p><p> disposal of                                                                   Mainly due to the increased</p><p> fixed assets,                                                                 cash receipts from disposals</p><p> intangible                                                                    of fixed assets in the current</p><p> assets     and                                                                period</p><p> other long-</p><p> term assets</p><p>                                                                               Mainly due to the new equity</p><p>                                                                               investment of RMB90 million</p><p> Cash paid for</p><p> investments</p><p>                                                                               Holdings Co., Ltd. in the</p><p>                                                                               current period.</p><p>                                                                               Mainly due to the disposal of</p><p>                                                                               equity in Shanghai Healthlong</p><p>                                                                               Biochemical Technology Co.,</p><p> Other      cash</p><p>                                                                               Ltd. and payment of other</p><p> paid related to</p><p> investing</p><p>                                                                               investment activities in the</p><p> activities</p><p>                                                                               previous period. The event is</p><p>                                                                               not recognized for the current</p><p>                                                                               period.</p><p>                                                                               Mainly due to the receipt of</p><p>                                                                               payment for the equity</p><p> Cash received</p><p>                                                                               incentive     expense      for</p><p> from capital        165,676,000.00           700,000.00        23,568.00</p><p>                                                                               restricted    shares     from</p><p> contributions</p><p>                                                                               employees in the current</p><p>                                                                               period.</p><p>                                                                               Mainly due to the issuance of</p><p>                                                                               “Proya Convertible Bond” in</p><p> Cash received</p><p>                                                                               the previous period for</p><p> from                300,000,000.00        946,996,018.87             -68.32</p><p>                                                                               RMB747 million. This event</p><p> borrowings</p><p>                                                                               is not recognized in the</p><p>                                                                               current period.</p><p>                                                                               Mainly due to the payment for</p><p> Other      cash</p><p>                                                                               acquisition of minority equity</p><p> paid related to</p><p> financing</p><p>                                                                               Cosmetics Co., Ltd. in the</p><p> activities</p><p>                                                                               current period.</p><p>(II) Description on significant changes in profit caused by non-primary business activities</p><p>□ Applicable √ Not applicable</p><p>(III) Analysis of assets and liabilities</p><p>√ Applicable □ Not applicable</p><p>                                          Annual Report 2022</p><p>                                                                                              Unit: RMB</p><p>                  Amount as</p><p>                                           Amount as</p><p>                  of the end   in total                    in total      YOY</p><p>                                          of the end of</p><p>      Item          of the      assets                      assets      change         Description</p><p>                                          the previous</p><p>                   current     (%)                         (%)         ratio (%)</p><p>                                              period</p><p>                    period</p><p>                                                                                   Mainly       due     to</p><p>                                                                                   increased         cash</p><p> Cash and cash    3,161,003,              2,391,048,24</p><p> equivalents         085.05                       9.81</p><p>                                                                                   operating activities</p><p>                                                                                   in the current period.</p><p>                                                                                   Mainly due to the</p><p>                                                                                   reduced balance of</p><p> Receivable</p><p> financing</p><p>                                                                                   bills as of the end of</p><p>                                                                                   the current period.</p><p>                                                                                   Mainly due to the</p><p>                                                                                   increased</p><p>                                                                                   prepayment          for</p><p> Prepayments                      1.58                          1.26       56.63   image      promotion</p><p>                         .15                         1</p><p>                                                                                   expenses as of the</p><p>                                                                                   end of the current</p><p>                                                                                   period.</p><p>                                                                                   Mainly due to the</p><p>                                                                                   increased        stock</p><p>                                                                                   quantity for 1Q2023</p><p> Inventories                     11.58                          9.67       49.36   arising from the</p><p>                                                                                   expanded         sales</p><p>                                                                                   scope       of     the</p><p>                                                                                   Company.</p><p>                                                                                   Mainly due to the</p><p>                                                                                   new             equity</p><p> Other equity                                                                      investment           of</p><p> instrument                       2.53                          1.22     159.57    RMB90 million to</p><p> investments                                                                       Hangzhou Gaolang</p><p>                                                                                   Holdings Co., Ltd.</p><p>                                                                                   in the current period.</p><p>                                                                                   Mainly due to the</p><p>                                                                                   additional</p><p>                                                                                   investment in the</p><p> Construction     207,378,93              108,678,896.</p><p> in progress            5.86                       27</p><p>                                                                                   Production       Base</p><p>                                                                                   Construction Project</p><p>                                                                                   (Phase I) and the</p><p>                                         Annual Report 2022</p><p>                 Amount as</p><p>                                          Amount as</p><p>                 of the end   in total                    in total     YOY</p><p>                                         of the end of</p><p>     Item          of the      assets                      assets     change          Description</p><p>                                         the previous</p><p>                  current     (%)                         (%)        ratio (%)</p><p>                                             period</p><p>                   period</p><p>                                                                                  Longwu          R&D</p><p>                                                                                  Center Construction</p><p>                                                                                  Project.</p><p>                                                                                  Mainly due to the</p><p>                                                                                  addition of an office</p><p>Right-of-use     6,410,634.                                                Not</p><p>assets                  25                                           applicable</p><p>                                                                                  of lease contracts in</p><p>                                                                                  the current period.</p><p>Long-term                                                                         Mainly due to the</p><p>prepaid                          0.33                         0.64      -35.67    amortization        of</p><p>                        .46                         1</p><p>expenses                                                                          renovation costs.</p><p>                                                                                  Mainly due to that</p><p>                                                                                  the        trademark</p><p>                                                                                  amount              of</p><p>                                                                                  RMB39.90 million</p><p>                                                                                  (SINGULADERM)</p><p>                                                                                  in the beginning</p><p>Other non-       5,554,726.              44,167,303.5</p><p>current assets          06                          6</p><p>                                                                                  transferred         to</p><p>                                                                                  intangible      assets</p><p>                                                                                  since the trademark</p><p>                                                                                  transfer registration</p><p>                                                                                  is completed in the</p><p>                                                                                  current period.</p><p>                                                                                  Mainly due to the</p><p>                                                                                  increase of the</p><p>Contract         174,602,83              91,151,985.3</p><p>liabilities            3.91                         2</p><p>                                                                                  and      the     point</p><p>                                                                                  conversion rate.</p><p>                                                                                  Mainly due to the</p><p>                                                                                  increased benefits</p><p>                                                                                  payable             to</p><p>                                                                                  employees at the</p><p>Employee</p><p>compensation                     2.16                         1.70       58.86</p><p>payable</p><p>                                                                                  expanded operation</p><p>                                                                                  scale and continuous</p><p>                                                                                  staffing adjustment</p><p>                                                                                  in the current period.</p><p>Taxes            152,918,87      2.65    99,893,176.9         2.16       53.08    Mainly due to the</p><p>                                           Annual Report 2022</p><p>                  Amount as</p><p>                                            Amount as</p><p>                  of the end    in total                    in total     YOY</p><p>                                           of the end of</p><p>     Item           of the       assets                      assets     change          Description</p><p>                                           the previous</p><p>                   current      (%)                         (%)        ratio (%)</p><p>                                               period</p><p>                    period</p><p>payable                  1.45                          7                            expanded sales scale</p><p>                                                                                    and the improved</p><p>                                                                                    profitability of the</p><p>                                                                                    Company.</p><p>                                                                                    Mainly       due     to</p><p>                                                                                    increased restricted</p><p>Other             216,392,18               62,162,153.5</p><p>payables                3.41                          5</p><p>                                                                                    obligations at the</p><p>                                                                                    end of the period.</p><p>Non-current                                                                         Mainly due to the</p><p>liabilities due   2,549,452.                                                 Not    transfer of lease</p><p>within      one          14                                            applicable   liabilities due within</p><p>year                                                                                one year.</p><p>                                                                                    Mainly due to the</p><p>                                                                                    addition of an office</p><p>Lease             3,718,119.                                                 Not</p><p>liabilities              41                                            applicable</p><p>                                                                                    of lease contracts in</p><p>                                                                                    the current period.</p><p>                                                                                    Mainly due to the</p><p>                                                                                    adjustment           of</p><p>                                                                                    offline channels, the</p><p>                                                                                    intensified</p><p>                                                                                    adjustment of the</p><p>                                                                                    department        store</p><p>Estimated         59,282,928               10,812,084.8</p><p>liabilities              .68                          8</p><p>                                                                                    optimization         of</p><p>                                                                                    household</p><p>                                                                                    chemicals outlets,</p><p>                                                                                    and the shrinking of</p><p>                                                                                    the       supermarket</p><p>                                                                                    channel.</p><p>                                                                                    Mainly due to the</p><p>                                                                                    increased deferred</p><p>Deferred                                                                            income              tax</p><p>income tax                         0.33    8,408,158.81         0.18      126.20    liabilities accrued</p><p>                         .67</p><p>liabilities                                                                         for           one-time</p><p>                                                                                    depreciation of fixed</p><p>                                                                                    assets.</p><p>Share capital                      4.91                         4.34       41.05</p><p>                                       Annual Report 2022</p><p>               Amount as</p><p>                                        Amount as</p><p>               of the end   in total                    in total      YOY</p><p>                                       of the end of</p><p>    Item         of the      assets                      assets      change           Description</p><p>                                       the previous</p><p>                current     (%)                         (%)         ratio (%)</p><p>                                           period</p><p>                 period</p><p>                                                                                 implemented          the</p><p>                                                                                 plan        for       the</p><p>                                                                                 capitalization         of</p><p>                                                                                 capital reserves and</p><p>                                                                                 the 2022 restricted</p><p>                                                                                 share incentive plan.</p><p>                                                                                 Mainly due to that</p><p>                                                                                 the          Company</p><p>                                                                                 implemented          the</p><p>                                                                                 incentive          plan,</p><p>Treasury       164,976,00</p><p>stock                0.00</p><p>                                                                                 liabilities           for</p><p>                                                                                 repurchase</p><p>                                                                                 obligations          and</p><p>                                                                                 included them in the</p><p>                                                                                 treasury stock.</p><p>                                                                                 Mainly due to the</p><p>                                                                                 changes                in</p><p>Other                   -                                                        translation</p><p>                                                  -                       Not</p><p>comprehensiv   1,918,603.     -0.03                         -0.03                difference             of</p><p>e income              07                                                         financial statements</p><p>                                                                                 denominated            in</p><p>                                                                                 foreign currencies.</p><p>                                                                                 Mainly due to the</p><p>                                                                                 withdrawal             of</p><p>                                                                                 statutory        surplus</p><p>                                                                                 reserve according to</p><p>                                                                                 the net profit of the</p><p>                                                                                 parent       company.</p><p>Surplus        141,759,73              100,634,780.                              The            statutory</p><p>reserve              4.50                       00                               surplus reserve does</p><p>                                                                                 not need to be</p><p>                                                                                 withdrawn if the</p><p>                                                                                 cumulative amount</p><p>                                                                                 reaches fifty percent</p><p>                                                                                 or more of the</p><p>                                                                                 registered capital.</p><p>Retained       2,300,384,              1,696,978,06                              Mainly        due      to</p><p>profits           763.19                       4.52                              increased net profit</p><p>                                           Annual Report 2022</p><p>                 Amount as</p><p>                                            Amount as</p><p>                 of the end     in total                    in total     YOY</p><p>                                           of the end of</p><p>     Item          of the        assets                      assets     change         Description</p><p>                                           the previous</p><p>                  current       (%)                         (%)        ratio (%)</p><p>                                               period</p><p>                   period</p><p>                                                                                   in the current period.</p><p>Other explanations</p><p>None</p><p>√ Applicable □ Not applicable</p><p>(1) Scale of assets</p><p>Including RMB216.10million of overseas assets, accounting for 3.74% of the total assets.</p><p>(2) Description of a high percentage of overseas assets</p><p>□ Applicable √ Not applicable</p><p>√ Applicable □ Not applicable</p><p>                                                                                              Unit: RMB</p><p>     Item              Ending book value                         Cause for restrictions</p><p> Cash and cash                                    Including transformer deposit, Pinduoduo deposit,</p><p> equivalents                                      L/C deposit, Tmall deposit, and Alipay deposit, etc.</p><p>     Total                      35,670,000.00</p><p>□ Applicable √ Not applicable</p><p>(IV) Analysis of industry operational information</p><p>√ Applicable □ Not applicable</p><p>Refer to the "Analysis of chemical operational information" below</p><p>                                           Annual Report 2022</p><p>Analysis of chemical operational information</p><p>(1).Industry policies and changes</p><p>□ Applicable √ Not applicable</p><p>(2).Major sub-industries and industrial status of the Company</p><p>√ Applicable □ Not applicable</p><p>See the description in "(I) Industry pattern and trends", "VI. Discussion and Analysis of the Company"s</p><p>Future Development", "Section III Management Discussion and Analysis".</p><p>Industrial status of the Company:</p><p>According to comprehensive industry data analysis, the Company has gained some market share in the</p><p>domestic cosmetics market.</p><p>(1). Major business models</p><p>√ Applicable □ Not applicable</p><p>See the description of business models in "III. Business Activities Carried out by the Company during the</p><p>Reporting Period", "Section III Management Discussion and Analysis".</p><p>Adjusted business models during the Reporting Period</p><p>□ Applicable √ Not applicable</p><p>(2). Major products</p><p>√ Applicable □ Not applicable</p><p>                                      Major upstream raw        Major downstream            Major price</p><p>    Products        Sub-industry</p><p>                                            materials           application areas       influencing factors</p><p>                                      Humectant, active</p><p>                                                                                        Personal   income,</p><p>Skincare                              substance, grease</p><p>                                                                                        skin type, lifestyle</p><p>(including       Skincare             wax,      emulsifier,     Skincare, cleansing</p><p>                                                                                        habits,       brand</p><p>cleansing)                            surfactant, essence,</p><p>                                                                                        preference</p><p>                                      packaging</p><p>                                      Grease          wax,                              Personal    income,</p><p>Make-up                                                         Make-up,      beauty,</p><p>                 Make-up              emulsifier,    toner,                             living habits, brand</p><p>cosmetics                                                       contour</p><p>                                      essence, packaging                                preference</p><p>                                                                                        Personal    income,</p><p>                                      Surfactant,</p><p>                                                                                        skin type, lifestyle</p><p>Body & hair      Body & hair          humectant, essence,       Body & hair</p><p>                                                                                        habits,        brand</p><p>                                      packaging</p><p>                                                                                        preference</p><p>(3). R&D innovation</p><p>√ Applicable □ Not applicable</p><p>See "5. New R&D strategy", "V. Main Operations during the Reporting Period", "Section III Management</p><p>Discussion and Analysis".</p><p>                                                        Annual Report 2022</p><p>(4). Production technologies and process</p><p>√ Applicable □ Not applicable</p><p>The Company"s products are mainly divided into skincare (including cleansing) and make-up cosmetics.</p><p>Their production processes are shown as follows:</p><p>       Skincare raw                                                                    Functional</p><p>        materials                                                                      components</p><p>                                                     Heat</p><p>        Heating to     Homogeneous               preservation               Cooling                 Filtration and</p><p>         dissolve      emulsification            and mixing                                           discharge</p><p>                                                                                                                     Inspection</p><p>                                                                                                                      of semi-</p><p>                                                                                                                      finished</p><p>                                                                                                                      products</p><p>       Warehousing       Cartoning                 Packing                  Filling                    Storage</p><p>                                     Inspection of</p><p>                                   finished products</p><p>         Cleansing</p><p>       raw materials</p><p>                                                     Heat</p><p>       Heating and                               preservation               Cooling                 Filtration and</p><p>         mixing                                  and mixing                                           discharge</p><p>                                                                                                                     Inspection</p><p>                                                                                                                      of semi-</p><p>                                                                                                                      finished</p><p>                                                                                                                      products</p><p>       Warehousing        Cartoning                    Packing               Filling                   Storage</p><p>                                     Inspection of</p><p>                                   finished products</p><p>    (1) Cosmetic powder blocks:</p><p>                                                        Annual Report 2022</p><p>       Powder raw                          Functional                                                   Inspection of</p><p>        materials                         components                                                    semi-finished</p><p>                                                                                                          products</p><p>         Mixing              Toning                       Crushing and                    Discharge                      Powder storage</p><p>                                                            sieving</p><p>       Warehousing        Cartoning                         Packing                           Forming                        Filling</p><p>                                                                                                                        Aluminum plate</p><p>                                          Inspection of                       Visual</p><p>                                            finished                        inspection</p><p>                                            products</p><p>    (2) Lipstick cosmetics</p><p>      Wax-based                                                   Functional</p><p>     raw materials                                               components</p><p>      Heating to                                        Toning                    Defoaming                 Filtration and</p><p>       dissolve                                                                                               discharge</p><p>                                                                                                                                          Inspection</p><p>                                                                                                                                           of semi-</p><p>                                                                                                                                           finished</p><p>                                                                                                                                           products</p><p>     Warehousing      Cartoning                        Packing                     Molding                     Storage</p><p>                                      Inspection of                   Visual</p><p>                                        finished                    inspection</p><p>                                        products</p><p>    (3) Eyelashes and eyeliners</p><p>         Basic raw                                                                             Functional</p><p>         materials                                                                             components</p><p>         Heating to    Homogeneous                      Toning                     Cooling                  Discharge</p><p>          dissolve     emulsification                                                                                                  Inspection</p><p>                                                                                                                                        of semi-</p><p>                                                                                                                                        finished</p><p>                                                                                                                                        products</p><p>        Warehousing      Cartoning                      Packing                     Filling                   Storage</p><p>                                       Inspection of</p><p>                                         finished</p><p>                                         products</p><p>(5). Production capacity and operation status</p><p>√ Applicable □ Not applicable</p><p>                                                                                                Unit: RMB ’0,000 Currency: RMB</p><p>                                              Annual Report 2022</p><p>                                                                                Amount of      Estimated time</p><p>                                           Capacity          Capacity         investment in     of completion</p><p>     Main plant or         Designed</p><p>                                          utilization         under              capacity         of capacity</p><p>       project             capacity</p><p>                                          ratio (%)        construction           under              under</p><p>                                                                               construction      construction</p><p>    Huzhou Skincare      300million             86.67    101.18                   16,801.64    December 2024</p><p>    Factory              pcs                             million pcs</p><p>    Huzhou               40 million pcs         25.06</p><p>    Cosmetics</p><p>    Factory</p><p>Change in production capacity</p><p>□ Applicable √ Not applicable</p><p>Adjustment of product line and optimization of capacity structure</p><p>□ Applicable √ Not applicable</p><p>Unexpected shutdown</p><p>□ Applicable √ Not applicable</p><p>(1). Basic information on major raw materials</p><p>√ Applicable □ Not applicable</p><p>                                                                YOY price</p><p>        Major raw                             Settlement                          Purchase</p><p>                           Purchase model                      change ratio                      Consumption</p><p>        materials                              method                             quantity</p><p>                                                                   (%)</p><p>                              Mainly by</p><p>                                                Settle</p><p>                             competitive</p><p>                                              within the                         About 1,560</p><p>    Packaging               procurement,                                                          About 1,510</p><p>                                              payment                -14.77          million</p><p>    materials              except for some                                                       million pieces</p><p>                                              period as                               pieces</p><p>                               strategic</p><p>                                               agreed</p><p>                               suppliers</p><p>                              Mainly by</p><p>                             competitive</p><p>                            procurement,</p><p>                                 while          Settle</p><p>                             establishing     within the</p><p>    Raw                                                                          About 2,052      About 1,953</p><p>                              long-term       payment                  5.31</p><p>    material_humectant                                                                  tons             tons</p><p>                               strategic      period as</p><p>                             cooperation       agreed</p><p>                                 with</p><p>                            advantageous</p><p>                               suppliers</p><p>    Raw                    Mainly by price      Settle                            About 754         About 720</p><p>    material_active          inquiry and      within the                               tons              tons</p><p>                                           Annual Report 2022</p><p> substance                comparison,       payment</p><p>                               while        period as</p><p>                           performing        agreed</p><p>                           diversified</p><p>                         cultivation of</p><p>                        suppliers with a</p><p>                        single source of</p><p>                              supply</p><p>                           Mainly by</p><p>                          competitive</p><p>                         procurement,</p><p>                               while          Settle</p><p> Raw                      establishing      within the</p><p>                                                                          About 850          About 810</p><p> material_grease            long-term       payment             24.62</p><p>                                                                                 tons              tons</p><p> wax                         strategic      period as</p><p>                          cooperation        agreed</p><p>                                with</p><p>                         advantageous</p><p>                             suppliers</p><p>                           Mainly by</p><p>                          competitive</p><p>                         procurement,</p><p>                                              Settle</p><p>                               while</p><p>                                            within the</p><p> Raw                      cooperating                                     About 160          About 150</p><p>                                            payment             31.46</p><p> material_emulsifier     with industry-                                          tons              tons</p><p>                                            period as</p><p>                              leading</p><p>                                             agreed</p><p>                          suppliers on</p><p>                            some raw</p><p>                            materials</p><p>                           Mainly by</p><p>                          competitive</p><p>                         procurement,</p><p>                               while          Settle</p><p>                          establishing      within the</p><p> Raw                                                                      About 102</p><p>                            long-term       payment              2.89                    About 92 tons</p><p> material_sunscreen                                                              tons</p><p>                             strategic      period as</p><p>                          cooperation        agreed</p><p>                                with</p><p>                         advantageous</p><p>                             suppliers</p><p>Impact of changes in the prices of major raw materials on the Company"s operating costs: Rising prices of</p><p>raw materials increase operating costs.</p><p>(2). Basic information on major sources of energy</p><p>√ Applicable □ Not applicable</p><p>                                          Annual Report 2022</p><p>                                                            YOY price</p><p>                       Purchase       Settlement                          Purchase</p><p>    Major energy                                           change ratio                Consumption</p><p>                        model          method                             quantity</p><p>                                                               (%)</p><p>                                      Prepayment and</p><p>                                      monthly</p><p>                  Fixed               settlement or</p><p>                  agreement with payment on</p><p>     Water                                                       0.00 201,279 tons      201,279 tons</p><p>                  the local water demand</p><p>                  company             according to the</p><p>                                      local</p><p>                                      requirements</p><p>                                      Prepayment and</p><p>                                      monthly</p><p>                  Fixed</p><p>                                      settlement or</p><p>                  agreement with</p><p>                                      payment on                         11.76 million 11.76 million</p><p>   Electricity    the local power                                0.00</p><p>                                      demand                                 kwh            kwh</p><p>                  supply</p><p>                                      according to the</p><p>                  company</p><p>                                      local</p><p>                                      requirements</p><p>                                      Prepayment and</p><p>                                      monthly</p><p>                  Fixed</p><p>                                      settlement or</p><p>                  agreement with</p><p>                                      payment on</p><p>       Gas        the local gas                                 38.67 368,936 cbm       368,936 cbm</p><p>                                      demand</p><p>                  supply</p><p>                                      according to the</p><p>                  company</p><p>                                      local</p><p>                                      requirements</p><p>Impact of changes in the prices of major energy on the Company"s operating costs: The price of gas is</p><p>increased by 38.67%, resulting in a slight increase in operating cost since the consumption of gas only</p><p>takes up a small part in the energy structure.</p><p>(3). Countermeasures for risks of fluctuations in the prices of raw materials</p><p>Major financial products such as derivatives</p><p>□ Applicable √ Not applicable</p><p>(4). Basic information on other methods adopted such as staged reserves</p><p>□ Applicable √ Not applicable</p><p>(1). Basic information on the Company"s primary business activities by sub-industry</p><p>√ Applicable □ Not applicable</p><p>                                                              Unit: RMB ’0,000 Currency: RMB</p><p>                                                                        Change      Gross profit</p><p>    Sub-      Operating Operating Gross Change in Change in</p><p>                                                                        in gross    margin for</p><p>  industry     revenue        cost  profit   operating   operating</p><p>                                                                         profit     products in</p><p>                                           Annual Report 2022</p><p>                                         margin     revenue      cost YOY     margin       the same</p><p>                                          (%)      YOY (%)          (%)      YOY (%)     industry and</p><p>                                                                                             field</p><p>    Skincare                                                                            No public</p><p>    (including                            70.51          38.56      29.68        2.02   information</p><p>    cleansing)                                                                          available</p><p>                                                                                        No public</p><p>    Make-up</p><p>    cosmetics</p><p>                                                                                        available</p><p>                                                                                        No public</p><p>    Body &</p><p>    hair</p><p>                                                                                        available</p><p>                                                                                        No public</p><p>    Others            0.00        0.00        -       -100.00      -100.00          -   information</p><p>                                                                                        available</p><p>(2). Basic information on the Company"s primary business activities by sales channel</p><p>√ Applicable □ Not applicable</p><p>                                                              Unit: RMB ’0,000 Currency: RMB</p><p>                                                                  Change in operating revenue</p><p>       Sales channel               Operating revenue</p><p>                                                                            YOY (%)</p><p> Online                                           578,803.44                               47.50</p><p> Offline                                           57,372.91                              -17.62</p><p>Statement of accounting policies</p><p>□ Applicable √ Not applicable</p><p>(1). Basic information on major work safety accidents of the Company during the Reporting Period</p><p>□ Applicable √ Not applicable</p><p>(2). Major environmental violations</p><p>□ Applicable √ Not applicable</p><p>                                                                           Annual Report 2022</p><p>(V) Analysis of investment</p><p>Overall analysis of external equity investments</p><p>√ Applicable □ Not applicable</p><p>                                                         Ending amount                                                   Beginning amount</p><p>     Item                                                   Impairment                                                      Impairment</p><p>                                  Carrying amount                                  Book value        Carrying amount                              Book value</p><p>                                                             provision                                                       provision</p><p> Other equity instrument</p><p> investments</p><p> Investment   in    joint</p><p> ventures</p><p> Investment in associates              216,906,642.52        81,442,213.22         135,464,429.30       181,555,246.18      14,670,468.59         166,884,777.59</p><p>     Total                             366,377,990.68        81,442,213.22         284,935,777.46       241,032,404.86      14,670,468.59         226,361,936.27</p><p>For details, see the description in "17. Long-term equity investments" and      "18. Other equity instrument investments ", "VII. Notes to the Items in Consolidated</p><p>Financial Statements", "Section X Financial Report" of this report.</p><p>□ Applicable √ Not applicable</p><p>□ Applicable √ Not applicable</p><p>√ Applicable □ Not applicable</p><p>                                                                                                                                     Unit: Yuan      Currency: RMB</p><p>                                       Profit and loss                         Impairment</p><p>                      Beginning                           Accumulated                            Amount of        Amount of</p><p> Asset category                        from changes                          accrued for the                                      Other changes     Ending amount</p><p>                       amount                             change in fair                        purchase for   sale/redemption</p><p>                                        in fair value                        current period</p><p>                                                                           Annual Report 2022</p><p>                                        for the current   value included                       the current     for the current</p><p>                                             period         in equities                          period             period</p><p> Other                56,402,400.00                                                          90,000,000.00                                      146,402,400.00</p><p>      Total           56,402,400.00                                                          90,000,000.00                                      146,402,400.00</p><p>For details, refer to the particulars contained in "18. Description of other equity instrument investments" in "VII. Notes to the Items of Consolidated Financial</p><p>Statements", of "Section X Financial Report" of this report</p><p>Description of securities investment</p><p>□ Applicable √ Not applicable</p><p>Description of private equity investment</p><p>□ Applicable √ Not applicable</p><p>Description of derivatives investment</p><p>□ Applicable √ Not applicable</p><p>                                            Annual Report 2022</p><p>□ Applicable √ Not applicable</p><p>(VI) Sale of major assets and equity</p><p>□ Applicable √ Not applicable</p><p>(VII) Analysis of major holding companies</p><p>√ Applicable □ Not applicable</p><p>                                                                                            Unit: RMB’0,000</p><p>                              Major</p><p>   Major       Nature of     products    Registered      Total                      Net         Holding or</p><p>                                                                    Net assets</p><p> subsidiary    business        and        capital        assets                    profit      shareholding</p><p>                             services</p><p>Zhejiang</p><p>Meiligu</p><p>              Cosmetics</p><p>Electronic                  Cosmetics      1,000.00    62,360.91    25,376.57     8,238.00       Holding</p><p>                sales</p><p>Commerce</p><p>Co., Ltd.</p><p>Hangzhou</p><p>Proya         Cosmetics                                                                  -</p><p>                            Cosmetics      5,000.00    27,637.31     5,554.91                    Holding</p><p>Trade Co.,      sales                                                             5,333.47</p><p>Ltd.</p><p>(VIII) Structured entities controlled by the Company</p><p>□ Applicable √ Not applicable</p><p>VI. Discussion and Analysis of the Company"s Future Development</p><p>(I) Industry pattern and trends</p><p>√ Applicable □ Not applicable</p><p>According to statistics from the National Bureau of Statistics, in 2022, the total retail sales of consumer</p><p>goods reached RMB43,973.3 billion, down by 0.2% YOY; the total retail sales of cosmetics reached</p><p>RMB393.6 billion, down by 4.5% YOY (covering consumer goods above designated units).</p><p>(II) Development strategy of the Company</p><p>√ Applicable □ Not applicable</p><p>Winning Now Winning Later, "6*N" strategy, enhanced core competence, and enriched brand matrix.</p><p>"6" represents new consumption, new marketing, new organization, new mechanism, new technology,</p><p>new intelligent manufacturing; "N" represents N brands created</p><p>(1) New consumption: Innovative services to meet more consumer needs and consumer value;</p><p>(2) New marketing: Digital marketing, fine omni-channel operation, and accurate and advanced consumer</p><p>insight. Focus on future marketing possibilities in new areas and make preparations;</p><p>(3) New organization: An efficient organization that is flat, platform-based, self-driven and collaborative;</p><p>(4) New mechanism: A flexible, diversified, business-oriented incentive mechanism to be established;</p><p>                                             Annual Report 2022</p><p>(5) New technology: The focus on basic scientific research and the actions taken to establish the presence</p><p>of new raw materials and new R&D technologies, develop more R&D partners and resources in different</p><p>fields to form a global R&D landscape, provide technological guarantee for targeted product enhancement,</p><p>and create a sustainable and unique R&D technological competitiveness; measures taken to further</p><p>improve the intelligent operation management system and carry out targeted transformation toward digital</p><p>intelligence and informatization to improve operational refinement and management efficiency in business</p><p>and organization and achieve process transparency and accurate decision-making;</p><p>(6) New intelligent manufacturing: Creation of an agile and flexible supply chain to serve the hero product</p><p>matrix and the application of the digital management system to improve production quality, strengthen the</p><p>supply chain supervision, and guarantee product quality.</p><p>- The core connotation of "6*N" is to enable or incubate different brands that meet different needs of</p><p>different consumers based on the above six capabilities.</p><p>While Proya, as the main brand, maintains rapid and steady development, the Company creates, replicates,</p><p>enables and incubates different brands to meet the different needs of different consumers based on the</p><p>successful experience and core competence, enlarges the customer base, extends the demand coverage of</p><p>the life cycle of customers, gradually builds and improves the multi-brand matrix, and achieves long-term</p><p>sustainable growth.</p><p>(III) Business plan</p><p>√ Applicable □ Not applicable</p><p>I. Construction of a multi-category and multi-brand matrix</p><p>Proya:</p><p>(1) Brand: Better establish the brand awareness of "A Scientific Choice for Skin" by more scientific</p><p>product portfolios, better and more delicate product experiences, and the output of the reasonable concept</p><p>of skincare, thus taking the brand to a new level. Maintain outstanding products as the core driver of the</p><p>brand, and make satisfactory services and experiences consumers" reason for choice. Dig deeper into the</p><p>brand"s insistence on products and belief in scientific formula, communicate with consumers in an all-</p><p>around manner, deliver needed products and great experiences to consumers, and make Proya a leader in</p><p>the era of "home-made products".</p><p>(2) Product: Better upgrade the product in formula, efficacy, design, and use experiences around the core</p><p>mid-end product line, consolidate the status of hero products; better divide the needs of users with different</p><p>skin types, reserve richer and more detailed efficacy and categories, and expand the coverage to more</p><p>consumers to satisfy their needs for skin care.</p><p>(3) Marketing: 1) In 2023, Proya will keep carving the brand by taking "exploration and discovery" as</p><p>the core, continuously express our opinions in gender equality, family responsibility, intimate relationships,</p><p>young people"s growth, mental health, and other socially important issues, so as to expand the impact of</p><p>brand long-termism beyond brand incidents. 2) Based on the brand identity of the year, Proya will build</p><p>its own online public welfare platform to carry long-term public welfare actions and content under the</p><p>brand"s core projects and extend care of the brand.</p><p>(4) Channel:</p><p>products, penetrate into the market of the essence category as the core of the brand, enhance the penetration</p><p>of face cream, face mask, facial care kits, and other core categories, further improve the proportion of</p><p>high-value users, better refine the operation, improve services, and lift the brand mindset.</p><p>                                             Annual Report 2022</p><p>achieve integrated operation of brand recommendation and purchase, improve the overall operation</p><p>efficiency, establish presence in the shelf e-commerce on TikTok, better work with high-quality KOLs,</p><p>and achieve diversified and healthy brand development in TikTok.</p><p>cooperation to realize resonance inside and outside the site; change to user-based operation for the</p><p>membership section with the focus on improving service level and user experiences and maintaining user</p><p>loyalty; continuously strengthen the refined operation of all traffic channels.</p><p>products and primarily aim at the direction of basic moisturizing and anti-aging products; beef up the</p><p>digitalization capability to empower offline sales, improve product turnover rate, and raise the satisfaction</p><p>of channel customers. Department stores: Focus on influential business district and large department store</p><p>groups, explore the new "online+offline" sales mode, and increase the repurchase rate and per customer</p><p>transaction.</p><p>Hapsode:</p><p>(1) Brand: Continuously consolidate the strategy of hero cleansing products, take the existing advantage</p><p>in the oil remover category, expand the customer base of Hapsode, and increase brand penetration in the</p><p>young population.</p><p>(2) Product: Complete the layout of the full cleansing product line based on Hapsode"s pyramid-typed</p><p>product system for oily skin. Keep improving the product efficacy of oil control in 2023 as the core</p><p>competitiveness of an oily skin care brand; create the product combo for oily and sensitive skin for the</p><p>soothing product line around the Ultra Soothing Facial Mask and the Ultra Soothing Serum.</p><p>(3) Marketing: Keep focusing on college students as the core target consumers and carry out serial brand</p><p>events to deliver Hapsode"s young and dynamic brand image.</p><p>(4) Channel: Focus on TikTok and Tmall and put more efforts on self live-streaming.</p><p>(1) Brand: Focus on building a professional brand of "Chinese make-up" around the brand core of</p><p>"Chinese make-up, original beauty" to deliver "original beauty" experiences to consumers. Consolidate</p><p>brand professionalism with marketing content, improve brand services by seeing through the target</p><p>customer group, and enhance the brand"s sense of value by innovating in brand peripherals and gifts.</p><p>(2) Product: Further expand the "Contour Line" advantages and keep increasing the brand penetration.</p><p>Continue to establish presence in the large make-up base category, reserve sub-categories such as liquid</p><p>foundation, cream foundation, cushion, and powder & pact, complete the make-up base mindset, and</p><p>create a "professional" brand image.</p><p>(3) Marketing: Carry out content marketing around new product launch, festival topics, and IP</p><p>cooperation.</p><p>(4) Channel: Focus on Tmall and TikTok.</p><p>(1) Brand: Establish the brand image of a scalp health expert from Japan, stabilize the product strength,</p><p>and strengthen the core brand efficacy as "a scalp health solution", allowing core consumers to recognize</p><p>the brand values of OR.</p><p>(2) Product: Further bring together international R&D capabilities and complete the global supply chain</p><p>system. Rely on Japan"s leading fundamental research and technological development advantages to erect</p><p>                                            Annual Report 2022</p><p>a technological barrier and offer consumers a complete scalp health solution. Make further presence in the</p><p>scalp solution market, upgrade hair masks, hair care essence oil, and other hair care products, and create</p><p>a new flagship product line.</p><p>(3) Marketing: Output the brand personality and accumulate brand assets by communicating OR"s brand</p><p>trait as a "professional scalp health care expert". Launch product marketing based on the core mindset of</p><p>a top Japanese brand and a scalp health expert, allow consumers to better understand the conditions of</p><p>their scalp, and help them build up the basic scalp health knowledge base; continue with the "tiny but</p><p>beautiful" brand marketing, advocate a lifestyle from scalp health to mental and physical health, penetrate</p><p>into the core population, and enhance the brand likability among target consumers.</p><p>(4) Channel: Focus on Tmall (Tmall Global, Tmall Flagship Store) and TikTok in the Chinese Mainland;</p><p>make more breakthroughs in physical stores in Japan while increasing the online traffic.</p><p>II. R&D construction</p><p>In 2023, the Company will keep adopting the internationalization strategy, complete and upgrade the</p><p>research and development system, introduce high-level and cross-discipline talents with a global vision</p><p>covering chemistry, chemical engineering, pharmacology, dermatology, statistics, and computational</p><p>biology; establish research and development laboratories at home and abroad based on R&D advantages</p><p>in all regions across the globe. While completing the system of consumer and technology insight,</p><p>technology development, raw material development, formula, product development, and efficacy</p><p>evaluation, the Company also strengthens strategic partnerships with globally-leading research institutions</p><p>specializing in biotechnologies, life sciences, cytology, and dermatology.</p><p>(1) Fundamental research: Continue to plan for the development pipeline of new technologies and new</p><p>raw materials, and develop advanced enabling technologies in computational biology, genomics, and</p><p>proteomics.</p><p>(2) Applied research: Guided by market demand, develop skin care and make-up products of various levels</p><p>with obvious efficacy, great skin feel and favorable costs, and complete the technological layout for future</p><p>iterations of all hero products.</p><p>(3) Clinical research: Continue with the clinical research and verification of products, explore new</p><p>methods to verify the efficacy of raw materials and products, and develop new efficacy testing methods</p><p>by using advanced instruments and statistics.</p><p>(IV) Possible risks</p><p>√ Applicable □ Not applicable</p><p>(1) The Company"s brand strategy and channel strategy fail to come up to expectations due to intensified</p><p>competition from various brands in the industry;</p><p>(2) The control of digital and precise delivery costs fails to come up to expectations due to intensified</p><p>competition in marketing and ads delivery.</p><p>(1) New brand incubation risk: Performance fails to come up to expectations despite big investment in</p><p>marketing;</p><p>(2) New category cultivation risk: Performance fails to come up to expectations due to different operation</p><p>modes for different categories and the incompetent team.</p><p>                                            Annual Report 2022</p><p>(V) Other</p><p>□ Applicable √ Not applicable</p><p>VII. Circumstances Where the Company Fails to Disclose Due to Non-applicability or Special</p><p>     Reasons Such as State Secrets and Trade Secrets and Statement of Reasons</p><p>□ Applicable √ Not applicable</p><p>                             Section IVCorporate Governance</p><p>I.    Description of Corporate Governance</p><p>√ Applicable □ Not applicable</p><p>During the Reporting Period, the Company continuously improved its standard operation and corporate</p><p>governance structure based on the actual situation pursuant to applicable laws and regulations, including</p><p>the Company Law, the Securities Law, the Listing Rules of the Shanghai Stock Exchange and the Code of</p><p>Corporate Governance of Listed Companies as well as the Articles of Association. The Company has set</p><p>up the general meeting of shareholders, Board of Directors, Board of Supervisors and special committees</p><p>under the Board of Directors as required and developed corresponding rules of procedure. Such rules</p><p>define the duties, powers, procedures and obligations of organizations at all levels in terms of decision-</p><p>making, supervision and implementation. They form a scientific and effective governance structure</p><p>featuring clear rights and responsibilities, mutual checks and balances, and mutual coordination. During</p><p>the Reporting Period, the Company consciously fulfilled the obligation for information disclosure,</p><p>managed investor relationships, and promoted the Company to continuously improve its standard</p><p>operation. The corporate governance status complies with the requirements of the normative documents</p><p>on the governance of listed companies issued by the CSRC.</p><p>Whether there are significant differences between the Company"s corporate governance and the</p><p>requirements of laws, administrative regulations and CSRC"s regulations on the governance of listed</p><p>companies; if so, explain the reasons.</p><p>□ Applicable √ Not applicable</p><p>II.   Specific measures taken by the Company"s controlling shareholders and actual controllers to</p><p>      ensure the Company"s independence in assets, personnel, finance, organization and business</p><p>      activities as well as solutions, work progress and subsequent work plans taken due to influence</p><p>      on the Company"s independence</p><p>□ Applicable √ Not applicable</p><p>Circumstances where any controlling shareholders, actual controllers and other entities under their control</p><p>engage in the same or similar business activities, as well as the impact of horizontal competition or major</p><p>changes in horizontal competition on the Company, resolutions taken, progress and follow-up resolutions</p><p>□ Applicable √ Not applicable</p><p>                                          Annual Report 2022</p><p>III. Meetings of the General Meeting of Shareholders during the Reporting Period</p><p>    Session        Date         Reference         Date of release                Resolution</p><p>                                                                    The meeting approved proposals</p><p>                                                                    including the Company"s Annual</p><p>                                                                    Report 2021 and its Summary, and</p><p>                                                                    the Plan for Annual Profit</p><p>                                                                    Distribution and Capitalization of</p><p>                                                                    Capital Reserves for 2021. For</p><p> General         May 12,    2022-027 on SSE</p><p>                                                 May 13, 2022       details, see the Announcement on</p><p> Meeting of      2022       website</p><p>                                                                    Resolutions of the 2021 Annual</p><p> Shareholders               (www.sse.com.cn)</p><p>                                                                    General Meeting of Shareholders</p><p>                                                                    (No.: 2022-027) released on the</p><p>                                                                    SSE website on May 13, 2022</p><p>                                                                    (http://www.sse.com.cn)        and</p><p>                                                                    relevant media.</p><p>                                                                    The meeting approved proposals</p><p>                                                                    including the Proposal on 2022</p><p>                                                                    Restricted Share Incentive Plan of</p><p>                                                                    the Company (Draft) and Its</p><p>                                                                    Summary, and the Proposal on</p><p> Extraordinary              Announcement No.                        Management Method for the 2022</p><p> General         July 25,   2022-041 on SSE                         Restricted Share Incentive Plan.</p><p>                                                 July 26, 2022</p><p> Meeting of      2022       website                                 For details, see the Announcement</p><p> Shareholders               (www.sse.com.cn)                        on Resolutions of the 2022 First</p><p> in 2022                                                            Extraordinary General Meeting of</p><p>                                                                    Shareholders (No.: 2022-041)</p><p>                                                                    released on the SSE website on</p><p>                                                                    July            26,           2022</p><p>                                                                    (http://www.sse.com.cn)        and</p><p>                                                                    relevant media.</p><p>Request of preferred shareholders with restored voting rights for convening an extraordinary general</p><p>meeting</p><p>□ Applicable √ Not applicable</p><p>Description of the General Meeting of Shareholders</p><p>□ Applicable √ Not applicable</p><p>                                                                  Annual Report 2022</p><p>IV. Directors, Supervisors and Senior Management</p><p>(I) Changes in shareholding and remuneration of current and resigned directors, supervisors and senior management during the Reporting Period</p><p>√ Applicable □ Not applicable</p><p>                                                                                                                                                   Unit: share</p><p>                                                                                                                                 Total pre-tax</p><p>                                                                                                                                remuneration         Any</p><p>                                                                   Number of</p><p>                                                                                   Number of        Change in                   received from    remuneration</p><p>                                                                   shares held</p><p>              Position                    Term start   Term end                    shares held        shares      Cause for     the Company        from the</p><p>  Name                     Gender   Age                               at the</p><p>               (Note)                        date        date                     at the end of     during the     change         during the      Company"s</p><p>                                                                  beginning of</p><p>                                                                                     the year          year                       Reporting         related</p><p>                                                                     the year</p><p>                                                                                                                                    Period          parties</p><p>                                                                                                                                (RMB’0,000)</p><p>                                                                                                                 Shares</p><p>            Chairman of</p><p>  HOU                                                                                                            converted</p><p>            the Board of    Male    59    7/30/2015    9/8/2024    69,764,815          97,670,741   27,905,926                         162.94        No</p><p>Juncheng                                                                                                         from capital</p><p>            Directors</p><p>                                                                                                                 reserve</p><p>                                                                                                                 Shares</p><p>                                                                                                                 converted</p><p>                                                                                                                 from capital</p><p>            Director,</p><p>  FANG                                                                                                           reserve and</p><p>            General         Male    54    7/30/2015    9/8/2024    36,347,843          45,772,470    9,424,627                         162.94        No</p><p>  Yuyou                                                                                                          shares</p><p>            Manager</p><p>                                                                                                                 reduced for</p><p>                                                                                                                 personal</p><p>                                                                                                                 capital need</p><p>  HOU</p><p>            Director        Male    35    9/9/2021     9/8/2024               0                0             0                          48.06        No</p><p> Yameng</p><p>  HOU       Deputy</p><p>                            Male    35    9/15/2021    9/8/2024               0                0             0                           0.00        No</p><p> Yameng     General</p><p>                                                               Annual Report 2022</p><p>           Manager</p><p>   MA      Independent</p><p>                         Male     53   5/13/2021   9/8/2024                0             0         0                     15.00   No</p><p>Dongming   Director</p><p>    GE     Independent</p><p>                         Male     48   9/9/2021    9/8/2024                0             0         0                     15.00   No</p><p> Weijun    Director</p><p>   HOU</p><p>           Supervisor    Female   34   5/2/2018    9/8/2024                0             0         0                     22.28   No</p><p>  Luting</p><p>  FANG</p><p>           Supervisor    Female   33   5/8/2018    9/8/2024                0             0         0                     32.02   No</p><p>   Qin</p><p> HU Lina   Supervisor    Female   35   9/9/2021    9/8/2024                0             0         0                     17.19   No</p><p>                                                                                                        Shares</p><p>                                                                                                        converted</p><p>                                                                                                        from capital</p><p>           Deputy                                                                                       reserve and</p><p>  JIN</p><p>           General       Male     61   4/16/2018   9/14/2024         54,981         216,973   161,992   grant      of    70.79   No</p><p> Yanhua</p><p>           Manager                                                                                      2022</p><p>                                                                                                        restricted</p><p>                                                                                                        stock</p><p>                                                                                                        incentive</p><p>                                                                                                        Shares</p><p>                                                                                                        converted</p><p>                                                                                                        from capital</p><p>                                                                                                        reserve and</p><p>WANG Li    CFO           Female   45   9/3/2018    9/14/2024         32,322         225,251   192,929   grant      of   120.17   No</p><p>                                                                                                        restricted</p><p>                                                                                                        stock</p><p>                                                                                                        incentive</p><p>                                                                        Annual Report 2022</p><p>              Deputy</p><p>              General</p><p>              Manager,</p><p>WANG Li                      Female    45     9/15/2021    9/14/2024                0             0             0                           0.00        No</p><p>              Secretary of</p><p>              the Board of</p><p>              Directors</p><p>   Total           /           /         /           /            /       106,199,961 143,885,435 37,685,474           /               666.40          /</p><p>Notes:</p><p>The total pre-tax remuneration received by the above directors, supervisors and the senior management from the Company during the Reporting Period is the total</p><p>pre-tax remuneration during their term of office in the Reporting Period.</p><p>     Name                                                                      Working experience</p><p>                  He once worked in Yiwu Liaoyuan Daily Chemical Co., Ltd., Hangzhou Proya Cosmetics Co., Ltd., and Hangzhou Proya Holding Co., Ltd. Since</p><p>                  August 2012, he has served as Chairman of the Company and its predecessor. As of the end of the Reporting Period, he concurrently served as</p><p>                  Executive Director and General Manager of Proya Trade, Executive Director of Meiligu, Executive Director of Chuangdai Electronics, Executive</p><p>                  Director of Yueqing Laiya, Inside Director and Representative Director of Korea Hanna, Executive Director and General Manager of Hapsode</p><p>     HOU</p><p>                  (Hangzhou), Executive Director and General Manager of Huzhou Hapsode, Executive Director and General Manager of Danyang Hapsode,</p><p>   Juncheng</p><p>                  Executive Director and General Manager of Mijing Siyu (Hangzhou), Executive Director and General Manager of Huzhou Younimi, Executive</p><p>                  Director of Proya (Hainan), Executive Director of Proya (Zhejiang), Chairman and General Manager of Hangzhou Kunyi Industrial Co., Ltd.,</p><p>                  Chairman of CBIC, Executive Director and General Manager of Huzhou Beauty Town Technology Incubation Park Co., Ltd., Director of Xinjiang</p><p>                  Huanyu New Silk Road Investment Development Co., Ltd., Director of Yongxinou (Ningbo) International Trading Co., Ltd., and Executive</p><p>                  Director of Zhejiang Zhujin Enterprise Management Co., Ltd.</p><p>                  He once worked in Shijiazhuang Liaoyuan Cosmetics Co., Ltd., Hangzhou Proya Cosmetics Co., Ltd., and Hangzhou Proya Holdings Co., Ltd.</p><p>                  Since 2007, he has been working in the Company and its predecessor. Since August 2012, he has served as Director and General Manager of the</p><p>    FANG          Company and its predecessor. As of the end of the Reporting Period, he concurrently served as General Manager of Meiligu, General Manager of</p><p>    Yuyou         Yueqing Laiya, Inside Director of Korea Hanna, Director of Hongkong Xinghuo, Executive Director and General Manager of Hangzhou Fangxiake</p><p>                  Investment Co., Ltd., Director of Hangzhou Kunyi Industrial Co., Ltd., Director of Hangzhou Tairentang Biotechnology Co., Ltd., Supervisor of</p><p>                  Zhejiang Boweihui Grapevine Technology Co., Ltd., and Director of Jiangsu Lenong Weimei Agricultural Technology Development Co., Ltd.</p><p>                                                                   Annual Report 2022</p><p>             He once worked in the E-commerce Department of Proya Cosmetics Co., Ltd., and has served as Director and Deputy General Manager of the</p><p>  HOU</p><p>             Company since September 2021. As of the end of the Reporting Period, he concurrently served as Executive Director and General Manager of</p><p> Yameng</p><p>             Hainan Mengya Enterprise Consulting Co., Ltd. and Executive Director and General Manager of Hangzhou TIMAGE.</p><p>             He used to be Deputy Director and Director of CSRC Zhejiang Branch, Director of the Commissioner"s Office of CSRC Shanghai Branch, and</p><p>  MA         Deputy General Manager and Secretary of the Board of Directors of Yongan Futures Co., Ltd. Since May 2021, he has served as Independent</p><p>Dongming     Director of the Company. As of the end of the Reporting Period, he concurrently served as Independent Director of Transwarp Technology</p><p>             (Shanghai) Co., Ltd., Independent Director of Zhejiang Shuangyuan Technology Co., Ltd., and Independent Director of Merit Interactive Co., Ltd.</p><p>             He once worked in Zhejiang Xingyun Law Firm and Xingyun Law Firm Shanghai Branch. From February 2006 to December 2021, he served as</p><p>             Professor, Doctoral Supervisor, and Legal Adviser of Shanghai University of Finance and Economics. Since January 2022, he has served as a full-</p><p>             time teacher (professor) at the Law School of Fudan University. Since September 2021, he has served as Independent Director of the Company.</p><p>             He also serves as Arbitrator at the China International Economic and Trade Arbitration Commission, Arbitrator at the Shanghai International</p><p>             Economic and Trade Arbitration Commission, Arbitrator at Shanghai Arbitration Commission ,Arbitrator at Shenzhen Court of International</p><p>GE Weijun</p><p>             Arbitration, Executive Officer of the China Commercial Law Society, Vice President of the Commercial Research Branch of the Shanghai Judicial</p><p>             Think Tank, Vice President of the Commercial Law Research Association of the Shanghai Law Society, Vice President of the Cultural Law</p><p>             Research Association of the Shanghai Law Society, Independent Director of Shanghai Huace Navigation Technology Ltd., Independent Director</p><p>             of Changzhou ECTEK Automotive Electronics System Co., Ltd., Independent Director of Hangzhou EZVIZ Network Co., Ltd. and Independent</p><p>             Director of Zheshang Development Group Co., Ltd.</p><p>             From July 2013 to January 2014, she served as an expatriate financial specialist at Zhonghui Accounting Firm. From February 2014 to June 2017,</p><p>             she served as a packaging material procurement specialist at the Purchasing Department of the Company. From June 2017 to April 2019, she served</p><p>HOU Luting   as a raw material procurement specialist at the Purchasing Department of the Company. From April 2019 to March 2021, she served as a raw</p><p>             material evaluation engineer. From March 2021 to December 2022, she served as a deputy price review manager. From December 2022 to present,</p><p>             she has served as a price review manager. Since May 2018, she has served as Supervisor of the Company.</p><p>             From November 2008 to January 2018, she served as Director of the Planning Department of the Company and its predecessor. From January 2018</p><p>FANG Qin     to July 2022, she served as Planning Strategy Manager of the Company. Since July 2022, she has served as Senior Planning Strategy Manager of</p><p>             the Company. Since May 2018, she has served as Supervisor of the Company.</p><p>             She once worked in Pan-China Certified Public Accountants (Special General Partnership), and has served as Strategy Supervisor at the Company</p><p> HU Lina</p><p>             since 2013, and has served as Supervisor of the Company since September 2021.</p><p>JIN Yanhua   He once worked in Zhejiang Sanmen Fertilizer Factory, Zhejiang InBev Yandangshan Beer Co., Ltd., Zhejiang InBev Jinhua Beer Co., Ltd.,</p><p>                                                                      Annual Report 2022</p><p>                Hangzhou Proya Cosmetics Co., Ltd., and Hangzhou Proya Holding Co., Ltd. From 2007 to August 2012, he served as General Manager of the</p><p>                Huzhou Factory under the Company and its predecessor. Since August 2012, he has served as General Manager of the Company"s Supply Chain</p><p>                Management Center; since April 2018, he has served as Deputy General Manager of the Company. As of the end of the Reporting Period, he</p><p>                concurrently served as Executive Director of Hanya (Huzhou), Executive Director of Huzhou UZERO, Manager of Chuangdai Electronics,</p><p>                Executive Director and General Manager of Proya Commercial, Executive Director and General Manager of Huzhou Niuke, Executive Director</p><p>                and General Manager of Hangzhou Wanyan, Executive Director and General Manager of Zhejiang Beute, Executive Director of Shanghai</p><p>                Zhongwen, Executive Director and General Manager of Ningbo Proya, Chairman of Ningbo Keshi, Chairman of Ningbo TIMAGE, Director of</p><p>                Hong Kong Keshi, Director of Hong Kong Wanyan, Director of Hong Kong Zhongwen, Executive Director of Zhejiang Qingya, Executive Director</p><p>                of Luxiaotie, Executive Director and General Manager of Hangzhou Yizhuo, Executive Director and General Manager of Hangzhou Weiluoke,</p><p>                Executive Director and General Manager of Hangzhou Oumisi, Director of Japan OR, Executive Director and General Manager of Guangzhou</p><p>                Qianxi, Director of Ningbo Xiyou Interactive Entertainment Culture Media Co., Ltd., General Manager of Proya (Hainan), Director of Korea</p><p>                Hapsode, Executive Director and General Manager of Xuzhou Laibo, Executive Director and General Manager of Shenggelan (Hangzhou),</p><p>                Chairman and General Manager of Ningbo Tangyu, Manager of Proya (Zhejiang), Executive Director and General Manager of Hangzhou Boxin,</p><p>                Executive Director and General Manager of Huzhou Keyan Trading Co., Ltd.</p><p>                She once served as CFO of Guangzhou Yingtai Digital Power Technology Co., Ltd., Financial Representative of US CELLSTAR (Phonest Star),</p><p>                Financial Manager of Shanghai Ruili Sports Co., Ltd., Financial Director of Vgrass Fashion Co., Ltd., Financial Director of Zhuoshang Clothing</p><p>  WANG Li       (Hangzhou) Co., Ltd., and Financial Director of Jiangsu Sunport Power Corp., Ltd. Since April 2023, she has served as Independent Director of</p><p>                Zhejiang Wazam New Materials Co., Ltd. She is currently Deputy General Manager, Secretary of the Board of Directors, and CFO of Proya</p><p>                Cosmetics Co., Ltd.</p><p>Other explanations</p><p>□ Applicable √ Not applicable</p><p>                                         Annual Report 2022</p><p>(II) Positions of current and resigned directors, supervisors and senior management during the</p><p>     Reporting Period</p><p>√ Applicable □ Not applicable</p><p>      Name of          Name of shareholder      Position held in</p><p>                                                                  Term start date Term end date</p><p>      employee                entity           shareholder entity</p><p>                     Peixian Deyi Network</p><p>    JIN Yanhua       Technology Partnership Executive Partner       August 2019      February 2022</p><p>                     (Limited Partnership)</p><p> Description    of None</p><p> position held in</p><p> shareholder</p><p> entities</p><p>Notes: Peixian Deyi Network Technology Partnership (Limited Partnership) was deregistered in February</p><p>√ Applicable □ Not applicable</p><p>  Name of                                     Position held in</p><p>               Name of another entity                              Term start date Term end date</p><p>  employee                                   shareholder entity</p><p>                                         Executive Director and</p><p>              Proya Trade                                          June 2011</p><p>                                         General Manager</p><p>                                                                   November</p><p>              Meiligu                    Executive Director</p><p>                                                                   December</p><p>              Chuangdai Electronics      Executive Director</p><p>                                                                   September</p><p>              Yueqing Laiya              Executive Director</p><p>                                         Inside Director and November</p><p>              Korea Hanna</p><p>                                         Representative Director   2011</p><p>                                         Executive Director and</p><p>              Hapsode (Hangzhou)                                   February 2018</p><p>                                         General Manager</p><p>    HOU</p><p>                                         Executive Director and</p><p>  Juncheng Huzhou Hapsode                                          May 2016</p><p>                                         General Manager</p><p>                                         Executive Director and December</p><p>              Danyang Hapsode</p><p>                                         General Manager           2016</p><p>                                         Executive Director and</p><p>              Mijing Siyu (Hangzhou)                               February 2018</p><p>                                         General Manager</p><p>                                         Chairman of the Board of                    November</p><p>              Huzhou Younimi                                       March 2019</p><p>                                         Directors                                   2022</p><p>                                         Executive Director and November</p><p>              Huzhou Younimi</p><p>                                         General Manager           2022</p><p>              Proya (Hainan)             Executive Director        January 2021</p><p>              Proya (Zhejiang)           Executive Director        May 2022</p><p>              Hangzhou Kunyi             Chairman and General April 2014</p><p>                                     Annual Report 2022</p><p>Name of                                 Position held in</p><p>            Name of another entity                              Term start date   Term end date</p><p>employee                               shareholder entity</p><p>           Industrial Co., Ltd.      Manager</p><p>           Cosmetics Industry</p><p>                                     Chairman of the Board of   December</p><p>           (Huzhou) Investment</p><p>                                     Directors                  2018</p><p>           Development Co., Ltd.</p><p>           Huzhou Beauty Town</p><p>                                     Executive Director and</p><p>           Technology Incubation                                January 2019</p><p>                                     General Manager</p><p>           Park Co., Ltd.</p><p>           Xinjiang Huanyu New</p><p>           Silk Road Investment      Director                   March 2021</p><p>           Development Co., Ltd.</p><p>           Yongxinou (Ningbo)</p><p>           International Trading     Director                   May 2022</p><p>           Co., Ltd.</p><p>           Zhejiang Zhujin</p><p>                                                                September</p><p>           Enterprise Management     Executive Director</p><p>           Co., Ltd.</p><p>                                                                November</p><p>           Meiligu                   General Manager</p><p>                                                                September</p><p>           Yueqing Laiya             General Manager</p><p>                                                                November</p><p>           Korea Hanna               Inside Director</p><p>           Hongkong Xinghuo          Director                   March 2019</p><p>                                                                                  November</p><p>           Huzhou Younimi            Director                   March 2019</p><p>           Hangzhou Fangxiake        Executive Director and</p><p> FANG                                                           May 2018</p><p>           Investment Co., Ltd.      General Manager</p><p> Yuyou</p><p>           Hangzhou Kunyi</p><p>                                     Director                   April 2014</p><p>           Industrial Co., Ltd.</p><p>           Hangzhou Tairentang                                  December</p><p>                                     Director</p><p>           Biotechnology Co., Ltd.                              2014</p><p>           Zhejiang Boweihui</p><p>                                                                November</p><p>           Grapevine Technology      Supervisor</p><p>           Co., Ltd.</p><p>           Jiangsu Lenong Weimei</p><p>           Agricultural Technology   Director                   May 2022</p><p>           Development Co., Ltd.</p><p>           Hangzhou Yishan                                      September</p><p>                                     Supervisor                                   January 2022</p><p>           Design Co., Ltd.                                     2017</p><p> HOU       Hainan Mengya</p><p>                                     Executive Director and     November</p><p>Yameng     Enterprise Consulting</p><p>                                     General Manager            2021</p><p>           Co., Ltd.</p><p>           Hangzhou TIMAGE           Executive Director and     March 2022</p><p>                                      Annual Report 2022</p><p>Name of                                   Position held in</p><p>             Name of another entity                              Term start date   Term end date</p><p>employee                                 shareholder entity</p><p>                                      General Manager</p><p>            Particle Culture</p><p>            Technology Group          Independent Director       October 2020      March 2022</p><p>            (Hangzhou) Co., Ltd.</p><p>            Transwarp Technology                                 December</p><p>                                      Independent Director</p><p>  MA        (Shanghai)Co., Ltd.                                  2020</p><p>Dongming    Zhejiang Shuangyuan</p><p>                                                                 December</p><p>            Science & Technology      Independent Director</p><p>            Development Co., Ltd.</p><p>            Merit Interactive Co.,</p><p>                                      Independent Director       May 2022</p><p>            Ltd.</p><p>            Wuxi Genecast</p><p>                                      Independent Director       January 2020      August 2022</p><p>            Biotechnology Co., Ltd.</p><p>            Shanghai Huace</p><p>                                                                 December</p><p>            Navigation Technology     Independent Director</p><p>            Ltd.</p><p>            Changzhou ECTEK</p><p>GE Weijun                                                        September</p><p>            Automotive Electronics    Independent Director</p><p>            System Co., Ltd.</p><p>            Hangzhou EZVIZ</p><p>                                      Independent Director       March 2022</p><p>            Network Co., Ltd.</p><p>            Zheshang Development</p><p>                                      Independent Director       May 2022</p><p>            Group Co., Ltd.</p><p>                                                                 December</p><p>            Anya (Huzhou)             Executive Director</p><p>            Huzhou UZERO              Executive Director         January 2018</p><p>            Chuangdai Electronics     Manager                    February 2018</p><p>                                      Executive Director and     September</p><p>            Proya Commercial</p><p>                                      General Manager            2018</p><p>                                      Executive Director and     December</p><p>            Huzhou Niuke</p><p>                                      General Manager            2018</p><p>                                      Executive Director and</p><p>            Hangzhou Wanyan                                      January 2019</p><p>  JIN                                 General Manager</p><p> Yanhua                               Executive Director and</p><p>            Zhejiang Beute                                       March 2019</p><p>                                      General Manager</p><p>                                      Chairman of the Board of</p><p>            Shanghai Zhongwen                                    April 2019</p><p>                                      Directors</p><p>                                      Executive Director and     December</p><p>            Ningbo Proya</p><p>                                      General Manager            2019</p><p>                                                                 September</p><p>            Ningbo Keshi              Director</p><p>            Ningbo TIMAGE             Director                   July 2019</p><p>            Peixian Deyi Network      Executive Partner          August 2019       February 2022</p><p>                                        Annual Report 2022</p><p>Name of                                     Position held in</p><p>               Name of another entity                                 Term start date   Term end date</p><p>employee                                   shareholder entity</p><p>              Technology Partnership</p><p>              (Limited Partnership)</p><p>              Hong Kong Keshi           Director                      March 2019</p><p>              Hong Kong Wanyan          Director                      October 2019</p><p>              Hong Kong Zhongwen        Director                      July 2019</p><p>              Zhejiang Qingya           Executive Director            May 2020</p><p>              Luxiaotie                 Executive Director            August 2020</p><p>                                        Executive Director      and</p><p>              Hangzhou Yizhuo                                         July 2020</p><p>                                        General Manager</p><p>                                        Executive Director      and</p><p>              Hangzhou Weiluoke                                       July 2020</p><p>                                        General Manager</p><p>                                        Executive Director      and</p><p>              Hangzhou Oumisi                                         August 2020</p><p>                                        General Manager</p><p>              Japan OR                  Director                      August 2020</p><p>                                        Executive Director      and</p><p>              Guangzhou Qianxi                                        October 2020</p><p>                                        General Manager</p><p>              Ningbo Xiyou</p><p>              Interactive                                             September</p><p>                                        Director</p><p>              Entertainment Culture                                   2020</p><p>              Media Co., Ltd.</p><p>              Proya (Hainan)            General Manager               January 2021</p><p>              Korea Hapsode             Director of the Company       June 2021</p><p>                                        Executive Director and</p><p>              Xuzhou Laibo                                            January 2022</p><p>                                        General Manager</p><p>                                        Executive Director and        September</p><p>              Huzhou Boyun                                                              August 2022</p><p>                                        General Manager               2020</p><p>              Xuzhou Proya</p><p>                                        Executive Director and</p><p>              Information Technology                                  January 2021      July 2022</p><p>                                        General Manager</p><p>              Co., Ltd.</p><p>              Singuladerm               Executive Director and</p><p>                                                                      October 2021</p><p>              (Hangzhou)                General Manager</p><p>                                        Chairman and General</p><p>              Ningbo Tangyu                                           October 2021</p><p>                                        Manager</p><p>              Proya (Zhejiang)          Manager                       May 2022</p><p>                                        Executive Director and        December</p><p>              Hangzhou Boxin</p><p>                                        General Manager               2022</p><p>              Huzhou Keyan Trading      Executive Director and</p><p>                                                                      March 2023</p><p>              Co., Ltd.                 General Manager</p><p>              Zhejiang Wazam New</p><p>WANG Li                                 Independent Director          April 2023</p><p>              Materials Co., Ltd.</p><p>Description</p><p>of position   None</p><p>held in</p><p>                                            Annual Report 2022</p><p> Name of                                        Position held in</p><p>                Name of another entity                                 Term start date    Term end date</p><p> employee                                      shareholder entity</p><p>other</p><p>entities</p><p>(III) Remuneration of directors, supervisors and senior management</p><p>√ Applicable □ Not applicable</p><p>                                    The remuneration of directors and supervisors of the Company shall</p><p>                                    be approved by the Remuneration and Appraisal Committee, the</p><p> Decision-making procedures for</p><p>                                    Board of Directors and the Board of Supervisors respectively. Then,</p><p> remuneration   of    directors,</p><p>                                    the remuneration plan shall be submitted to the general meeting of</p><p> supervisors    and      senior</p><p>                                    shareholders for deliberation. The remuneration of senior</p><p> management</p><p>                                    management shall be deliberated by the Remuneration and</p><p>                                    Appraisal Committee and the Board of Directors.</p><p> Basis for determination of</p><p>                                    The annual remuneration of the Company"s directors, supervisors</p><p> remuneration     of   directors,</p><p>                                    and senior management shall be paid based on basic pay and</p><p> supervisors      and     senior</p><p>                                    performance appraisal results.</p><p> management</p><p> Actual payment of remuneration</p><p> of directors, supervisors and      Paid.</p><p> senior management</p><p> Total remuneration actually        During the Reporting Period, the Company"s directors, supervisors</p><p> received by all directors,         and senior management actually received a total remuneration of</p><p> supervisors      and     senior    RMB6.6640 million from the Company (including current and</p><p> management as of the end of the    resigned supervisors and senior management during the Reporting</p><p> Reporting Period                   Period).</p><p>(IV) Changes in the Company"s directors, supervisors and senior management</p><p>□ Applicable √ Not applicable</p><p>(V) Description of punishments by the CSRC in the past three years</p><p>□ Applicable √ Not applicable</p><p>(VI) Other</p><p>□ Applicable √ Not applicable</p><p>V.   Meetings of the Board of Directors held during the Reporting Period</p><p>      Session               Date                                     Resolution</p><p>                                            The meeting approved proposals including the Proposal on</p><p> third session of     January 12, 2022      Restrictions for the Third Release Period of the Restricted</p><p> Board of Directors                         Shares Granted for the First Time and with Reserve under</p><p>                                            the 2018 Restricted Share Incentive Plan, the Proposal on the</p><p>                                        Annual Report 2022</p><p>                                        Use of Raised Funds to Replace Self-raised Funds Already</p><p>                                        Invested in Fundraising Projects, and the Proposal on Using</p><p>                                        Some Idle Raised Fund for Cash Management. For details,</p><p>                                        see the Announcement on Resolutions of the 4th Meeting of</p><p>                                        the Third Session of Board of Directors (No.: 2022-002)</p><p>                                        disclosed by the Company on the SSE website</p><p>                                        (http://www.sse.com.cn) and relevant media on January 13,</p><p>                                        The meeting approved proposals including the Company"s</p><p>                                        Annual Report 2021 and its Summary, the Company"s ESG</p><p>                                        Report 2021, and the Company"s Plan for Profit Distribution</p><p>third session of     April 20, 2022     see the Announcement on Resolutions of the 5th Meeting of</p><p>Board of Directors                      the Third Session of Board of Directors (No.: 2022-014)</p><p>                                        disclosed by the Company on the SSE website</p><p>                                        (http://www.sse.com.cn) and relevant media on April 22,</p><p>                                        The meeting approved proposals including the Proposal on</p><p>                                        and Its Summary, and the Proposal on Formulating the</p><p>                                        Assessment Management Method for the 2022 Restricted</p><p>third session of     July 8, 2022</p><p>                                        Share Incentive Plan. For details, see the Announcement on</p><p>Board of Directors</p><p>                                        Resolutions of the 6th Meeting of the Third Session of Board</p><p>                                        of Directors (No.: 2022-033) released on the SSE website on</p><p>                                        July 9, 2022 (http://www.sse.com.cn) and relevant media.</p><p>                                        The meeting approved the Proposal on the Granting of</p><p>third session of     July 25, 2022      Announcement on Granting of Restricted Shares to Incentive</p><p>Board of Directors                      Recipients (No.: 2022-044) released on the SSE website on</p><p>                                        July 26, 2022 (http://www.sse.com.cn) and relevant media.</p><p>                                        The meeting approved proposals including the Company"s</p><p>                                        Special Report on the Semi-annual Storage and Actual Use</p><p>                                        of Raised Fund. For details, see the Announcement on</p><p>third session of     August 24, 2022</p><p>                                        Resolutions of the 8th Meeting of the Third Session of Board</p><p>Board of Directors</p><p>                                        of Directors (No.: 2022-045) disclosed by the Company on</p><p>                                        the SSE website (http://www.sse.com.cn) and relevant media</p><p>                                        on August 26, 2022.</p><p>                                        The meeting approved the Company"s 2022 Third Quarter</p><p>third session of     October 27, 2022   disclosed by the Company on the SSE website</p><p>Board of Directors                      (http://www.sse.com.cn) and relevant media on October 28,</p><p>                                                        Annual Report 2022</p><p>VI. Performance of Duties by Directors</p><p>(I) Directors attending meetings of the Board of Directors and general meetings of shareholders</p><p>                                                                                                                          Attendance at</p><p>                                                                                                                             general</p><p>                                                  Attendance at meetings of the Board of Directors</p><p>                                                                                                                           meetings of</p><p>                                                                                                                          shareholders</p><p>                                Number</p><p>                                             Number                           Number        Number</p><p>                                    of                                                                   Fail to attend</p><p>  Director     Independent                       of         Number of             of            of</p><p>                                meetings                                                                      two          Number of</p><p>   name       director or not               meetings      meetings of the     meetings      meetings</p><p>                                  of the                                                                 consecutive         general</p><p>                                              of the         Board of          of the        of the</p><p>                                Board of                                                                  meetings of     meetings of</p><p>                                            Board of         Directors        Board of      Board of</p><p>                                Directors                                                                the Board of     shareholders</p><p>                                            Directors       attended by       Directors     Directors</p><p>                                  to be                                                                  Directors or       attended</p><p>                                             attended     communication       attended       absent</p><p>                                attended                                                                       not</p><p>                                            in person                         by proxy        from</p><p>                                this year</p><p> HOU</p><p>                   No                   6           6                    0             0             0        No                      2</p><p> Juncheng</p><p> FANG</p><p>                   No                   6           6                    0             0             0        No                      2</p><p> Yuyou</p><p> HOU</p><p>                   No                   6           6                    0             0             0        No                      2</p><p> Yameng</p><p> MA</p><p>                   Yes                  6           6                    6             0             0        No                      2</p><p> Dongming</p><p> GE</p><p>                   Yes                  6           6                    6             0             0        No                      2</p><p> Weijun</p><p>Explanation on absence from two consecutive meetings of the Board of Directors</p><p>□ Applicable √ Not applicable</p><p> Number of meetings of the Board of Directors held</p><p> during the year</p><p> Including: number of on-site meetings                              0</p><p> Number of meetings held by communication                           0</p><p> Number of meetings held both on site and by</p><p> communication</p><p>(II) Circumstances where directors object to the Company"s relevant matters</p><p>□ Applicable √ Not applicable</p><p>(III) Other</p><p>□ Applicable √ Not applicable</p><p>VII. Special Committees under the Board of Directors</p><p>√ Applicable □ Not applicable</p><p>(1). Members of special committees under the Board of Directors</p><p>    Category of special</p><p>                                                    Name of member</p><p>        committee</p><p>Audit Committee         HOU Yameng, MA Dongming, GE Weijun</p><p>Nomination Committee    HOU Juncheng, MA Dongming, GE Weijun</p><p>Remuneration        and</p><p>                        FANG Yuyou, MA Dongming, GE Weijun</p><p>Appraisal Committee</p><p>                                         Annual Report 2022</p><p>Strategy Committee           HOU Juncheng, MA Dongming, GE Weijun</p><p>(2). Four meetings held by the Audit Committee during the Reporting Period</p><p>                                                                         Important</p><p>                                                                                          Other</p><p>                                                                         comments</p><p>    Date                           Description                                         performance</p><p>                                                                             and</p><p>                                                                                         of duties</p><p>                                                                        suggestions</p><p>            The 3rd meeting of the third session of the Audit</p><p>            Committee was held to deliberate on and approve the</p><p>            Company"s Annual Report 2021 and its Summary, the</p><p>            Company"s 2022 Q1 Report, the Company"s Annual</p><p>            Financial Final Report 2021, the Performance Report</p><p>                                                                       Approve</p><p>                                                                       these</p><p>            of Directors, the Company"s Internal Control Evaluation</p><p>                                                                       proposals and</p><p>            Report 2021, the 2021 Special Report on the Annual</p><p>                                                                       agree to</p><p> April 20, Storage and Actual Use of Raised Fund, the Company"s</p><p>                                                                       submit them     None</p><p>                                                                       to the Board</p><p>            Reserves for 2021, the Proposal on Payment of Audit</p><p>                                                                       of Directors</p><p>            Fees for 2021 and Further Employment of the Accounting</p><p>                                                                       for</p><p>            Firm for 2022, the Proposal on the Estimated Amount of</p><p>                                                                       deliberation</p><p>            Daily Related-party Transactions for 2022, the Proposal</p><p>            on the Accrual of Asset Impairment Provision for 2021,</p><p>            the Proposal on the Adjustment of the Conversion Price</p><p>            of "Proya Convertible Bond", and the Company"s Annual</p><p>            Internal Audit Work Report 2021.</p><p>                                                                       Approve</p><p>                                                                       these</p><p>                                                                       proposals and</p><p>            The 4th meeting of the third session of Audit Committee</p><p>                                                                       agree to</p><p> July 8,    was held to deliberate on and approve the Proposal on</p><p>                                                                       submit them     None</p><p>                                                                       to the Board</p><p>            (Draft) and Its Summary.</p><p>                                                                       of Directors</p><p>                                                                       for</p><p>                                                                       deliberation</p><p>                                                                       Approve</p><p>            The 5th meeting of the third session of Audit Committee these</p><p>            was held to deliberate on and approve the                  proposals and</p><p>            Company"s 2022 Semi-annual Report and its Summary, agree to</p><p> August</p><p>            the 2022 Special Report on the Semi-annual Storage and submit them         None</p><p>            Actual Use of Raised Fund, and the Proposal on the to the Board</p><p>            Adjustment of the Conversion Price of "Proya of Directors</p><p>            Convertible Bond".                                         for</p><p>                                                                       deliberation</p><p>                                         Annual Report 2022</p><p>                                                                       Approve</p><p>                                                                       these</p><p>                                                                       proposals and</p><p>             The 6th meeting of the third session of Audit Committee   agree to</p><p> October</p><p>             was held to deliberate on and approve the Company"s       submit them     None</p><p>                                                                       of Directors</p><p>                                                                       for</p><p>                                                                       deliberation</p><p>(3). Three meetings held by the Remuneration and Appraisal Committee during            the Reporting</p><p>     Period</p><p>                                                                         Important</p><p>                                                                                          Other</p><p>                                                                         comments</p><p>    Date                           Description                                         performance</p><p>                                                                             and</p><p>                                                                                         of duties</p><p>                                                                        suggestions</p><p>                                                                       Approve</p><p>            The 1st meeting of the third session of Remuneration and these</p><p>            Appraisal Committee was held to deliberate on and proposals and</p><p>            approve the Proposal on the Satisfaction of Conditions agree to</p><p> January</p><p>            for Releasing the Sales Restrictions for the Third Release submit them     None</p><p>            Period of the Restricted Shares Granted for the First to the Board</p><p>            Time and with Reserve under the 2018 Restricted Share of Directors</p><p>            Incentive Plan.                                            for</p><p>                                                                       deliberation</p><p>                                                                       Approve</p><p>                                                                       these</p><p>            The 2nd meeting of the third session of Remuneration and proposals and</p><p>            Appraisal Committee was held to deliberate on and agree to</p><p> April 20,</p><p>            approve the Proposal on Confirming the Remuneration of submit them         None</p><p>            Directors for 2021 and the Proposal on Confirming the to the Board</p><p>            Remuneration of Senior Management for 2021.                of Directors</p><p>                                                                       for</p><p>                                                                       deliberation</p><p>                                                                       Approve</p><p>            The 3rd meeting of the third session of Remuneration and</p><p>                                                                       these</p><p>            Appraisal Committee was held to deliberate on and</p><p>                                                                       proposals and</p><p>            approve the Proposal on 2022 Restricted Share Incentive</p><p>                                                                       agree to</p><p> July 8,    Plan of the Company (Draft) and Its Summary, the</p><p>                                                                       submit them     None</p><p>                                                                       to the Board</p><p>            Method for the 2022 Restricted Share Incentive Plan, and</p><p>                                                                       of Directors</p><p>            the Proposal on Verifying the List of Incentive Recipients</p><p>                                                                       for</p><p>            for the 2022 Restricted Share Incentive Plan.</p><p>                                                                       deliberation</p><p>(4). One meeting held by the Strategy Committee during the Reporting Period</p><p>                                          Annual Report 2022</p><p>                                                                          Important</p><p>                                                                                           Other</p><p>                                                                          comments</p><p>    Date                            Description                                         performance</p><p>                                                                              and</p><p>                                                                                          of duties</p><p>                                                                         suggestions</p><p>                                                                        Approve</p><p>                                                                        these</p><p>                                                                        proposals and</p><p>             The 2nd meeting of the third session of Strategy</p><p>                                                                        agree to</p><p> April 20,   Committee was held to deliberate on and approve the</p><p>                                                                        submit them     None</p><p>                                                                        to the Board</p><p>                                                                        of Directors</p><p>                                                                        for</p><p>                                                                        deliberation</p><p>(5). Dissenting matters</p><p>□ Applicable √ Not applicable</p><p>VIII. Explanation on the Company"s Risks Identified by the Board of Supervisors</p><p>□ Applicable √ Not applicable</p><p>The Board of Supervisors had no objection to matters supervised during the Reporting Period.</p><p>IX. Employees of the Parent Company and Major Subsidiaries as of the End of the Reporting</p><p>    Period</p><p>(I) Employees</p><p> Number of current employees of the parent                                                     1,129</p><p> company</p><p> Number of current employees of major                                                          2,048</p><p> subsidiaries</p><p> Total number of employees                                                                     3,177</p><p> Number of retired employees to be supported by                                                    4</p><p> the parent company and major subsidiaries</p><p>                                       Specialty composition</p><p>                    Category                                      Number of employees</p><p>               Production workers                                                                276</p><p>                 Sales specialists                                                             2,370</p><p>                  Management                                                                     302</p><p>                 R&D personnel                                                                   229</p><p>                      Total                                                                    3,177</p><p>                                      Educational background</p><p>                 Education level                                    Number (persons)</p><p>               Bachelor and above                                                              1,217</p><p>                    Associate                                                                    724</p><p>              High school and below                                                            1,236</p><p>                      Total                                                                    3,177</p><p>                                           Annual Report 2022</p><p>(II) Remuneration policy</p><p>√ Applicable □ Not applicable</p><p>Value creation is the Company"s basis for salary distribution. Performance is an intuitive reflection of</p><p>value. By establishing a comprehensive and objective performance evaluation system, the Company</p><p>combines salary distribution and performance evaluation of employees with an aim to fully guide and</p><p>motivate employees to create value.</p><p>(III) Training program</p><p>√ Applicable □ Not applicable</p><p>The Company adheres to the goal of gathering and training outstanding professionals by always</p><p>considering staff learning and growth as a primary task, and continuously innovating in and optimizing</p><p>training research, training topics, training forms, training implementation, training evaluation and</p><p>improvement, and trainer management. In terms of the form of learning, the Company combines internal</p><p>and external learning and fully improves the engagement of employees in training, thus making the</p><p>training more effective.</p><p>(IV) Labor outsourcing</p><p>√ Applicable □ Not applicable</p><p> Total man-hours for labor outsourcing</p><p> Total remuneration paid for labor outsourcing                                     RMB53,644,979.66</p><p>Labor Service Co., Ltd. to outsource auxiliary services including canteen, greening, cleaning, and goods</p><p>handling, loading and unloading, and packaging to the latter and pay consideration for the agreed</p><p>quantities.</p><p>Enterprise Management Co., Ltd. to outsource services such as partial goods handling, loading and</p><p>unloading, combined packaging, and mask folding to the latter, and pay consideration for the agreed</p><p>quantities.</p><p>X.   Profit Distribution or Capital Reserve Conversion Plan</p><p>(I) Development, implementation or adjustment of the cash dividend distribution policy</p><p>√ Applicable □ Not applicable</p><p>The Company held the 16th meeting of the second session of Board of Directors and the 3rd extraordinary</p><p>General Meeting of Shareholders on October 12, 2020 and October 28, 2020 respectively and approved</p><p>the Proposal on the Company"s Planning for Dividends to Shareholders for the Next Three Years (2020-</p><p>I. Factors considered in developing the planning for dividend distribution to shareholders</p><p>To promote the long-term and sustainable development, based on a comprehensive analysis of the</p><p>corporate development strategy, shareholder requirements and expectations, social capital costs, and</p><p>external financing environment, the Company has solicited and listened to the requirements and</p><p>expectations of shareholders, especially small and medium shareholders, fully considered the Company"s</p><p>current and future profitability, cash flow, development stage, project investment capital needs, and bank</p><p>credit, balanced the short-term and long-term interests of shareholders, and made institutional</p><p>                                             Annual Report 2022</p><p>arrangements for profit distribution, so as to establish a sustainable and stable mechanism for dividend</p><p>distribution to investors to ensure the continuity and stability of the Company"s profit distribution policy.</p><p>II. Principles for planning for dividend distribution to shareholders</p><p>The Company implements a continuous and stable profit distribution policy, attaches importance to</p><p>reasonable investment returns to investors while considering sustainable development, and has established</p><p>a continuous and stable mechanism for returns to investors in combination with the Company"s</p><p>profitability and actual needs for the future development strategy. The Company shall make a profit</p><p>distribution plan in accordance with the Articles of Association. The Company"s Board of Directors, Board</p><p>of Supervisors and General Meeting of Shareholders shall fully consider the opinions of independent</p><p>directors, supervisors and public investors in deciding and demonstrating the profit distribution policy.</p><p>III. Planning for dividend distribution to shareholders (2020-2022)</p><p>reasonable investment returns to investors as well as the Company"s actual operating conditions and</p><p>sustainable development for the current year in profit distribution.</p><p>by laws and regulations. The distribution shall not exceed the accumulated distributable profits, and shall</p><p>not undermine the Company"s ability to continue as a going concern. When eligible for cash dividends,</p><p>the Company shall distribute profits first in cash.</p><p>When eligible for cash dividends under the Company"s Articles of Association, the Company shall, in</p><p>principle, distribute profits in cash on a yearly basis. The Company"s Board of Directors may propose that</p><p>the Company should distribute interim cash dividends according to the Company"s profitability and capital</p><p>needs. The Company shall maintain the continuity and stability of the profit distribution policy, and</p><p>distribute every year at least 20% of the distributable profits achieved for the current year. The Company"s</p><p>Board of Directors shall propose a differentiated cash dividend policy in line with the procedure under the</p><p>Company"s Articles of Association after a comprehensive analysis of factors such as industry</p><p>characteristics, development stage, its own business mode, profitability, and major spending arrangements.</p><p>(1) The Company shall evaluate the implemented plan for dividend distribution to shareholders once every</p><p>three years. According to applicable laws and regulations, the Company"s operating conditions, and the</p><p>opinions of shareholders (especially small and medium investors) and independent directors, the Company</p><p>may modify its current profit distribution policy when necessary and make a new plan for dividend</p><p>distribution to shareholders. Upon adjustment, the plan for dividend distribution to shareholders shall be</p><p>approved by voting at the General Meeting of Shareholders.</p><p>(2) The Company"s Board of Directors shall make an appropriate annual distribution plan or an interim</p><p>profit distribution plan as necessary for development after fully considering the Company"s profitability,</p><p>cash flow, development capital needs, financing costs, and the external financing environment, and</p><p>implement them upon the approval by the Company"s General Meeting of Shareholders.</p><p>During the Reporting Period, the Company approved the 2021 annual profit distribution plan at the 2021</p><p>Annual General Meeting of Shareholders, whereby distributing a cash dividend of RMB8.60 (tax inclusive)</p><p>for each 10 shares to all shareholders registered as of the record date on the basis of the total share capital</p><p>as of the record date for dividend distribution for a total of RMB172,868,570.76 (tax inclusive). The said</p><p>dividend distribution was completed on May 30, 2022.</p><p>(II) Special description of the cash dividend policy</p><p>√ Applicable □ Not applicable</p><p>                                             Annual Report 2022</p><p> Is the cash dividend policy acceptable under the Company"s Articles of Association or</p><p>                                                                                           √Yes □No</p><p> as required by resolutions at the General Meeting of Shareholders?</p><p> Are dividend distribution standard and ratio clearly defined?                             √Yes □No</p><p> Are decision-making procedures and mechanisms complete?                                   √Yes □No</p><p> Do independent directors fulfill their duties and play their roles diligently?            √Yes □No</p><p> Do minority shareholders have the opportunity to fully express their opinions and</p><p>                                                                                           √Yes □No</p><p> demands, and are their legitimate rights and interests fully protected?</p><p>(III) Where the Company made profits and the parent company could provide positive profits</p><p>      available to shareholders for distribution but did not propose a cash profit distribution plan</p><p>      during the Reporting Period, the Company shall disclose the reasons in details and the purpose</p><p>      and use of undistributed profits.</p><p>□ Applicable √ Not applicable</p><p>(IV) Profit distribution and capitalization of capital reserves during the Reporting Period</p><p>√ Applicable □ Not applicable</p><p>                                                                         Unit: Yuan      Currency: RMB</p><p> Number of bonus shares distributed per 10 shares</p><p> (shares)</p><p> Dividends per 10 shares (RMB) (tax included)                                                    8.70</p><p> Conversions per 10 shares (shares)                                                                   4</p><p> Amount of cash dividends (tax included)                                              246,661,938.03</p><p> Net profit attributable to ordinary shareholders of</p><p> the Company in the annual consolidated statement                                     817,400,223.93</p><p> of dividends</p><p> Proportion in the net profit attributable to ordinary</p><p> shareholders of the Company in the consolidated                                                30.18</p><p> statement (%)</p><p> Amount of shares repurchased in cash included in</p><p> cash dividends</p><p> Total dividend amount (tax included)                                                 246,661,938.03</p><p> Proportion of the dividend amount in the net profit</p><p> attributable to ordinary shareholders of the                                                   30.18</p><p> Company in the consolidated statement (%)</p><p>XI. The Company"s Equity Incentive Plans, Employee Stock Ownership Plans or Other Employee</p><p>    Incentives and Their Impact</p><p>(I)   Relevant incentive matters disclosed in the temporary announcement and with no progress</p><p>      or changes in subsequent implementation</p><p>√ Applicable □ Not applicable</p><p>              Matter                                              Reference</p><p> Announcement on the Satisfaction</p><p>                                        SSE website, Shanghai Securities News, Securities Times on</p><p> of Conditions for Releasing the</p><p>                                        January 13, 2022</p><p> Sales Restrictions for the Third</p><p>                                             Annual Report 2022</p><p> Release Period of the Restricted</p><p> Shares Granted for the First Time</p><p> and with Reserve under the 2018</p><p> Restricted Share Incentive Plan</p><p> and Listing</p><p> Announcement         on      2022</p><p> Restricted Share Incentive Plan of     SSE website, Shanghai Securities News, Securities Times on July</p><p> the Company (Draft) and Its            9, 2022</p><p> Summary</p><p> Announcement on the Granting of</p><p>                                        SSE website, Shanghai Securities News, Securities Times on July</p><p> Restricted Shares to Incentive</p><p> Recipients</p><p> Announcement on the Granting</p><p>                                        SSE website, Shanghai Securities News, Securities Times on</p><p> Result of the 2022 Restricted</p><p>                                        September 8, 2022</p><p> Stock Incentive Plan</p><p>(II)   Incentives not disclosed in the interim announcement or with subsequent progress</p><p>Equity incentives</p><p>□ Applicable √ Not applicable</p><p>Other explanations</p><p>□ Applicable √ Not applicable</p><p>Employee stock ownership plans</p><p>□ Applicable √ Not applicable</p><p>Other incentives</p><p>□ Applicable √ Not applicable</p><p>(III) Equity incentives granted to directors and senior management during the Reporting Period</p><p>□ Applicable √ Not applicable</p><p>√ Applicable □ Not applicable</p><p>                                                                                                   Unit: share</p><p>                                      Number of                                      Number</p><p>                         Number</p><p>                                        newly                                           of        Market price</p><p>                            of                      Price of</p><p>                                       granted                                      restricted    as of the end</p><p>                        restricted                 restricted   Unloc</p><p>                                      restricted                          Locked      shares          of the</p><p>   Name     Position      shares                     shares      ked</p><p>                                        shares                            shares    held at the    Reporting</p><p>                       held at the                  granted     shares</p><p>                                      during the                                    end of the       Period</p><p>                       beginning                    (RMB)</p><p>                                      Reporting                                     Reporting        (RMB)</p><p>                       of the year</p><p>                                       Period                                         Period</p><p> JIN       Deputy         54,981         140,000       78.56      76,97   140,000     216,973     36,338,638.0</p><p> Yanhua    General                                                    3                                      4</p><p>           Manager</p><p> WANG      Deputy         32,322         180,000       78.56      45,25   180,000     225,251     37,725,037.4</p><p>                                            Annual Report 2022</p><p> Li         General                                                 1                                    8</p><p>            Manager,</p><p>            Secretary</p><p>            of the</p><p>            Board of</p><p>            Directors,</p><p>            CFO</p><p>                 /         87,303       320,000       /          122,2   320,000     442,224        /</p><p>   Total</p><p>Note: The Company implemented the 2021 Equity Distribution Plan on May 30, 2022, in which the</p><p>Company distributed to all shareholders a cash dividend of RMB8.60 (tax inclusive) per 10 shares based</p><p>on the total share capital as of the record date on which equity distribution is implemented and issued 4</p><p>shares for every 10 shares to all shareholders through capitalization of the capital reserve. The "unlocked</p><p>shares" and "number of restricted shares held at the end of the period" mentioned in the table above include</p><p>the shared converted through the capitalization of the capital reserve in 2021.</p><p>(IV) Evaluation mechanism for senior management as well as the establishment and</p><p>     implementation of the incentive mechanism during the Reporting Period</p><p>√ Applicable □ Not applicable</p><p>During the Reporting Period, the Company"s General Manager and other senior management were</p><p>evaluated based on performance indicators and their annual performance remuneration was submitted by</p><p>the Remuneration and Appraisal Committee to the Board of Directors for deliberation.</p><p>XII. Construction and Implementation of the Internal Control System during the Reporting Period</p><p>√ Applicable □ Not applicable</p><p>The Company has developed relevant systems including the Internal Audit System, the External</p><p>Guarantee Decision-making Management System, the Related-party Transaction Management System,</p><p>the Raised Funds Management System, and the Information Disclosure Management System, and</p><p>established processes for company establishment/investment/change applications, entrusted wealth</p><p>management application, and guarantee application. The Company continuously improves the internal</p><p>control system and related processes, regulates the implementation of the internal control system,</p><p>strengthens the supervision and inspection of internal control, and promotes the healthy and sustainable</p><p>development of the Company.</p><p>Description on Material deficiencies in internal control during the Reporting Period</p><p>□ Applicable √ Not applicable</p><p>XIII. Management and Control of Subsidiaries during the Reporting Period</p><p>√ Applicable □ Not applicable</p><p>The Company has developed systems including the External Investment and Operation Decision-making</p><p>System and the Subsidiary Management System to implement centralized control over subsidiaries. The</p><p>Company HQ is responsible for its finance, asset operation and overall strategic planning while all</p><p>subsidiaries develop their strategic plans based on the Company"s overall strategic planning.</p><p>XIV. Description of the Internal Control Audit Report</p><p>√ Applicable □ Not applicable</p><p>                                           Annual Report 2022</p><p>During the Reporting Period, Pan-China Certified Public Accountants (Special General Partnership), the</p><p>Company"s internal control auditing firm, issued the Internal Control Audit Report (Tian Jian Shen [2023]</p><p>No.3129), in which opinion the Company had maintained effective internal control over financial</p><p>reporting in all material aspects as of December 31, 2022 pursuant to the Basic Rules for Internal Control</p><p>and other applicable provisions.</p><p>Whether to disclose the internal control audit report: Yes</p><p>Type of opinion in the internal control audit report: standard unqualified opinion</p><p>XV. Correction of Problems Identified in the Special Campaign for Governance of Listed</p><p>    Companies</p><p>None</p><p>XVI. Other</p><p>□ Applicable √ Not applicable</p><p>                Section V Environmental and Social Responsibility</p><p>I.   Environmental Information</p><p> Whether to establish the environmental protection</p><p>                                                                                                    Yes</p><p> mechanism</p><p> Investment in environmental protection during the</p><p> Reporting Period (Unit: RMB’0,000)</p><p>(I) Environmental issues of the Company and major subsidiaries included in the list of primary</p><p>    pollutant discharge entities announced by the environmental authority</p><p>□ Applicable √ Not applicable</p><p>(II) Environmental issues of the Company not included in the list of primary pollutant discharge</p><p>     entities</p><p>√ Applicable □ Not applicable</p><p>□ Applicable √ Not applicable</p><p>     entities</p><p>√ Applicable □ Not applicable</p><p>During the Reporting Period, the Company passed the ISO14001:2015 Environmental Management</p><p>System certification (valid until February 14, 2025). The emission of greenhouse gases and discharge of</p><p>industrial wastewater, air emissions, and residues mainly occur from product production.</p><p>The wastewater produced by the Company mainly comes from domestic sewage and production</p><p>wastewater and is discharged to landscape water pools or to the outside through a consolidated water pipe</p><p>after being treated by the sewage treatment station. The air emissions produced mainly comes from boilers.</p><p>The Company has formulated the Sewage Treatment Management System, the Boiler Management System,</p><p>                                            Annual Report 2022</p><p>and other management documents to strictly control the discharge of wastewater and air emissions. During</p><p>the Reporting Period, the Company discharged wastewater and air emissions up to standards.</p><p>Main administrative measures taken during the Reporting Period include:</p><p>(1) Wastewater:</p><p>The Company installed the Multi Vision COD online automatic monitoring instrument, and monitored the</p><p>COD in treated water 24 hours a day to ensure class-A sewage discharge; constructed a sewage treatment</p><p>system to make sure treated sewage is highly purified and recycled; renovated environmental protection</p><p>technologies in the production park:</p><p>① Underground pipeline CCTV detection system: Consisting of crawlers, lenses, cable reels, and a</p><p>control system, the underground pipeline CCTV detection system is used to clear the blockage in the</p><p>pipeline inside the park and maintain and repair the pipeline network, so as to prevent the risk of sewage</p><p>leakage due to outdated pipeline and provide reliable technological support for zero sewage discharge;</p><p>② Perform technological transformation on the anaerobic tower of the sewage treatment station to</p><p>improve the biological anaerobic effect;</p><p>③ Increase the capacity and efficiency of the air flotation tank of the sewage treatment station to 10 tons;</p><p>improve the capability of treating gas explosion of sewage in the air flotation tank, and enhance the clean</p><p>water treatment capacity on the original basis.</p><p>(2) Air emissions:</p><p>① Huzhou production base (skincare factory): A air emissions treatment facility for the cream production</p><p>line was added to reduce the emission of dust and organic air emissions. After being use, the facility can</p><p>collect 99% dust and remove 75% organic air emissions. A highly-precise volatile organic chemical (VOC)</p><p>gas collection device was installed to effectively reduce unorganized gas emission;</p><p>② Huzhou production base (make-up factory): A Swiss-made VOC gas and dust treatment facility was</p><p>added.</p><p>(3) The Company properly disposes of solid waste generated in production and operations. The Company</p><p>manages solid wastes in a macroscopical manner and our factories can track the whole process data on</p><p>solid wastes and prevent risks by requesting to report the amount of generated hazardous waste on the</p><p>National Information System Platform for the Management of Solid Wastes and Chemicals every year,</p><p>selecting hazardous waste treatment service providers through open bidding on the platform, and</p><p>requesting for the treatment of hazardous wastes on the platform.</p><p>□ Applicable √ Not applicable</p><p>(III) The Company"s performance in helping protect the environment, prevent pollution and fulfill</p><p>      environmental responsibilities</p><p>√ Applicable □ Not applicable</p><p>The emission of greenhouse gases and discharge of industrial wastewater, air emissions, and residues</p><p>mainly occur from product production. Moreover, the consumption of energy, raw materials, and other</p><p>resources principally occurs when products are made. Therefore, sustainable production can improve the</p><p>usage efficiency of resources and energy in production processes, reduce pollutants and greenhouse gas</p><p>emissions, and build a resource-saving and eco-friendly production system.</p><p>During the Reporting Period, the Company carried out a new round of audits on cleaner production in the</p><p>Huzhou Production Base (skincare factory). We investigated the current situation of pollutant emissions,</p><p>                                            Annual Report 2022</p><p>energy management, and environmental protection, and also developed several cleaner production</p><p>implementation programs according to the investigation results.</p><p>During the Reporting Period, the Huzhou Production Base (skincare factory) planned and implemented</p><p>(1) Reduced waste water discharge by 4,400 tons;</p><p>(2) Reduced COD emission by 0.17 tons and ammonia nitrogen emission by 0.001 tons;</p><p>(3) Reduced the generation of hazardous waste by 3 tons;</p><p>(4) Reduced carbon dioxide emissions by 322.73 tons;</p><p>(5) Saved electricity by 565.9 MWh;</p><p>(6) Saved raw materials worth RMB108 thousand;</p><p>(7) Saved natural gas by 3,000 Nm³;</p><p>(8) Saved water by 4,600 m³.</p><p>(IV) Measures taken to reduce carbon emissions during the Reporting Period and their effects</p><p> Whether to take carbon emission</p><p>                                                                                                    Yes</p><p> reduction measures</p><p> Carbon dioxide emission equivalent</p><p> reduced (unit: ton)</p><p>                                            policies to suppliers, cooperate with them to reduce carbon</p><p>                                            emissions in the stage of procurement, and prioritize</p><p>                                            suppliers with low carbon emissions.</p><p>                                            (1) Regularly collect carbon emissions data, invite</p><p>                                            professional third parties to conduct data audits, and make</p><p>                                            improvements to correct deviations inside the Company;</p><p>                                            (2) Carry out energy-saving and technology upgrade</p><p> Type of carbon emission reduction</p><p>                                            projects to improve energy efficiency;</p><p> measures (such as electricity generation</p><p>                                            (3) Carry out clean energy replacement and increase the</p><p> with clean energy, carbon reduction</p><p>                                            proportion of clean energy use through photovoltaic power</p><p> technologies used in production, or the</p><p>                                            generation and the purchase of green electricity.</p><p> development and production of new</p><p> products that help reduce carbon</p><p>                                            reduce carbon emissions after packaging disposal through</p><p> emissions)</p><p>                                            packaging usage reduction, packaging recycling, and other</p><p>                                            methods.</p><p>                                            and logistics system to reduce energy consumption in the</p><p>                                            process of warehousing and logistics by rationally arranging</p><p>                                            warehouses and planning transportation routes.</p><p>                                            sustainable consumption to consumers to provide them with</p><p>                                            more sustainable choices.</p><p>Specific description</p><p>□ Applicable √ Not applicable</p><p>                                          Annual Report 2022</p><p>II. Social Responsibility</p><p>(I)   Whether to independently disclose social responsibility reports, sustainable development</p><p>      reports, or ESG reports</p><p>√ Applicable □ Not applicable</p><p>For details, see the Proya Sustainable Development & Environmental, Social, and Governance (ESG)</p><p>Report 2022 disclosed by the Company on the SSE website (www.sse.com.cn) disclosed on the same day.</p><p>(II) Description of social responsibilities</p><p>√ Applicable □ Not applicable</p><p>  External donation and charity</p><p>                                    Quantity/content                       Description</p><p>             projects</p><p>                                                          Include funds and materials donated by the</p><p> Total investment (RMB’0,000)                  143.46     Company to various community philanthropy</p><p>                                                          and charitable activities</p><p>                                                          Shanghai Adream Foundation for the "One</p><p>                                                          County, One Dream" charity project.</p><p>                                                          Village, Jiulong County, Ganzi Prefecture,</p><p>                                                          Sichuan Province, and donated RMB100,000</p><p> Including: fund (RMB’0,000)                   140.00</p><p>                                                          to village school so they could buy stationery</p><p>                                                          and books;</p><p>                                                          to the charity project jointly operated by the</p><p>                                                          Wuxing District Charity Federation of</p><p>                                                          Huzhou and Proya.</p><p>                                                          The Company donated anti-epidemic supplies</p><p> Cash value        of   materials</p><p> (RMB’0,000)</p><p>                                                          Hangzhou</p><p> Number       of    beneficiaries</p><p> (person)</p><p>Specific description</p><p>□ Applicable √ Not applicable</p><p>III. Poverty Alleviation and Rural Revitalization Progress</p><p>√ Applicable □ Not applicable</p><p>   Poverty alleviation and rural</p><p>                                       Quantity/content                      Description</p><p>       revitalization project</p><p>                                                                to Shanghai Adream Foundation for the</p><p> Total investment (RMB’0,000)                             110   "One County, One Dream" charity</p><p>                                                                project.</p><p>                                     Annual Report 2022</p><p>                                                           Liwu Village, Jiulong County, Ganzi</p><p>                                                           Prefecture, Sichuan Province, and</p><p>                                                           donated RMB100,000 to village school</p><p>                                                           so they could buy stationery and books;</p><p> Including: fund (RMB’0,000)                         110</p><p> Cash     value    of   materials</p><p> (RMB’0,000)</p><p> Number of beneficiaries (person)                8,085</p><p> Form of support (such as</p><p> industrial support, employment      Education support</p><p> support, education support, etc.)</p><p>Specific description</p><p>□ Applicable √ Not applicable</p><p>                                                                        Annual Report 2022</p><p>                                                         Section VI           Important Matters</p><p>I.     Fulfillment of Commitments</p><p>(I)     Commitments made by the Company"s actual controllers, shareholders, related parties, acquirers and the Company and other relevant parties during</p><p>        the Reporting Period or continuing to the Reporting Period</p><p>√ Applicable □ Not applicable</p><p>                                                                                                                                                          The next</p><p>                                                                                                                            Whether the     Cause for       step in</p><p>                                                                                                                 Any        commitment         any        the event</p><p>                                                                                                 Date and</p><p>     Background      Type         Promisor                     Description                                   deadline for     is timely     failure to   of failure</p><p>                                                                                                 duration</p><p>                                                                                                             performance     and strictly    perform           to</p><p>                                                                                                                             performed       in time       perform</p><p>                                                                                                                                                           in time</p><p>                  Restrictions   Directors,   (1) During their terms as the Company"s            Date:       No             Yes             Not          Not</p><p>                  on sales       senior       director/senior management, they shall not         November                                   applicable   applicable</p><p>                                 management   transfer more than 25% of their total shares       15, 2017</p><p>                                 HOU          directly or indirectly held in the Company each    Duration:</p><p>                                 Juncheng,    year. Within six months after leaving office,      November</p><p>                                 FANG         they shall not transfer their shares directly or   15, 2017</p><p>                                 Yuyou and    indirectly held in the Company. (2) If their       to long-</p><p> IPO-related                     CAO          shares in the Company are sold within two          term</p><p> commitments                     Liangguo     years upon expiration of the lock-up period,</p><p>                                              the selling price shall not be lower than the</p><p>                                              offering price. If the closing price of the</p><p>                                              Company"s shares is lower than the offering</p><p>                                              price for 20 consecutive trading days within 6</p><p>                                              months after the Company"s IPO, or the</p><p>                                              closing price as of the end of the 6-month</p><p>                                              period after the Company"s IPO is lower than</p><p>                                                       Annual Report 2022</p><p>                            the offering price, the lock-up period for their</p><p>                            shares in the Company will be automatically</p><p>                            extended for 6 months. Their commitments</p><p>                            above shall survive job change and</p><p>                            resignation. (3) Should any of them/their</p><p>                            partnership violate the said share lock-up</p><p>                            commitments, the lock-up period for</p><p>                            their/their partnership"s shares in the Company</p><p>                            will be automatically extended for 6 months.</p><p>Restrictions   Senior       (1) Within 12 months from the date of the           Date:       No   Yes   Not          Not</p><p>on sales       management   Company"s IPO, they shall not transfer or           April 16,              applicable   applicable</p><p>               JIN Yanhua   authorize any other to manage their shares          2018</p><p>                            directly or indirectly held in the Company or       Duration:</p><p>                            have the Company repurchase such shares. (2)        April 16,</p><p>                            During their terms as the Company"s senior          2018 to</p><p>                            management, they shall not transfer more than       long-term</p><p>                            held in the Company each year. Within six</p><p>                            months after leaving office, they shall not</p><p>                            transfer their shares directly or indirectly held</p><p>                            in the Company. (3) If their shares in the</p><p>                            Company are sold within two years upon</p><p>                            expiration of the lock-up period, the selling</p><p>                            price shall not be lower than the offering price.</p><p>                            If the closing price of the Company"s shares is</p><p>                            lower than the offering price for 20</p><p>                            consecutive trading days within 6 months after</p><p>                            the Company"s IPO, or the closing price as of</p><p>                            the end of the 6-month period after the</p><p>                                                       Annual Report 2022</p><p>                            Company"s IPO is lower than the offering</p><p>                            price, the lock-up period for their shares in the</p><p>                            Company will be automatically extended for 6</p><p>                            months. Their commitments above shall</p><p>                            survive job change and resignation. (4) Should</p><p>                            any of them/their partnership violate the said</p><p>                            share lock-up commitments, the lock-up</p><p>                            period for their/their partnership"s shares in the</p><p>                            Company will be automatically extended for 6</p><p>                            months.</p><p>Restrictions   Senior       (1) Within 12 months from the date of the            Date:        No   Yes   Not          Not</p><p>on sales       management   Company"s IPO, they shall not transfer or            September               applicable   applicable</p><p>               WANG Li      authorize any other to manage their shares           3,    2018</p><p>                            directly or indirectly held in the Company or        Duration:</p><p>                            have the Company repurchase such shares. (2)         September</p><p>                            During their terms as the Company"s senior           3, 2018 to</p><p>                            management, they shall not transfer more than        long-term</p><p>                            held in the Company each year. Within six</p><p>                            months after leaving office, they shall not</p><p>                            transfer their shares directly or indirectly held</p><p>                            in the Company. (3) If their shares in the</p><p>                            Company are sold within two years upon</p><p>                            expiration of the lock-up period, the selling</p><p>                            price shall not be lower than the offering price.</p><p>                            If the closing price of the Company"s shares is</p><p>                            lower than the offering price for 20</p><p>                            consecutive trading days within 6 months after</p><p>                            the Company"s IPO, or the closing price as of</p><p>                                                        Annual Report 2022</p><p>                             the end of the 6-month period after the</p><p>                             Company"s IPO is lower than the offering</p><p>                             price, the lock-up period for their shares in the</p><p>                             Company will be automatically extended for 6</p><p>                             months. Their commitments above shall</p><p>                             survive job change and resignation. (4) Should</p><p>                             any of them/their partnership violate the said</p><p>                             share lock-up commitments, the lock-up</p><p>                             period for their/their partnership"s shares in the</p><p>                             Company will be automatically extended for 6</p><p>                             months.</p><p>Restrictions   Controlling   (1) Within 24 months upon expiration of the          Date:       No   Yes   Not          Not</p><p>on sales       shareholder   lock-up period, they shall not directly or           November               applicable   applicable</p><p>               and actual    indirectly reduce their shares in the Issuer by      15, 2017</p><p>               controller    more than 6% of the total number of shares of        Duration:</p><p>               HOU           the Issuer before such IPO. (2) They must sell       November</p><p>               Juncheng      shares in the Company through methods                15, 2017</p><p>               and FANG      including but not limited to collective trading      to long-</p><p>               Aiqin         through bidding, block trading, and transfer by      term</p><p>                             agreement and transfer by agreement in line</p><p>                             with applicable laws, regulations and rules. (3)</p><p>                             Before selling the Company"s shares, they</p><p>                             shall announce the same three trading days in</p><p>                             advance, discharge the obligation to disclose</p><p>                             information in a timely and accurate manner as</p><p>                             per the rules of the securities exchange, except</p><p>                             to the extent that their shares in the Company</p><p>                             are less than 5%. (4) Should they fail to</p><p>                             perform the said intent of share reduction, they</p><p>                                                        Annual Report 2022</p><p>                              must explain the cause for failing to do so in</p><p>                              the Company"s General Meeting of</p><p>                              Shareholders and the media designated by the</p><p>                              CSRC and publicly apologize to the</p><p>                              Company"s shareholders and public investors.</p><p>Restrictions   Shareholders   (1) If they intend to reduce shares after the      Date:       No   Yes   Not          Not</p><p>on sales       FANG           lock-up period expires, they will prudently        November               applicable   applicable</p><p>               Yuyou and      make a share reduction plan as necessary for       15, 2017</p><p>               LI Xiaolin     the Company to stabilize the share price and       Duration:</p><p>               directly       conduct operations and capital operations as       November</p><p>               holding        required by the CSRC and the exchange on           15, 2017</p><p>               more than      shareholders for share reduction, whereby          to long-</p><p>               the            the lock-up period. (2) They must sell shares</p><p>               Company        in the Company with methods including but</p><p>                              not limited to collective trading through</p><p>                              bidding, block trading, and transfer by</p><p>                              agreement in line with applicable laws,</p><p>                              regulations and rules. (3) Before selling the</p><p>                              Company"s shares, they shall announce the</p><p>                              same three trading days in advance, discharge</p><p>                              the obligation to disclose information in a</p><p>                              timely and accurate manner as per the rules of</p><p>                              the securities exchange except to the extent</p><p>                              that their shares in the Company are less than</p><p>                              intent of share reduction, they must explain the</p><p>                              cause for failing to do so in the Company"s</p><p>                              General Meeting of Shareholders and the</p><p>                                            Annual Report 2022</p><p>                  media designated by the CSRC and publicly</p><p>                  apologize to the Company"s shareholders and</p><p>                  public investors.</p><p>Other   The       When the preconditions for enabling the share     Date:       No   Yes   Not          Not</p><p>        Company   price stabilization plan are met, if the          November               applicable   applicable</p><p>                  Company fails to take specific measures to        15, 2017</p><p>                  stabilize the share price, the Company must       Duration:</p><p>                  explain the cause for failing to do so in the     November</p><p>                  Company"s General Meeting of Shareholders         15, 2017</p><p>                  and the media designated by the CSRC and          to long-</p><p>                  publicly apologize to the Company"s               term</p><p>                  shareholders and public investors. In the event</p><p>                  of losses to investors not as a result of force</p><p>                  majeure, the Company will be liable for</p><p>                  compensation to investors by law, and be</p><p>                  liable otherwise as required by laws,</p><p>                  regulations and competent regulators; if the</p><p>                  losses are caused due to force majeure, the</p><p>                  Company shall work out a plan in the shortest</p><p>                  possible time to minimize losses to investors</p><p>                  and submit it to the General Meeting of</p><p>                  Shareholders for deliberation, so as to protect</p><p>                  the interests of the Company"s investors as</p><p>                  much as possible. Within three years from the</p><p>                  date of the Company"s IPO, if the Company</p><p>                  appoints     new    directors    and     senior</p><p>                  management, the Company will require such</p><p>                  new directors and senior management to fulfill</p><p>                  the commitments made by the directors and</p><p>                                                   Annual Report 2022</p><p>                       senior management at the time of the</p><p>                       Company"s IPO.</p><p>Other   The            When the preconditions for enabling the share         Date:       No   Yes   Not          Not</p><p>        Company"s      price stabilization plan are met, if failing to       November               applicable   applicable</p><p>        controlling    take specific measures to stabilize the share         15, 2017</p><p>        shareholders   price, they must explain the cause for failing to     Duration:</p><p>        and actual     do so at the Issuer"s General Meeting of              November</p><p>        controllers    Shareholders and the media designated by the          15, 2017</p><p>                       CSRC and publicly apologize to the Issuer"s           to long-</p><p>                       shareholders and public investors. Where the          term</p><p>                       commitment is not fulfilled, they will not</p><p>                       receive shareholder dividends from the Issuer</p><p>                       within 5 working days from the date when the</p><p>                       said incident occurs, and they will not be able</p><p>                       to transfer their shares until they take measures</p><p>                       to stabilize the share price as per the said plan</p><p>                       and achieve results.</p><p>Other   The            When the preconditions for enabling the share         Date:       No   Yes   Not          Not</p><p>        Company"s      price stabilization plan are met, if failing to       November               applicable   applicable</p><p>        directors      take specific measures to stabilize the share         15, 2017</p><p>        (excluding     price as per the plan to stabilize the share price,   Duration:</p><p>        independent    they must explain the cause for failing to do so      November</p><p>        directors)     at the Issuer"s General Meeting of                    15, 2017</p><p>        and senior     Shareholders and the media designated by the          to long-</p><p>        management     CSRC and publicly apologize to the Issuer"s           term</p><p>                       shareholders and public investors. Where the</p><p>                       commitment is not fulfilled, they will not</p><p>                       receive remuneration and shareholder</p><p>                       dividends (if any) from the Issuer within 5</p><p>                                             Annual Report 2022</p><p>                  working days from the date when the said</p><p>                  incident occurs, and they will not be able to</p><p>                  transfer their shares until they take measures to</p><p>                  stabilize the share price as per the said plan and</p><p>                  achieve results.</p><p>Other   The       If the Company"s prospectus contains false           Date:       No   Yes   Not          Not</p><p>        Company   records, misleading statements or major              November               applicable   applicable</p><p>                  omissions, which causes investors to suffer          15, 2017</p><p>                  losses in securities transactions, the Company       Duration:</p><p>                  will compensate investors for such losses by         November</p><p>                  law. After the illegal facts mentioned above         15, 2017</p><p>                  are identified by the CSRC or the stock              to long-</p><p>                  exchange or the judicial authority where the         term</p><p>                  Company is located, the Company will</p><p>                  actively compensate investors for direct</p><p>                  economic losses incurred therefrom by settling</p><p>                  with investors with respect to measurable</p><p>                  economic losses directly incurred to investors,</p><p>                  mediating with investors through a third party</p><p>                  and establishing an investor compensation</p><p>                  fund based on the principles of procedure</p><p>                  simplification,         active        negotiation,</p><p>                  compensation in advance, and effective</p><p>                  protection of investors" interests, especially</p><p>                  small and medium investors. If found to have</p><p>                  violated the said commitments, the Company</p><p>                  will publicly apologize to shareholders and</p><p>                  public investors for failing to perform the said</p><p>                  compensation measures at the General</p><p>                                                  Annual Report 2022</p><p>                       Meeting of Shareholders and the media</p><p>                       designated by the CSRC and compensate</p><p>                       investors for the actual losses identified by the</p><p>                       CSRC and the judicial authority.</p><p>Other   The Issuer"s   If the Issuer"s prospectus contains false           Date:       No   Yes   Not          Not</p><p>        controlling    records, misleading statements or major             November               applicable   applicable</p><p>        shareholders   omissions, which causes investors to suffer         15, 2017</p><p>        and actual     losses in securities transactions, they will        Duration:</p><p>        controllers    compensate investors for such losses by law.        November</p><p>                       After the illegal facts mentioned above are         15, 2017</p><p>                       identified by the CSRC or the stock exchange        to long-</p><p>                       or the judicial authority where the Company is      term</p><p>                       located, the Company will actively</p><p>                       compensate investors for direct economic</p><p>                       losses incurred therefrom by settling with</p><p>                       investors with respect to measurable economic</p><p>                       losses directly incurred to investors, mediating</p><p>                       with investors through a third party and</p><p>                       establishing an investor compensation fund</p><p>                       based on the principles of procedure</p><p>                       simplification,        active       negotiation,</p><p>                       compensation in advance, and effective</p><p>                       protection of investors" interests, especially</p><p>                       small and medium investors. If found to have</p><p>                       violated the said commitments, the Company"s</p><p>                       controlling shareholders and actual controllers</p><p>                       will publicly apologize to the Issuer"s</p><p>                       shareholders and public investors for failing to</p><p>                       perform the said compensation measures at the</p><p>                                                 Annual Report 2022</p><p>                      Issuer"s General Meeting of Shareholders and</p><p>                      the media designated by the CSRC and will not</p><p>                      receive shareholder dividends from the Issuer</p><p>                      within 5 working days from the date when the</p><p>                      said commitments are violated, and their</p><p>                      shares in the Issuer will not be transferred until</p><p>                      they take compensation measures as per the</p><p>                      said commitments and achieve results.</p><p>Other   Directors,    If the Issuer"s prospectus contains false            Date:       No   Yes   Not          Not</p><p>        supervisors   records, misleading statements or major              November               applicable   applicable</p><p>        and senior    omissions, which causes investors to suffer          15, 2017</p><p>        management    losses in securities transactions, they will         Duration:</p><p>                      compensate investors for such losses by law.         November</p><p>                      After the illegal facts mentioned above are          15, 2017</p><p>                      identified by the CSRC or the stock exchange         to long-</p><p>                      or the judicial authority where the Company is       term</p><p>                      located, the Company will actively</p><p>                      compensate investors for direct economic</p><p>                      losses incurred therefrom by settling with</p><p>                      investors with respect to measurable economic</p><p>                      losses directly incurred to investors, mediating</p><p>                      with investors through a third party and</p><p>                      establishing an investor compensation fund</p><p>                      based on the principles of procedure</p><p>                      simplification,        active        negotiation,</p><p>                      compensation in advance, and effective</p><p>                      protection of investors" interests, especially</p><p>                      small and medium investors. If found to have</p><p>                      violated the said commitments, the Company"s</p><p>                                             Annual Report 2022</p><p>                  directors, supervisors and senior management</p><p>                  will publicly apologize to the Issuer"s</p><p>                  shareholders and public investors for failing to</p><p>                  perform the said compensation measures at the</p><p>                  Issuer"s General Meeting of Shareholders and</p><p>                  the media designated by the CSRC and will not</p><p>                  receive remuneration (or allowances) and</p><p>                  shareholder dividends (if any) from the Issuer</p><p>                  within 5 working days from the date when the</p><p>                  said commitments are violated, and their</p><p>                  shares in the Issuer will not be transferred until</p><p>                  they take compensation measures as per the</p><p>                  said commitments and achieve results.</p><p>Other   The       In order to ensure the effective use of the          Date:       No   Yes   Not          Not</p><p>        Company   proceeds from the IPO, effectively prevent the       November               applicable   applicable</p><p>                  risk of diluting immediate returns and improve       15, 2017</p><p>                  future returns, the Company intends to take          Duration:</p><p>                  measures including tightening operation              November</p><p>                  management and internal control, accelerating        15, 2017</p><p>                  the progress of fundraising projects, and            to long-</p><p>                  strengthening the investor return mechanism,         term</p><p>                  so as to improve asset quality, increase</p><p>                  operation revenue, raise future earnings, and</p><p>                  achieve sustainable development to fill the</p><p>                  diluted immediate returns. The Company</p><p>                  promises to continuously improve various</p><p>                  measures to fill the diluted spot returns in</p><p>                  accordance with the implementation rules</p><p>                  issued by the CSRC and Shanghai Stock</p><p>                                                Annual Report 2022</p><p>                      Exchange. If found to have violated the said</p><p>                      commitments, the Company will promptly</p><p>                      announce the facts and cause of such violation,</p><p>                      except for force majeure or other reasons not</p><p>                      attributable to the Company, apologize to the</p><p>                      Company"s shareholders and public investors,</p><p>                      make supplementary commitments or</p><p>                      substitute commitments to investors to protect</p><p>                      the interests of investors as much as possible,</p><p>                      and      implement      such    supplementary</p><p>                      commitments or substitute commitments</p><p>                      subject to the approval by the Company"s</p><p>                      General Meeting of Shareholders.</p><p>Other   Controlling   In order to ensure that the Company"s             Date:       No   Yes   Not          Not</p><p>        shareholder   measures to fill the diluted immediate returns    November               applicable   applicable</p><p>        and actual    can be effectively performed, they, as the        15, 2017</p><p>        controller    Company"s controlling shareholder and actual      Duration:</p><p>        HOU           controller, promise that: (1) Under no            November</p><p>        Juncheng      circumstances will they abuse the position as     15, 2017</p><p>        and FANG      the controlling shareholder and actual            to long-</p><p>        Aiqin         controller by ultra vires interfering with the    term</p><p>                      Company"s operation and management</p><p>                      activities or encroaching on the Company"s</p><p>                      interests; (2) After the CSRC and Shanghai</p><p>                      Stock Exchange have otherwise released</p><p>                      opinions and implementation rules on</p><p>                      measures to fill the diluted immediate returns</p><p>                      and relevant commitments, if the Company"s</p><p>                      relevant provisions and their commitments</p><p>                                               Annual Report 2022</p><p>                     contradict such rules, they will immediately</p><p>                     make supplementary commitments in line with</p><p>                     such rules of the CSRC and Shanghai Stock</p><p>                     Exchange, and actively promote the Company</p><p>                     to issue new commitments or measures up to</p><p>                     the requirements of the CSRC and Shanghai</p><p>                     Stock Exchange; (3) They will fully,</p><p>                     completely and timely perform the Company"s</p><p>                     measures to fill the diluted immediate returns</p><p>                     and their commitments regarding the measures</p><p>                     to fill the diluted immediate returns. If found</p><p>                     to have violated such commitments, which</p><p>                     causes losses to the Company or shareholders,</p><p>                     they are willing to: ① state the cause and</p><p>                     apologize at the General Meeting of</p><p>                     Shareholders and the media designated by the</p><p>                     CSRC; ② be liable for compensation to the</p><p>                     Company and/or shareholders by law; ③</p><p>                     unconditionally accept the penalties or</p><p>                     regulatory measures taken by the CSRC and/or</p><p>                     Shanghai Stock Exchange and other securities</p><p>                     regulators as per their current rules. The said</p><p>                     measures to fill the diluted immediate returns</p><p>                     shall not be deemed to constitute a guarantee</p><p>                     for the Company"s future profits.</p><p>Other   Directors,   In order to ensure that the Company"s             Date:      No   Yes   Not          Not</p><p>        senior       measures to fill the diluted immediate returns    November              applicable   applicable</p><p>        management   can be effectively performed, they, as the        15, 2017</p><p>                          Annual Report 2022</p><p>Company"s directors and senior management,        Duration:</p><p>promise that: (1) They will not offer benefits    November</p><p>to other entities or individuals for free or on   15, 2017</p><p>unfair terms, or otherwise harm the Company"s     to long-</p><p>interests; (2) They will strictly follow the      term</p><p>Company"s budget management by limiting</p><p>their duty-related consumption to the extent</p><p>required, subject to the Company"s</p><p>supervision, and free from waste or</p><p>extravagance; (3) They will not use the</p><p>Company"s assets to engage in investment and</p><p>consumption activities unrelated to their</p><p>duties; (4) They will actively promote the</p><p>improvement of the Company"s compensation</p><p>system to better meet the requirements for</p><p>filling the diluted immediate returns; support</p><p>the Company"s Board of Directors or</p><p>Remuneration Committee to link the</p><p>development, revision, and supplementation of</p><p>the Company"s compensation system with the</p><p>implementation of the measures to fill the</p><p>diluted immediate returns; promise that the</p><p>vesting conditions for the Company"s equity</p><p>incentives will be linked to the implementation</p><p>of the Company"s measures to fill the diluted</p><p>immediate returns; (5) After the CSRC and</p><p>Shanghai Stock Exchange have otherwise</p><p>released the opinions and implementation</p><p>rules on the measures to fill the diluted</p><p>                          Annual Report 2022</p><p>immediate returns and relevant commitments,</p><p>if the Company"s relevant provisions and their</p><p>commitments contradict such rules, they will</p><p>immediately        make         supplementary</p><p>commitments in line with such rules of the</p><p>CSRC and Shanghai Stock Exchange, and</p><p>actively promote the Company to issue new</p><p>commitments or measures up to the</p><p>requirements of the CSRC and Shanghai Stock</p><p>Exchange; (6) They will fully, completely and</p><p>timely perform the Company"s measures to fill</p><p>the diluted immediate returns and their</p><p>commitments regarding the measures to fill the</p><p>diluted immediate returns. If found to have</p><p>violated such commitments, which causes</p><p>losses to the Company or shareholders, they</p><p>are willing to: ①       state the cause and</p><p>apologize at the General Meeting of</p><p>Shareholders and the media designated by the</p><p>CSRC; ② be liable for compensation to the</p><p>Company and/or shareholders by law; ③</p><p>unconditionally accept the penalties or</p><p>regulatory measures taken by the CSRC and/or</p><p>Shanghai Stock Exchange and other securities</p><p>regulators as per their current rules. The said</p><p>measures to fill the diluted immediate returns</p><p>shall not be deemed to constitute a guarantee</p><p>for the Issuer"s future profits.</p><p>                                                      Annual Report 2022</p><p>Avoiding      Controlling   1. They do not and will not directly or            Date:       No   Yes   Not          Not</p><p>horizontal    shareholder   indirectly engage in any activities constituting   November               applicable   applicable</p><p>competition   and actual    horizontal competition with the existing and       15, 2017</p><p>              controller    future businesses of the Company and its           Duration:</p><p>              HOU           holding subsidiaries, including but not limited    November</p><p>              Juncheng      to the R&D, production and sale of any             15, 2017</p><p>              and FANG      products same as or similar to those of the        to long-</p><p>              Aiqin         Company and its holding subsidiaries. They         term</p><p>                            shall be liable for the economic losses to the</p><p>                            Company caused by violation of the above</p><p>                            commitments. 2. For the enterprises under</p><p>                            their control, They will perform their</p><p>                            obligations under such commitments by</p><p>                            assigning agencies and personnel (including</p><p>                            but not limited to directors and managers), and</p><p>                            They shall be liable for the economic losses to</p><p>                            the Company caused by violation of the above</p><p>                            commitments. 3. From the date of signing this</p><p>                            letter of commitment, if the Company further</p><p>                            expands its product and business scope, the</p><p>                            enterprises under their control shall not</p><p>                            compete with the Company within the</p><p>                            expanded product or business scope, or will, in</p><p>                            case of any possible competition with the</p><p>                            Company within the expanded product or</p><p>                            business scope, withdraw from the</p><p>                            competition by: (1) stopping the production of</p><p>                            competing or potentially competing products;</p><p>                            (2) stopping the operation of competing or</p><p>                                                              Annual Report 2022</p><p>                                    potentially    competing        business;    (3)</p><p>                                    transferring the competing business to the</p><p>                                    Company; or (4) transferring the competing</p><p>                                    business to an unrelated third party. 4. Their</p><p>                                    shareholding companies, including Hangzhou</p><p>                                    Huazhuang Industrial Investment Co., Ltd.,</p><p>                                    Huzhou Mogan Wangshu Cosmetics Industry</p><p>                                    Phase I Venture Capital Partnership (Limited</p><p>                                    Partnership), and companies that they invest</p><p>                                    in, engage in no cosmetics business or related</p><p>                                    upstream and downstream business. If they</p><p>                                    engage in such businesses in the future, They</p><p>                                    commit that they will withdraw their</p><p>                                    investment in those business through equity</p><p>                                    transfer and other means, and that the</p><p>                                    Company will be given priority to invest in the</p><p>                                    said enterprises according to legal provisions</p><p>                                    and the consent of other shareholders of those</p><p>                                    enterprises.</p><p>              Other   Controlling   Commitments on the effective fulfillment of        Date:       No   Yes   Not          Not</p><p>                      shareholder   the Company"s measures to fill the diluted         April 21,              applicable   applicable</p><p>                      and actual    immediate returns: 1. Under no circumstances       2021</p><p>                      controller    will they interfere with the Company"s             Duration:</p><p>Commitments</p><p>                      HOU           operation and management activities or             April 21,</p><p>on</p><p>                      Juncheng      encroach on the company"s interests by ultra       2021 to</p><p>refinancing</p><p>                      and FANG      vires; 2. From the date of the issuance of these   long-term</p><p>                      Aiqin         commitments to the date of the Company"s</p><p>                                    public issuance of A-share convertible</p><p>                                    corporate bonds, if the CSRC releases new</p><p>                                                Annual Report 2022</p><p>                     regulatory rules on the measures to fill the</p><p>                     diluted immediate returns and relevant</p><p>                     commitments and the above-mentioned</p><p>                     commitments can no longer satisfy the new</p><p>                     regulatory      rules,    they      will    make</p><p>                     supplementary commitments in line with the</p><p>                     latest rules of the CSRC; 3. They will</p><p>                     practically fulfill the Company"s measures for</p><p>                     filling the diluted immediate returns and their</p><p>                     commitments regarding the measures to fill the</p><p>                     diluted immediate returns. Where they violate</p><p>                     those commitments, causing losses to the</p><p>                     Company or investors, they will assume the</p><p>                     compensation liability to the Company or</p><p>                     investors according to law. As one of the</p><p>                     parties responsible for the measures to fill the</p><p>                     immediate returns, should they violate or</p><p>                     refuse to fulfill the above commitments, they</p><p>                     shall be subject to the punishment or relevant</p><p>                     regulatory measures imposed on them by the</p><p>                     securities regulatory authorities such as the</p><p>                     CSRC and the SSE in accordance with the</p><p>                     relevant regulations and rules.</p><p>Other   Directors,   Commitments on the effective fulfillment of          Date:       No   Yes   Not          Not</p><p>        senior       the Company"s measures to fill the diluted           April 21,              applicable   applicable</p><p>        management   immediate returns: 1. They will not offer            2021</p><p>                     benefits to other entities or individuals for free   Duration:</p><p>                     or on unfair terms, or otherwise harm the            April 21,</p><p>                     Company"s interests; 2. They will limit their</p><p>                          Annual Report 2022</p><p>duty-related consumption; 3. They will not use     2021 to</p><p>the Company"s assets to engage in investment       long-term</p><p>and consumption activities unrelated to their</p><p>duties; 4. The compensation system developed</p><p>by the Board of Directors and the</p><p>Remuneration and Appraisal Committee will</p><p>be linked to the implementation of the</p><p>measures for filling the diluted immediate</p><p>returns; 5. If the Company issues equity</p><p>incentives in the future, the vesting conditions</p><p>for the Company"s equity incentives will be</p><p>linked to the implementation of the Company"s</p><p>measures to fill the diluted immediate returns;</p><p>commitments to the date of the Company"s</p><p>public issuance of A-share convertible</p><p>corporate bonds, if the CSRC releases new</p><p>regulatory rules on the measures to fill the</p><p>diluted immediate returns and relevant</p><p>commitments and the above-mentioned</p><p>commitments can no longer satisfy the new</p><p>regulatory      rules,    they     will   make</p><p>supplementary commitments in line with the</p><p>latest rules of the CSRC. As one of the parties</p><p>responsible for the measures to fill the</p><p>immediate returns, should they violate or</p><p>refuse to fulfill the above commitments, they</p><p>shall be subject to the punishment or relevant</p><p>regulatory measures imposed on them by the</p><p>                        Annual Report 2022</p><p>securities regulatory authorities such as the</p><p>CSRC and the SSE in accordance with the</p><p>relevant regulations and rules.</p><p>                                          Annual Report 2022</p><p>(II)   Statement of whether the Company"s assets or projects fulfilled the original profit forecast</p><p>       and its reason where the Company had profit forecasts on assets or projects and the Reporting</p><p>       Period fell within the term of profit forecasts</p><p>□Fulfilled □Unfulfilled √Not applicable</p><p>(III) Execution of the performance undertakings and their impact on the goodwill impairment</p><p>      testing</p><p>□ Applicable √ Not applicable</p><p>                                                                 Annual Report 2022</p><p>II. Non-operating Occupation of Funds by the Controlling Shareholders and Other Related Parties during the Reporting Period</p><p>□ Applicable √ Not applicable</p><p>III. Illegal Guarantee</p><p>□ Applicable √ Not applicable</p><p>                                           Annual Report 2022</p><p>IV. Explanation of the Company"s Board of Directors on the "Non-standard Audit Report" from</p><p>    the Accounting Firm</p><p>□ Applicable √ Not applicable</p><p>V.   Analysis and Explanation from the Company on the Reasons and Impact of Changes in</p><p>     Accounting Policies, Accounting Estimates or Correction on Significant Accounting Errors</p><p>(I) Analysis and explanation from the Company on the reasons and impact of changes in</p><p>    accounting policies or accounting estimates</p><p>√ Applicable □ Not applicable</p><p>For details, see the description in "44. Changes in significant accounting policies and accounting</p><p>estimates", "V. Significant Accounting Policies and Accounting Estimates", "Section X Financial Report".</p><p>(II) Analysis and explanation from the Company on the reasons and impact of the correction on</p><p>     significant accounting errors</p><p>□ Applicable √ Not applicable</p><p>(III) Communication with the previous accounting firm</p><p>□ Applicable √ Not applicable</p><p>(IV) Other explanations</p><p>□ Applicable √ Not applicable</p><p>VI. Appointment and Dismissal of the Accounting Firm</p><p>                                                                           Unit: Yuan      Currency: RMB</p><p>                                                                       Current accounting firm</p><p>                                                                  Pan-China Certified Public Accountants</p><p> Name of the domestic accounting firm</p><p>                                                                            (Special General Partnership)</p><p> Remuneration of the domestic accounting firm                                                   1,400,000</p><p> Term of office of the domestic accounting firm                                                         12</p><p> Names of CPAs from the domestic accounting firm                          YIN Zhibin, WANG Xiaokang</p><p>                                                                  YIN Zhibin: 3 years of continual term of</p><p> Continual term of audit service provided by the CPAs                                        audit service</p><p> from the in the domestic accounting firm                          WANG Xiaokang: 5 years of continual</p><p>                                                                                     term of audit service</p><p>                                                      Name                           Remuneration</p><p>                                   Pan-China          Certified        Public</p><p> Accounting firm for internal</p><p>                                   Accountants         (Special       General                   200,000</p><p> control and audit</p><p>                                   Partnership)</p><p>Explanation on appointment and dismissal of the accounting firm</p><p>□ Applicable √ Not applicable</p><p>                                           Annual Report 2022</p><p>Explanation on the change of accounting firm during the Auditing Period</p><p>□ Applicable √ Not applicable</p><p>VII. Particulars on Risk of Delisting</p><p>(I) Reasons for the delisting risk warning</p><p>□ Applicable √ Not applicable</p><p>(II) Measures to be taken by the Company</p><p>□ Applicable √ Not applicable</p><p>(III) Situation and causes for termination of listing</p><p>□ Applicable √ Not applicable</p><p>VIII. Matters Related to Bankruptcy and Reorganization</p><p>□ Applicable √ Not applicable</p><p>IX. Material Litigations and Arbitrations</p><p>□ The Company had material litigations and arbitrations during the year √ The Company had no material</p><p>litigations and arbitrations during the year</p><p>X.   Suspected Violations, Penalties and Rectifications of the Company and Its Directors,</p><p>     Supervisors, Senior Management, Controlling Shareholders and Actual Controllers</p><p>□ Applicable √ Not applicable</p><p>XI. Integrity of the Company and Its Controlling Shareholders and Actual Controllers During the</p><p>    Reporting Period</p><p>√ Applicable □ Not applicable</p><p>    During the Reporting Period, the Company and its controlling shareholders and actual controllers</p><p>were in good faith.</p><p>XII. Significant Related-party Transactions</p><p>(I) Related-party transactions pertaining to daily operation</p><p>   the follow-up implementation</p><p>□ Applicable √ Not applicable</p><p>   follow-up implementation</p><p>√ Applicable □ Not applicable</p><p>The 5th meeting of the third session of Board of Directors and the 2021 annual General Meeting of</p><p>Shareholders were held by the Company on April 20, 2022 and May 12, 2022 respectively to deliberate</p><p>                                           Annual Report 2022</p><p>on and approve the Proposal on the Estimated Amount of Daily Related-party Transactions for 2022. For</p><p>details, see the Announcement on the Estimated Amount of Daily Related-party Transactions for 2022</p><p>(No.: 2022-020) disclosed by the Company on the SSE website (www.sse.com.cn) on April 22, 2022. The</p><p>number of daily related-party transactions of the Company in 2022 does not exceed the estimated number</p><p>at the beginning of the year.</p><p>The estimated and actual amounts of the Company"s daily related-party transactions in 2022 are as follows:</p><p>   Category of</p><p>                                                                                   Actual amount in</p><p>  related-party           Related party          Estimated amount in 2022</p><p>   transactions</p><p>    Deposits in</p><p>                      Zhejiang Yueqing Rural       No more than RMB150</p><p>  bank accounts</p><p>                      Commercial Bank Co.,         million for daily amount       RMB146.67million</p><p> opened with the</p><p>                               Ltd.</p><p>   related party</p><p>                      Huzhou Beauteville</p><p>     Information of</p><p>                     Technology Incubator             RMB1.8 million               RMB1.12million</p><p>      related lease</p><p>                            Co., Ltd.</p><p>Note: The "actual amount in 2022" represents the balance in the accounts as of March 15, 2022 as Zhejiang</p><p>Yueqing Rural Commercial Bank Co., Ltd. has no longer been identified as an affiliated entity of the</p><p>Company since March 16, 2022. From January 1, 2022 to March 15, 2022, the Company obtained a deposit</p><p>interest of RMB1.44million from Zhejiang Yueqing Rural Commercial Bank Co., Ltd.</p><p>□ Applicable √ Not applicable</p><p>(II) Related-party transactions arising from acquisition and disposal of assets or equity</p><p>       the follow-up implementation</p><p>□ Applicable √ Not applicable</p><p>       follow-up implementation</p><p>□ Applicable √ Not applicable</p><p>□ Applicable √ Not applicable</p><p>       performance</p><p>□ Applicable √ Not applicable</p><p>(III) Significant related-party transactions pertaining to joint external investment</p><p>       the follow-up implementation</p><p>□ Applicable √ Not applicable</p><p>                                           Annual Report 2022</p><p>     follow-up implementation</p><p>□ Applicable √ Not applicable</p><p>□ Applicable √ Not applicable</p><p>(IV) Credits and debits with related parties</p><p>     the follow-up implementation</p><p>□ Applicable √ Not applicable</p><p>     follow-up implementation</p><p>□ Applicable √ Not applicable</p><p>□ Applicable √ Not applicable</p><p>(V) Financial business between the Company and related financial companies, holding financial</p><p>companies and related parties</p><p>□ Applicable √ Not applicable</p><p>(VI) Other</p><p>□ Applicable √ Not applicable</p><p>XIII. Significant Contracts and Their Performance</p><p>(I) Trusteeship, contracting and leasing</p><p>□ Applicable √ Not applicable</p><p>□ Applicable √ Not applicable</p><p>□ Applicable √ Not applicable</p><p>                                Annual Report 2022</p><p>(II) Guarantee</p><p>□ Applicable √ Not applicable</p><p>                                           Annual Report 2022</p><p>(III) Entrusting others to manage cash assets</p><p>(1) Overall condition of entrusted wealth management</p><p>□ Applicable √ Not applicable</p><p>Others</p><p>□ Applicable √ Not applicable</p><p>(2) Individual entrusted wealth management</p><p>□ Applicable √ Not applicable</p><p>Others</p><p>□ Applicable √ Not applicable</p><p>(3) Impairment provisions of entrusted wealth management</p><p>□ Applicable √ Not applicable</p><p>(1) Overall condition of entrusted loans</p><p>□ Applicable √ Not applicable</p><p>Others</p><p>□ Applicable √ Not applicable</p><p>(2) Individual entrusted loans</p><p>□ Applicable √ Not applicable</p><p>Others</p><p>□ Applicable √ Not applicable</p><p>(3) Impairment provisions of entrusted loans</p><p>□ Applicable √ Not applicable</p><p>□ Applicable √ Not applicable</p><p>(IV) Other material contracts</p><p>□ Applicable √ Not applicable</p><p>XIV. Other Major Matters That Have A Significant Impact on Investors" Value Judgments and</p><p>     Investment Decisions</p><p>□ Applicable √ Not applicable</p><p>                                                      Annual Report 2022</p><p>                       Section VII           Shareholders and Changes in Shares</p><p>    I.     Changes in Share Capital</p><p>    (I)   Table of changes in shares</p><p>                                                                                                         Unit: ’0,000 shares</p><p>                     Before this change         Increase or decrease (+ or -) due to this change             After this change</p><p>                                                                  Shares</p><p>                                          Issuance               converted</p><p>                               Percent                Bonus                                                           Percentage</p><p>                     Number                of new                  from          Other        Subtotal    Number</p><p>                               age (%)                shares                                                             (%)</p><p>                                           shares                 capital</p><p>                                                                  reserve</p><p>I.     Restricted</p><p>shares</p><p>by the state</p><p>by state-owned</p><p>legal persons</p><p>by           other   34.7201    0.1727         210                              -34.7201    175.2799          210          0.7407</p><p>domestic funds</p><p>Wherein: Shares</p><p>held            by</p><p>domestic non-</p><p>state-owned</p><p>legal persons</p><p>Shares held by</p><p>domestic natural     34.7201    0.1727         210                              -34.7201    175.2799          210          0.7407</p><p>persons</p><p>by foreign funds</p><p>Wherein: Shares</p><p>held by foreign</p><p>legal persons</p><p>        Shares</p><p>held by foreign</p><p>natural persons</p><p>II. Unrestricted</p><p>outstanding                    99.8273                          8,040.3986       35.2718                                  99.2593</p><p>shares</p><p>Ordinary Shares        2765                                                                        04         469</p><p>funded shares</p><p>listed</p><p>domestically</p><p>funded shares</p><p>listed overseas</p><p>                                                Annual Report 2022</p><p>III. Total shares   20,100.                                                       8,250.95   28,351.9</p><p>    √ Applicable □ Not applicable</p><p>    On January 12, 2022, the 4th meeting of the third session of Board of Directors and the 4th meeting of the</p><p>    third session of Board of Supervisors were held to deliberate on and approve the Proposal on the</p><p>    Satisfaction of Conditions for Releasing the Sales Restrictions for the Third Release Period of the</p><p>    Restricted Shares Granted for the First Time and with Reserve under the 2018 Restricted Share Incentive</p><p>    Plan, agreeing that the Company may handle the release procedure for the incentive recipients who meet</p><p>    the conditions for releasing the sales restrictions. A total of 347,201 restricted shares were released from</p><p>    the sales restriction. The circulation date of released shares is January 20, 2022. The number of the</p><p>    unrestricted circulating shares of the Company increased from 200,662,765 before the listing to</p><p>    listing to 0.</p><p>    On May 12, 2022, the 2021 annual General Meeting of Shareholders was held to deliberate on and approve</p><p>    the Company"s Plan for Profit Distribution and Capitalization of Capital Reserves for 2021, in which the</p><p>    Company distributed to all shareholders a cash dividend of RMB8.60 (tax inclusive) per 10 shares based</p><p>    on the total share capital as of the record date on which equity distribution is implemented and issued 4</p><p>    shares for every 10 shares to all shareholders through capitalization of the capital reserve, totaling</p><p>    number of the unrestricted circulating shares of the Company increased from 201,009,966 before the</p><p>    listing to 281,413,952.</p><p>    On July 25, 2022, the 7th meeting of the third session of Board of Directors and the 7th meeting of the</p><p>    third session of Board of Supervisors were held to deliberate on and approve the Proposal on the Granting</p><p>    of Restricted Shares to Incentive Recipients, which considered that the granting conditions specified in the</p><p>    restricted shares would be granted to 101 eligible incentive recipients at the consideration of</p><p>    RMB78.56/share on July 25, 2022, which is considered the grant day. On September 6, 2022, the Company</p><p>    completed the registration of the grant under the 2022 Restricted Share Incentive Plan at CSDC Shanghai</p><p>    Branch. The number of the restricted circulating shares of the Company increased from 0 before the listing</p><p>    to 2,100,000.</p><p>    With the Approval of the CSRC, namely, the Reply on Approving Proya Cosmetics Co., Ltd."s Public</p><p>    Issuance of Convertible Corporate Bonds (Zheng Jian Xu Ke [2021] No. 3408), on December 8, 2021,</p><p>    the Company publicly issued 7,517,130 convertible bonds with a face value of RMB100 per share and a</p><p>    total face value of RMB751,713,000, with a term of 6 years. With the approval of the SSE"s Self-</p><p>    Regulatory Supervision Decision Letter [2021] No. 503, the convertible corporate bonds issued by the</p><p>    Company amounting to RMB751,713,000 would be listed and traded on the Shanghai Stock Exchange</p><p>    from January 4, 2022, with the short name of "Proya Convertible Bond" and the bond code of "113634".</p><p>    The Proya Convertible Bond started conversion on June 14, 2022. As of December 31, 2022, RMB776,000</p><p>    of Proya Convertible Bond had been converted to A-share stocks of the Company, generating 5,517 shares.</p><p>    The number of the unrestricted circulating shares of the Company increased by 5,517.</p><p>                                               Annual Report 2022</p><p>       financial indicators in the last year and period (if any)</p><p>√ Applicable □ Not applicable</p><p>Implementation of the 2021 plan for capitalization of capital reserves: calculated based on the diluted total</p><p>share capital after the capitalization of capital reserves.</p><p>Changes in other shares: no material impact.</p><p>       authority requires</p><p>□ Applicable √ Not applicable</p><p>(II) Changes in restricted shares</p><p>√ Applicable □ Not applicable</p><p>                                                                                                     Unit: Share</p><p>                   Number of     Number of        Number of</p><p>                                                                     Number of</p><p>                    restricted   restricted       restricted                                           Date of</p><p>                                                                     restricted      Reason for</p><p>      Name of       shares at      shares           shares                                            releasing</p><p>                                                                    shares at the       sales</p><p>     shareholder       the        released        increased                                           the sales</p><p>                                                                     end of the      restriction</p><p>                   beginning     during the       during the                                         restriction</p><p>                                                                        year</p><p>                   of the year      year             year</p><p>                                                                                    Restricted</p><p> JIN Yanhua            39,320         39,320          140,000           140,000                      -</p><p>                                                                                    Stock</p><p>                                                                                    Incentive Plan</p><p>                                                                                    Restricted</p><p> WANG Li               22,382         22,382          180,000           180,000                      -</p><p>                                                                                    Stock</p><p>                                                                                    Incentive Plan</p><p> granted for                                                                        The grant for</p><p> the first time                                                                     the first time</p><p> under 2018                                                                         under     2018   January</p><p> Restricted                                                                         Restricted       20, 2022</p><p> Stock                                                                              Stock</p><p> Incentive                                                                          Incentive Plan</p><p> Plan</p><p> granted with                                                                       The grant with</p><p> reserve under                                                                      reserve under</p><p> Restricted                                                                         Restricted       20, 2022</p><p> Stock                                                                              Stock</p><p> Incentive                                                                          Incentive Plan</p><p> Plan</p><p>                                               Annual Report 2022</p><p> granted under</p><p>                                                                                Restricted</p><p> Restricted                0               0        1,780,000       1,780,000                    -</p><p>                                                                                Stock</p><p> Stock</p><p>                                                                                Incentive Plan</p><p> Incentive</p><p> Plan</p><p>     Total           347,201        347,201         2,100,000       2,100,000         /              /</p><p>II.   Issuance and Listing of Securities</p><p>(I) Issuance of securities as of the Reporting Period</p><p>√ Applicable □ Not applicable</p><p>                                                                            Unit: Share Currency: RMB</p><p>                                                                              Number of</p><p>                                     Issue</p><p>    Category of                                                                 shares</p><p>                                   price (or        Issue       Circulation                Termination</p><p>  shares and their   Issue date                                              available for</p><p>                                   interest        quantity        date                       date</p><p>    derivatives                                                               circulation</p><p>                                     rate)</p><p>                                                                              and trading</p><p> Convertible corporate bonds and warrant bonds</p><p>     Convertible</p><p> corporate bonds</p><p>Issuance of securities in the Reporting Period (provide separate explanation on bonds with different</p><p>interest rates in their duration):</p><p>√ Applicable □ Not applicable</p><p>With the Approval of the CSRC, namely, the Reply on Approving Proya Cosmetics Co., Ltd."s Public</p><p>Issuance of Convertible Corporate Bonds (Zheng Jian Xu Ke [2021] No. 3408), on December 8, 2021,</p><p>the Company publicly issued 7,517,130 convertible bonds with a face value of RMB100 per share and a</p><p>total face value of RMB751,713,000. These convertible bonds were issued at face value with a term of 6</p><p>years.</p><p>With the approval of the SSE"s Self-Regulatory Supervision Decision Letter [2021] No. 503, the</p><p>convertible corporate bonds issued by the Company amounting to RMB751,713,000 would be listed and</p><p>traded on the Shanghai Stock Exchange from January 4, 2022, with the short name of "Proya Convertible</p><p>Bond" and the bond code of "113634". The nominal interest rate of the convertible corporate bonds issued</p><p>this time was as follows: 0.30% in the first year, 0.50% in the second year, 1.00% in the third year, 1.50%</p><p>in the fourth year, 1.80% in the fifth year, and 2.00% in the sixth year. The duration of the convertible</p><p>corporate bonds runs from December 8, 2021 to December 7, 2027.</p><p>According to relevant regulations and the Prospectus of Proya Cosmetics Co., Ltd. for the Public Offering</p><p>of A-Share Convertible Corporate Bonds, this “Proya Convertible Bond” issued by the Company can be</p><p>converted to the Company"s shares from June 14, 2022. The convertible period is from June 14, 2022 to</p><p>December 7, 2027. The initial conversion price is 195.98 RMB/share. The latest conversion price is 138.92</p><p>RMB/share. The historical adjustments to the conversion price are as follows:</p><p>“Proya Convertible Bond” was adjusted to RMB139.37/share on May 30, 2022. For details, see the</p><p>Announcement of Proya Cosmetics Co., Ltd. on Adjustment of Conversion Price due to 2021 Equity</p><p>                                             Annual Report 2022</p><p>Distribution Plan (No.: 2022-029) released by the Company on the SSE website on May 24, 2022</p><p>(www.sse.com.cn).</p><p>Plan was completed, the conversion price of the “Proya Convertible Bond” has been adjusted to 138.92</p><p>RMB/share since September 9, 2022. For details, see the Announcement of Proya Cosmetics Co., Ltd. on</p><p>Adjustment of Conversion Price due to Additional Issuance from Granting of Restricted Shares (No.:</p><p>(II) Changes in the total number of shares and shareholder structure of the Company and changes</p><p>     in the structure of assets and liabilities of the Company</p><p>√ Applicable □ Not applicable</p><p>The total number of the Company"s ordinary shares at the beginning and end of the Reporting Period was</p><p>The Company"s total assets and total liabilities at the beginning of the Reporting Period amounted to</p><p>RMB4,633,049,783.03 and RMB1,746,209,355.96 respectively, with the asset-liability ratio of 37.69%.</p><p>The Company"s total assets and total liabilities at the end of the Reporting Period amounted to</p><p>RMB5,778,071,824.19 and RMB2,240,848,493.90 respectively, with the asset-liability ratio of 38.78%.</p><p>(III) Existing internal employee shares</p><p>□ Applicable √ Not applicable</p><p>III. Shareholders and Actual Controllers</p><p>(I) Total number of shareholders</p><p> Total number of shareholders of ordinary shares as</p><p> of the end of the Reporting Period</p><p> Total number of shareholders of ordinary shares at</p><p> the end of last month prior to the disclosure date                                                  13,080</p><p> of the Annual Report</p><p> Total number of shareholders of preferred shares</p><p> whose voting rights have been restored as of the                                                          0</p><p> end of the Reporting Period</p><p> Total number of shareholders of preferred shares</p><p> whose voting rights have been restored at the end</p><p> of last month prior to the disclosure date of the</p><p> Annual Report</p><p>(II) Table of shareholdings of the top ten shareholders and the top ten shareholders of circulating</p><p>     shares (or unrestricted shareholders) as of the end of the Reporting Period</p><p>                                                                                                  Unit: share</p><p>                               Shareholdings of the top ten shareholders</p><p>    Name of                     Number of                    Number            Pledged,</p><p>                     Change                   Percentage                                         Nature of</p><p>   shareholder                  shares held                     of             marked or</p><p>                    during the                    (%)                                           shareholder</p><p>   (full name)                   at the end                 restricted          frozen</p><p>                                       Annual Report 2022</p><p>                Reporting     of the                        shares       Share</p><p>                                                                                  Number</p><p>                 Period       period                         held        status</p><p>                                                                                           Domestic</p><p>HOU</p><p>Juncheng</p><p>                                                                                           person</p><p>Hong Kong</p><p>Securities</p><p>Clearing        17,317,429   64,473,469         22.74                0   None              Other</p><p>Company</p><p>Limited</p><p>                                                                                           Domestic</p><p>FANG Yuyou       9,424,627   45,772,470         16.14                0   None              natural</p><p>                                                                                           person</p><p>China</p><p>Construction</p><p>Bank Co.,</p><p>Ltd. - Yinhua</p><p>Fuyu Theme       5,801,301    5,801,301           2.05               0   None              Other</p><p>Hybrid</p><p>Securities</p><p>Investment</p><p>Fund</p><p>China</p><p>Construction</p><p>Bank Co.,</p><p>Ltd. - CUAM</p><p>Consumer</p><p>Industry</p><p>Hybrid</p><p>Securities</p><p>Investment</p><p>Fund</p><p>Aberdeen</p><p>Standard</p><p>Investment</p><p>Management</p><p>(Asia) Co.,</p><p>Ltd. -</p><p>Aberdeen</p><p>Standard -</p><p>China A-share</p><p>Equity Fund</p><p>                                        Annual Report 2022</p><p>Industrial and</p><p>Commercial</p><p>Bank of China</p><p>Limited -</p><p>Jingshun</p><p>Changcheng</p><p>Emerging</p><p>Growth</p><p>Hybrid</p><p>Securities</p><p>Investment</p><p>Fund</p><p>Industrial and</p><p>Commercial</p><p>Bank of China</p><p>Limited        -</p><p>CUAM</p><p>Consumption          300,002    1,500,089          0.53         0   None              Other</p><p>Upgrade</p><p>Hybrid</p><p>Securities</p><p>Investment</p><p>Fund</p><p>                                                                                      Domestic</p><p>CAO</p><p>                   -2,407,401   1,362,537          0.48         0   None              natural</p><p>Liangguo</p><p>                                                                                      person</p><p>J. P. Morgan</p><p>Securities</p><p>PLC - Self-</p><p>owned Capital</p><p>                      Shareholdings of the top ten unrestricted shareholders</p><p>                             Number of unrestricted               Type and number of shares</p><p>    Name of shareholder</p><p>                              circulating shares held                Type                Number</p><p>HOU Juncheng                               97,670,741        RMB ordinary shares        97,670,741</p><p>Hong      Kong    Securities</p><p>Clearing Company Limited</p><p>FANG Yuyou                                 45,772,470        RMB ordinary shares        45,772,470</p><p>China Construction Bank</p><p>Co., Ltd. - Yinhua Fuyu</p><p>Theme Hybrid Securities</p><p>Investment Fund</p><p>China Construction Bank</p><p>Co., Ltd. - CUAM Consumer</p><p>Industry Hybrid Securities</p><p>Investment Fund</p><p>                                            Annual Report 2022</p><p> Aberdeen              Standard</p><p> Investment       Management</p><p> (Asia) Co., Ltd. - Aberdeen                     2,552,293        RMB ordinary shares         2,552,293</p><p> Standard - China A-share</p><p> Equity Fund</p><p> Industrial and Commercial</p><p> Bank of China Limited -</p><p> Jingshun          Changcheng                    2,380,000        RMB ordinary shares         2,380,000</p><p> Emerging Growth Hybrid</p><p> Securities Investment Fund</p><p> Industrial and Commercial</p><p> Bank of China Limited -</p><p> CUAM             Consumption                    1,500,089        RMB ordinary shares         1,500,089</p><p> Upgrade Hybrid Securities</p><p> Investment Fund</p><p> CAO Liangguo                                    1,362,537        RMB ordinary shares         1,362,537</p><p> J. P. Morgan Securities PLC</p><p> - Self-owned Capital</p><p> Explanation on the special</p><p> account      for    repurchase</p><p>                                   None</p><p> among       the     top     ten</p><p> shareholders</p><p> Explanation on the above-</p><p> mentioned        shareholders"</p><p> entrusting voting rights,         None</p><p> entrusted voting rights and</p><p> abstention from voting rights</p><p> Explanation on the related</p><p> relationship or parties acting    FANG Yuyou is the younger brother of HOU Juncheng"s spouse FANG</p><p> in concert among the above        Aiqin, so HOU Juncheng and FANG Yuyou are related.</p><p> shareholders</p><p> Explanation        on       the</p><p> shareholders of preferred</p><p> shares with voting rights         None</p><p> restored        and       their</p><p> shareholdings</p><p>Shareholdings and sales restrictions of the top ten restricted shareholders</p><p>√ Applicable □ Not applicable</p><p>                                                                                              Unit: share</p><p>                                                 Number of       Availability of restricted</p><p>                 Name of shareholder of                                                          Sales</p><p>  Number                                          restricted     shares for circulation and</p><p>                   restricted shares                                                          restrictions</p><p>                                                 shares held              trading</p><p>                                               Annual Report 2022</p><p>                                                                                   Number of</p><p>                                                                     Time of</p><p>                                                                                   new shares</p><p>                                                                    availability</p><p>                                                                                    available</p><p>                                                                        for</p><p>                                                                                       for</p><p>                                                                    circulation</p><p>                                                                                   circulation</p><p>                                                                    and trading</p><p>                                                                                   and trading</p><p>                                                                                                 See      the</p><p>                                                                                                 explanation</p><p>                                                                                                 below for</p><p>                                                                                                 details</p><p> Explanation on the related relationship or</p><p> parties acting in concert among the above None</p><p> shareholders</p><p>Note: The restricted shares held by equity incentive recipients are those granted under the 2022 Restricted</p><p>Stock Incentive Plan. The restricted period was 12 months, 24 months, and 36 months from the completion</p><p>of their registration with CSDC Shanghai Branch (September 6, 2022).</p><p>(III) Strategic investors or general legal persons becoming the top ten shareholders because of</p><p>      placing of new shares</p><p>□ Applicable √ Not applicable</p><p>IV. Controlling shareholders and Actual Controllers</p><p>(I) Controlling shareholders</p><p>□ Applicable √ Not applicable</p><p>√ Applicable □ Not applicable</p><p> Name                                        HOU Juncheng and Fang Aiqin</p><p> Nationality                                 Chinese</p><p> Acquire residence permits in other</p><p>                                             No</p><p> countries or regions or not</p><p>                                             HOU Juncheng and Fang Aiqin are husband and wife. HOU</p><p>                                             Juncheng serves as the Chairman of the Company, and Fang</p><p>    Main job and title</p><p>                                             Aiqin serves as the Senior Purchasing Consultant of the</p><p>                                             Company.</p><p>□ Applicable √ Not applicable</p><p>□ Applicable √ Not applicable</p><p>                                           Annual Report 2022</p><p>       controlling shareholders</p><p>√ Applicable □ Not applicable</p><p>(II) Actual controllers</p><p>□ Applicable √ Not applicable</p><p>√ Applicable □ Not applicable</p><p> Name                                    HOU Juncheng and Fang Aiqin</p><p> Nationality                             Chinese</p><p> Acquire residence permits in other</p><p>                                         No</p><p> countries or regions or not</p><p>                                         HOU Juncheng and Fang Aiqin are husband and wife. HOU</p><p>                                         Juncheng serves as the Chairman of the Company, and Fang</p><p>    Main job and title</p><p>                                         Aiqin serves as the Senior Purchasing Consultant of the</p><p>                                         Company.</p><p>    Shareholdings in other domestic or</p><p>    overseas listed companies over the   None</p><p>    past 10 years</p><p>□ Applicable √ Not applicable</p><p>□ Applicable √ Not applicable</p><p>       controllers</p><p>√ Applicable □ Not applicable</p><p>                                         Annual Report 2022</p><p>     management</p><p>□ Applicable √ Not applicable</p><p>(III) Other explanations on controlling shareholders and actual controllers</p><p>□ Applicable √ Not applicable</p><p>V.   The accumulative number of pledged shares of the Company"s controlling shareholders or the</p><p>     largest shareholder and its persons acting in concert accounted for more than 80% of the</p><p>     Company"s shares held by them</p><p>□ Applicable √ Not applicable</p><p>VI. Other Legal Person Shareholders with More Than 10% Shareholdings</p><p>□ Applicable √ Not applicable</p><p>VII. Explanation on Limitation on Reduction of Shareholding</p><p>□ Applicable √ Not applicable</p><p>VIII.Specific Implementation of Share Repurchase During the Reporting Period</p><p>□ Applicable √ Not applicable</p><p>                  Section VIII Information on Preferred Shares</p><p>□ Applicable √ Not applicable</p><p>                                             Annual Report 2022</p><p>                            Section IX          Information on Bonds</p><p>I.   Enterprise Bonds, Corporate Bonds and Non-financial Corporate Debt Financing Instruments</p><p>□ Applicable √ Not applicable</p><p>II. Convertible Corporate Bonds</p><p>√ Applicable □ Not applicable</p><p>(I) Issuance of convertible bonds</p><p>√ Applicable □ Not applicable</p><p>With the Approval of the CSRC, namely, the Reply on Approving Proya Cosmetics Co., Ltd."s Public</p><p>Issuance of Convertible Corporate Bonds (Zheng Jian Xu Ke [2021] No. 3408), on December 8, 2021,</p><p>the Company publicly issued 7,517,130 convertible bonds with a face value of RMB100 per share and a</p><p>total face value of RMB751,713,000. These convertible bonds were issued at face value with a term of 6</p><p>years.</p><p>With the approval of the SSE"s Self-Regulatory Supervision Decision Letter [2021] No. 503, the</p><p>convertible corporate bonds issued by the Company amounting to RMB751,713,000 would be listed and</p><p>traded on the Shanghai Stock Exchange from January 4, 2022, with the short name of "Proya Convertible</p><p>Bond" and the bond code of "113634". The nominal interest rate of the convertible corporate bonds issued</p><p>this time was as follows: 0.30% in the first year, 0.50% in the second year, 1.00% in the third year, 1.50%</p><p>in the fourth year, 1.80% in the fifth year, and 2.00% in the sixth year. The duration of the convertible</p><p>corporate bonds runs from December 8, 2021 to December 7, 2027.</p><p>According to relevant regulations and the Prospectus of Proya Cosmetics Co., Ltd. for the Public Offering</p><p>of A-Share Convertible Corporate Bonds, this “Proya Convertible Bond” issued by the Company can be</p><p>converted to the Company"s shares from June 14, 2022. The convertible period is from June 14, 2022 to</p><p>December 7, 2027. The initial conversion price is 195.98 RMB/share. The latest conversion price is 138.92</p><p>RMB/share. The historical adjustments to the conversion price are as follows:</p><p>Proya Convertible Bond was adjusted to RMB139.37/share on May 30, 2022. For details, see the</p><p>Announcement of Proya Cosmetics Co., Ltd. on Adjustment of Conversion Price due to 2021 Equity</p><p>Distribution Plan (No.: 2022-029) released by the Company on the SSE website on May 24, 2022</p><p>(www.sse.com.cn).</p><p>Plan was completed, the conversion price of the Proya Convertible Bond has been adjusted to 138.92</p><p>RMB/share since September 9, 2022. For details, see the Announcement of Proya Cosmetics Co., Ltd. on</p><p>Adjustment of Conversion Price due to Additional Issuance from Granting of Restricted Shares (No.:</p><p>(II) Holders and guarantors of convertible bonds during the Reporting Period</p><p>√ Applicable □ Not applicable</p><p> Name of the convertible corporate</p><p>                                                                                   Proya Convertible Bond</p><p> bond</p><p> Number of holders of the convertible</p><p> corporate bond at the end of the</p><p>                                          Annual Report 2022</p><p>Reporting Period</p><p>Guarantors of the convertible bond of</p><p>                                                                                          None</p><p>the Company</p><p>The top ten holders of the convertible bond are as follows:</p><p>                                          Number of bonds held at</p><p>  Name of holders of the convertible</p><p>                                          the end of the Reporting    Holding ratio (%)</p><p>            corporate bond</p><p>                                               Period (RMB)</p><p>Dajia Assets - Minsheng Bank - Dajia</p><p>Assets - Selected Conservative</p><p>Portfolio No.5 (Issue 2) Collective</p><p>Asset Management Product</p><p>China Merchants Bank Co., Ltd. -</p><p>Huabao Convertible Bond Securities                       40,233,000                       5.36</p><p>Investment Fund</p><p>ICBC Credit Suisse Ruixi Fixed-</p><p>income Pension Product - Bank of                         26,647,000                       3.55</p><p>China Limited</p><p>Industrial and Commercial Bank of</p><p>China Limited - Southern Profitable</p><p>Return Bond Securities Investment</p><p>Fund</p><p>Dajia Assets - China Merchants Bank -</p><p>Dajia Assets - Selected Conservative</p><p>Portfolio No.1 (Issue 1) Collective</p><p>Asset Management Product</p><p>Industrial and Commercial Bank of</p><p>China Limited - Yinhua Convertible                       21,487,000                       2.86</p><p>Bond Securities Investment Fund</p><p>Dajia Assets - China CITIC Bank -</p><p>Dajia Assets Houkun No.40 Collective                     20,481,000                       2.73</p><p>Asset Management Product</p><p>Generali Asset Management -</p><p>Industrial and Commercial Bank of</p><p>China - Generali Asset Management -                      19,000,000                       2.53</p><p>Selected Bond Asset Management</p><p>Product</p><p>Dajia Assets - Postal Savings Bank of</p><p>China - Dajia Assets - Selected</p><p>Conservative Portfolio No.6 (Issue 2)</p><p>Collective Asset Management Product</p><p>China Merchants Bank Co., Ltd. -</p><p>Oriental    Juli   Bond      Securities                  12,500,000                       1.66</p><p>Investment Fund</p><p>                                          Annual Report 2022</p><p>(III) Changes in convertible bonds during the Reporting Period</p><p>√ Applicable □ Not applicable</p><p>                                                                         Unit: Yuan         Currency: RMB</p><p>  Name of the                           Increase or decrease due to this change</p><p>  convertible      Before this                                                                After this</p><p>                                      Share</p><p>   corporate        change                              Redemption          Sell-back          change</p><p>                                    conversion</p><p>     bond</p><p> Proya</p><p> Convertible        751,713,000           776,000                    0                  0    750,937,000</p><p> Bond</p><p>Cumulative conversion of convertible bonds during the Reporting Period</p><p>√ Applicable □ Not applicable</p><p> Name of the convertible corporate bond                                          Proya Convertible Bond</p><p> Amount of shares converted from bonds in the</p><p> Reporting Period (RMB)</p><p> Number of shares converted from bonds in the</p><p> Reporting Period (share)</p><p> Accumulated number of shares converted from</p><p> bonds (share)</p><p> Proportion of the accumulated number of</p><p> converted shares in the total number of issued                                                    0.0020</p><p> shares of the Company before conversion (%)</p><p> Amount of bonds not converted into shares</p><p> (RMB)</p><p> Proportion of unconverted convertible bonds in</p><p> the total amount of convertible bonds issued (%)</p><p>(IV) Historical adjustments to the conversion price</p><p>√ Applicable □ Not applicable</p><p>                                                                            Unit: Yuan      Currency: RMB</p><p> Name of the convertible</p><p>                                                                                 Proya Convertible Bond</p><p> corporate bond</p><p>   Date of         Adjusted          Time of            Media of          Explanation on adjustments to</p><p>  adjustment    conversion price    disclosure          disclosure             the conversion price</p><p>                                                                         Since     the    2021      Equity</p><p>                                                     SSE website,</p><p>                                                                         Distribution      Plan        was</p><p>                                                     Shanghai</p><p>                                                                         implemented by the Company,</p><p> May      30,   139.37             May      24,      Securities</p><p>                                                                         the conversion price of the Proya</p><p>                                                                         Convertible Bond was adjusted</p><p>                                                     Securities</p><p>                                                                         to 139.37 RMB/share on May</p><p>                                                     Times</p><p>                                             Annual Report 2022</p><p>                                                                            Announcement        of      Proya</p><p>                                                                            Cosmetics      Co.,    Ltd.    on</p><p>                                                                            Adjustment of Conversion Price</p><p>                                                                            due to 2021 Equity Distribution</p><p>                                                                            Plan (No.: 2022-029) released</p><p>                                                                            by the Company on the SSE</p><p>                                                                            website on May 24, 2022</p><p>                                                                            (www.sse.com.cn).</p><p>                                                                            Since the registration of</p><p>                                                                            restricted shares involved in the</p><p>                                                                            grant under the 2022 Restricted</p><p>                                                                            Stock Incentive Plan was</p><p>                                                                            completed, the conversion price</p><p>                                                                            of the Proya Convertible Bond</p><p>                                                      SSE website,          has been adjusted to 138.92</p><p>                                                      Shanghai              RMB/share since September 9,</p><p> September      138.92               September        Securities            2022. For details, see the</p><p>                                                      Securities            Cosmetics      Co.,    Ltd.    on</p><p>                                                      Times                 Adjustment of Conversion Price</p><p>                                                                            due to Additional Issuance from</p><p>                                                                            Granting of Restricted Shares</p><p>                                                                            (No.: 2022-052) released by the</p><p>                                                                            Company on the SSE website on</p><p>                                                                            September          8,        2022</p><p>                                                                            (www.sse.com.cn).</p><p> Latest conversion price as of the</p><p> end of the Reporting Period</p><p>(V) The Company"s liabilities, changes in credit, and cash arrangements for debt repayment in</p><p>    future years</p><p>□ Applicable √ Not applicable</p><p>(VI) Other explanations on convertible bonds</p><p>□ Applicable √ Not applicable</p><p>                                Section X Financial Report</p><p>I.   Audit Report</p><p>√ Applicable □ Not applicable</p><p>                                         Audit Report</p><p>                                     Tian Jian Shen [2023]        No.3128</p><p>To all shareholders of Proya Cosmetics Co., Ltd.:</p><p>                                             Annual Report 2022</p><p>I. Audit Opinion</p><p>We have audited the financial statements of Proya Cosmetics Co., Ltd. (hereinafter referred to as "Proya"),</p><p>which comprise the consolidated and parent company"s balance sheets as at December 31, 2022, the</p><p>consolidated and parent company"s income statements, the consolidated and parent company"s cash flow</p><p>statements, and the consolidated and parent company"s statements of changes in shareholders" equity for</p><p>the year of 2022, as well as notes to financial statements.</p><p>In our opinion, the accompanying financial statements were prepared in accordance with the Accounting</p><p>Standards for Business Enterprises in all material aspects and give a true and fair view of the consolidated</p><p>and parent company"s financial position of Proya as at December 31, 2022 and of its consolidated and</p><p>parent company"s operating results and cash flows for the year of 2022.</p><p>II. Basis of Audit Opinion</p><p>We have conducted our audit in accordance with the Chinese Auditing Standards for Certified Public</p><p>Accountants. The "Responsibilities of CPAs for the Audit of the Financial Statements" herein further</p><p>illustrate our responsibilities under those standards. In accordance with the Code of Professional Ethics of</p><p>Chinese Certified Public Accountants, we are independent of Proya and have performed other</p><p>responsibilities in respect of professional ethics. We believe that the audit evidence we have obtained is</p><p>sufficient and appropriate to provide a basis for our opinion.</p><p>III. Key Audit Matters</p><p>Key audit matters are, in our professional judgment, most significant in our audit of the financial</p><p>statements for the current period. These matters were addressed in the context of our audit of the financial</p><p>statements as a whole, and in forming our opinion thereon, we do not provide a separate opinion on these</p><p>matters.</p><p>(I) Recognition of revenue</p><p>For relevant information disclosure, refer to "38. Revenue" in "V. Significant Accounting Policies and</p><p>Estimates", "61. Operating revenue and operating costs" in "VII. Notes to the Items of Consolidated</p><p>Financial Statements", and "6. Segment information" in "XVI. Other Significant Matters" of "Section X</p><p>Financial Report" herein.</p><p>The operating revenue of Proya primarily comes from the sale of cosmetics. The operating revenue for</p><p>Pursuant to the sales contract between Proya and its customer, under the distribution model, the sales</p><p>revenue is recognized by Proya when its products are delivered to and accepted by the buyers. Under the</p><p>agency sales model, the sales revenue is recognized by Proya when its products are delivered to the agent</p><p>and the agent completes the sales and issues the sales list for goods. Under the direct sales model, the sales</p><p>revenue is recognized by Proya when its products are delivered to its consumer and the consumer confirms</p><p>the receipt and makes the payment.</p><p>Since operating revenue is one of the key performance indicators of Proya, there is an inherent risk that</p><p>the management of Proya (hereinafter referred to as the "management") achieves specific goals or</p><p>expectations through inappropriate recognition of revenue. Therefore, we identify the recognition of</p><p>revenue as a key audit matter.</p><p>For recognition of revenue, we primarily implemented the following audit procedures:</p><p>                                             Annual Report 2022</p><p>(1) To obtain an understanding of key internal controls related to the recognition of revenue, evaluate the</p><p>design of these controls, determine whether these controls were implemented, and test the operational</p><p>effectiveness of these controls;</p><p>(2) To issue letters to the main customers to confirm the sales amount in 2022 and the balance of accounts</p><p>receivable as at the end of 2022;</p><p>(3) To test details and make a spot-check on supporting documents for recognition of revenue (including</p><p>sales contracts, delivery documents, receipts, agency sales lists, and sales invoices), understand major</p><p>contract terms or conditions, and evaluate the appropriateness of the method for recognition of revenue;</p><p>(4) To implement analysis procedures, including analysis on fluctuations in revenue of each month of</p><p>(5) To obtain the rebate and subsidy policies, rebate and subsidy calculation sheets and other information,</p><p>and check whether the withholding amount of rebate and subsidy as at the end of 2022 was sufficient; to</p><p>analyze whether the amount of rebate and subsidy and the withholding amount were reasonable based on</p><p>the rebate and subsidy policy as well as the revenue in 2022; and to check the settlement after the rebate</p><p>and subsidy withholding period as at the end of 2022;</p><p>(6) To obtain the return and exchange policy, calculation sheet of provisions and other information, and</p><p>check whether the estimated future return and exchange rate is reasonable; to check the subsequent return</p><p>and exchange situation and compare it with the estimated return and exchange data;</p><p>(7) To learn about the inventory and stock age of each major dealer as at the end of 2022 and check whether</p><p>the inventory amount and structure of the dealer were reasonable;</p><p>(8) To analyze the sales data of main online chain stores by calculating the consumption per capita,</p><p>consumption per time, purchase times and repurchase information of customers of online chain stores and</p><p>comparing them with the selling prices and normal use days of Proya products, so as to judge the rationality</p><p>of the above data in combination with normal consumption habits and analyze the authenticity and</p><p>rationality of the income of online chain stores;</p><p>(9) To compare the background transaction data, Alipay receipt data and sales revenue data on financial</p><p>accounts of online chain stores, and analyze the matching attribute of data, so as to check the authenticity</p><p>of sales from the online chain stores;</p><p>(10) To check whether the information related to the operating revenue is properly presented in the</p><p>financial statements.</p><p>(II) Net realizable value of inventories</p><p>For relevant information disclosure, refer to "15. Inventories" in "V. Significant Accounting Policies and</p><p>Estimates" and "9. Inventories" in "VII. Notes to the Items of Consolidated Financial Statements" of</p><p>"Section X Financial Report" herein.</p><p>As of December 31, 2022, the book balance of inventories of Proya amounted to RMB710.13million, the</p><p>provision for devaluation of inventories amounted to RMB41.08million, and the carrying value of</p><p>inventories amounted to RMB669.05million.</p><p>At the balance sheet date, inventories are measured at the lower of cost and net realizable value, and</p><p>provision for devaluation of inventories is made if the cost of a single inventory is higher than its net</p><p>realizable value. On the basis of considering the purpose of holding inventories, the management</p><p>determines the estimated selling price based on the historical selling price, actual selling price, and future</p><p>market trends, and also determines the net realizable value based on the amount after deducting the</p><p>estimated cost of completion, estimated sale expense and relevant taxes from the estimated sale price of</p><p>inventories.</p><p>                                              Annual Report 2022</p><p>Since the amount of inventories is significant and the determination of the net realizable value of</p><p>inventories involves significant judgment by the management, we identified the net realizable value of</p><p>inventories as a key audit matter.</p><p>For net realizable value of inventories, we primarily implemented the following audit procedures:</p><p>(1) To obtain an understanding of key internal controls related to the net realizable value of inventories,</p><p>evaluate the design of these controls, determine whether these controls were implemented, and test the</p><p>operational effectiveness of these controls;</p><p>(2) To obtain the accrual policy and calculation process for provision for devaluation of inventories, and</p><p>re-check the calculation process;</p><p>(3) To obtain the list of products that are no longer sold, count the products rolling off the production lines</p><p>in the inventories and the corresponding raw material inventories, and verify whether the provision for</p><p>devaluation of inventories was accrued for the raw material inventories;</p><p>(4) To check whether the inventories as at the end of the period had long inventory ages, outdated models</p><p>and changes in market demand in combination with the inventory monitoring, and evaluate whether the</p><p>management reasonably estimated the net realizable value;</p><p>(5) To check whether the information related to the net realizable value of inventories was properly</p><p>presented in the financial statements.</p><p>IV. Other Information</p><p>The management is responsible for the other information, which comprises all the information covered in</p><p>the Annual Report other than the financial statements and this audit report.</p><p>Our audit opinion on the financial statements does not cover the other information and we do not express</p><p>any form of assurance conclusion thereon.</p><p>In connection with our audit of the financial statements, our responsibility is to read the other information</p><p>and, in doing so, consider whether the other information is materially inconsistent with the financial</p><p>statements or our knowledge obtained in the audit or otherwise appears to be materially misstated.</p><p>If, based on the work we have performed, we conclude that there is a material misstatement of this other</p><p>information, we are required to report that fact. We have nothing to report in this regard.</p><p>V. Responsibilities of the Management and Those Charged With Governance for the Financial</p><p>Statements</p><p>The management is responsible for the preparation of financial statements that give a true and fair view in</p><p>accordance with the Accounting Standards for Business Enterprises, and for the design, implementation</p><p>and maintenance of necessary internal control to enable the preparation of financial statements that are</p><p>free from material misstatement, whether due to fraud or error.</p><p>In preparing the financial statements, the management is responsible for assessing Proya"s ability to</p><p>continue as a going concern, disclosing, as applicable, matters related to going concern and using the going</p><p>concern basis of accounting unless the management either intends to liquidate the Company or to cease</p><p>operations, or has no realistic alternative but to do so.</p><p>The governance of Proya (hereinafter referred to as "governance") is responsible for overseeing the</p><p>financial reporting process of Proya.</p><p>VI. Responsibilities of CPAs for the Audit of the Financial Statements</p><p>Our objective is to obtain reasonable assurance of whether there is a material misstatement in the financial</p><p>statements as a whole due to fraud or error and to issue an audit report containing audit opinion.</p><p>                                             Annual Report 2022</p><p>Reasonable assurance is a highly reliable assurance, but is not a guarantee that an audit conducted in</p><p>accordance with China Standards on Auditing will always identify a material misstatement when it exists.</p><p>Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate,</p><p>they could reasonably be expected to influence the economic decisions of users taken on the basis of these</p><p>financial statements.</p><p>As part of an audit in accordance with the auditing standards, we exercise professional judgment and</p><p>maintained professional skepticism throughout the audit. We also:</p><p>(I) Identify and assess the risks of material misstatement of the financial statements, whether due to fraud</p><p>or error, design and perform audit procedures responsive to those risks, and obtain audit evidence that is</p><p>sufficient and appropriate to provide a basis for our opinion. The risk of not identifying a material</p><p>misstatement resulting from fraud is higher than that of failing to detect one resulting from error, as fraud</p><p>may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal</p><p>control.</p><p>(II) Obtain an understanding of internal control related to the audit to design the appropriate audit</p><p>procedures.</p><p>(III) Evaluate the appropriateness of accounting policies used and the reasonableness of accounting</p><p>estimates and related disclosures made by the management.</p><p>(IV) Conclude on the appropriateness of the management"s use of the going concern basis of accounting</p><p>and, based on the audit evidence obtained, determined whether a material uncertainty exists related to</p><p>events or conditions that may significantly affect Proya"s ability to continue as a going concern. If we</p><p>conclude that a material uncertainty exists, we are required to draw attention in our audit report to the</p><p>related disclosures in the financial statements or, if such disclosures are inadequate, to modify our opinion.</p><p>Our conclusions are based on the audit evidence obtained up to the date of our audit report. However,</p><p>future events or conditions may cause Proya to cease to continue as a going concern.</p><p>(V) Evaluate the overall presentation, structure and content of the financial statements, and determine</p><p>whether the financial statements reflect the related transactions and events fairly.</p><p>(VI) Obtain sufficient and appropriate audit evidence of the financial information of the entity or business</p><p>activity of Proya in order to express an opinion on the financial statements. We are responsible for</p><p>directing, supervising and performing group audits. We take full responsibility for the audit opinion.</p><p>We communicate with the governance regarding, among other matters, the planned scope and timing of</p><p>the audit and significant audit findings, including any significant deficiencies in internal control that we</p><p>identify during the audit.</p><p>We also provide a statement to those charged with governance on compliance with ethical requirements</p><p>related to independence, and communicate with them all relationships and other matters that may be</p><p>reasonably considered to affect our independence, as well as related precautions (if applicable).</p><p>From the matters we discussed with the those charged with governance, we determine those matters were</p><p>of most significance in the audit of the financial statements for the current period and are therefore the key</p><p>audit matters. We describe these matters in the audit report unless laws or regulations preclude public</p><p>disclosure about these matters or when, in extremely rare circumstances, we determine that a matter should</p><p>not be communicated in our audit report because the adverse consequences of doing so would reasonably</p><p>be expected to outweigh the public interest benefits of such communication.</p><p>Pan-China Certified Public Accountants LLP          Chinese CPA: YIN Zhibin</p><p>(Project Partner)</p><p>Hangzhou, China                                     Chinese CPA: WANG Xiaokang</p><p>                                              Annual Report 2022</p><p>                                                    April 19, 2023</p><p>II. Financial Statements</p><p>                                      Consolidated Balance Sheet</p><p>                                         As at December 31, 2022</p><p>Prepared by: Proya Cosmetics Co., Ltd.</p><p>                                                                               Unit: Yuan     Currency: RMB</p><p>              Item                   Notes       As at December 31, 2022         As at December 31, 2021</p><p> Current assets:</p><p>  Cash and cash equivalents         VII. 1                3,161,003,085.05                  2,391,048,249.81</p><p>  Clearing settlement funds</p><p>    Loans to banks and other</p><p> financial institutions</p><p>   Held-for-trading     financial</p><p> assets</p><p>   Derivative financial assets</p><p>   Notes receivable</p><p>   Accounts receivable              VII. 5                    102,157,898.41                 138,626,627.90</p><p>   Receivable financing             VII. 6                                                      3,242,000.00</p><p>   Prepayments                      VII. 7                     91,483,523.15                  58,406,647.11</p><p>   Premiums receivable</p><p>    Reinsurance        premium</p><p> receivable</p><p>   Reserves for reinsurance</p><p> contract receivable</p><p>   Other receivables                VII. 8                     73,564,083.63                  66,043,707.81</p><p>   Including: Interest receivable</p><p>           Dividends receivable</p><p>   Financial assets purchased</p><p> under resale agreements</p><p>   Inventories                      VII. 9                    669,051,326.73                 447,938,758.29</p><p>   Contract assets</p><p>   Held-for-sale assets</p><p>   Non-current assets due</p><p> within one year</p><p>   Other current assets             VII. 13                  49,735,996.57                     53,534,962.39</p><p>      Total current assets                                4,146,995,913.54                  3,158,840,953.31</p><p> Non-current assets:</p><p>   Loans and advances          to</p><p> customers</p><p>   Debt investments</p><p>                                               Annual Report 2022</p><p>  Other debt investments</p><p>  Long-term receivables</p><p>  Long-term             equity       VII. 17</p><p>investments</p><p>  Other equity         instrument    VII. 18</p><p>investments</p><p>  Other non-current financial</p><p>assets</p><p>  Investment real estate             VII. 20                    68,654,700.81     70,321,868.00</p><p>  Fixed assets                       VII. 21                   570,376,309.67    558,981,209.20</p><p>  Construction in progress           VII. 22                   207,378,935.86    108,678,896.27</p><p>  Bearer biological assets</p><p>  Oil and gas assets</p><p>  Right-of-use assets                VII. 25                     6,410,634.25</p><p>  Intangible assets                  VII. 26                   420,316,883.26    397,145,124.29</p><p>  Development expenditure</p><p>  Goodwill</p><p>  Long-term prepaid expenses         VII. 29                    19,142,604.46     29,756,474.11</p><p>  Deferred income tax assets         VII. 30                    48,305,338.82     38,796,018.02</p><p>  Other non-current Assets           VII. 31                     5,554,726.06     44,167,303.56</p><p>     Total non-current assets                              1,631,075,910.65     1,474,208,829.72</p><p>        Total assets                                       5,778,071,824.19     4,633,049,783.03</p><p>Current liabilities:</p><p>   Short-term borrowings             VII. 32                   200,195,890.41    200,251,506.85</p><p>   Loans from the central bank</p><p>   Placements from banks and</p><p>other financial institutions</p><p>   Held-for-trading      financial</p><p>liabilities</p><p>   Derivative            financial</p><p>liabilities</p><p>   Notes payable                     VII. 35                    69,626,352.12     79,156,771.40</p><p>   Accounts payable                  VII. 36                   475,427,484.23    404,026,241.16</p><p>   Advance from customers            VII. 37                       464,328.26        173,769.85</p><p>   Contract liabilities              VII. 38                   174,602,833.91     91,151,985.32</p><p>   Financial assets sold under</p><p>repurchase agreements</p><p>   Customer deposits and</p><p>deposits from banks and other</p><p>financial institutions</p><p>  Funds from securities trading</p><p>agencies</p><p>  Funds from underwriting</p><p>securities agencies</p><p>                                               Annual Report 2022</p><p>  Employee         compensation      VII. 39</p><p>payable</p><p>  Taxes payable                      VII. 40                   152,918,871.45     99,893,176.97</p><p>  Other payables                     VII. 41                   216,392,183.41     62,162,153.55</p><p>  Including: Interest payable</p><p>          Dividends payable</p><p>   Fees    and    commissions</p><p>payable</p><p>   Amounts payable under</p><p>reinsurance contracts</p><p>  Held-for-sale liabilities</p><p>  Non-current liabilities due        VII. 43</p><p>within one year</p><p>  Other current liabilities          VII. 44                  10,820,499.59         9,521,415.32</p><p>    Total current liabilities                              1,427,936,644.88     1,024,986,070.14</p><p>Non-current liabilities:</p><p>  Insurance contract reserves</p><p>  Long-term borrowings</p><p>  Bonds payable                      VII. 46                   724,491,557.93    695,586,778.80</p><p>  Including: Preferred stock</p><p>          Perpetual bonds</p><p>  Lease liabilities                  VII. 47                     3,718,119.41</p><p>  Long-term payables</p><p>  Long-term         employee</p><p>compensation payable</p><p>  Povisions                          VII. 50                    59,282,928.68     10,812,084.88</p><p>   Deferred income                   VII. 51                     6,399,811.33       6,416,263.33</p><p>   Deferred     income        tax    VII. 30</p><p>liabilities</p><p>   Other non-current liabilities</p><p>      Total            non-current</p><p>liabilities</p><p>         Total liabilities                                 2,240,848,493.90     1,746,209,355.96</p><p>Owners" equity (or shareholders" equity):</p><p>  Paid-in capital (or share          VII. 53</p><p>capital)</p><p>  Other equity instruments           VII. 54                    50,903,510.12     50,956,622.11</p><p>  Including: Preferred stock</p><p>         Perpetual bonds</p><p>  Capital reserve                    VII. 55                   914,815,786.22    834,272,205.66</p><p>   Less: Treasury shares             VII. 56                   164,976,000.00       5,628,128.21</p><p>   Other         comprehensive       VII. 57</p><p>                                                                -1,918,603.07      -1,247,674.10</p><p>income</p><p>   Special reserve</p><p>                                                Annual Report 2022</p><p>   Surplus reserve                    VII. 59                   141,759,734.50                 100,634,780.00</p><p>   General risk reserve</p><p>   Retained profits                   VII. 60               2,300,384,763.19                  1,696,978,064.52</p><p>    Total owners" equity (or                                3,524,488,659.96                  2,876,975,835.98</p><p> shareholders"             equity)</p><p> attributable to equity holders of</p><p> the parent company</p><p>    Minority interests                                           12,734,670.33                    9,864,591.09</p><p>      Total owners" equity (or</p><p> shareholders" equity)</p><p>         Total liabilities and</p><p> owners" equity (or shareholders"                           5,778,071,824.19                  4,633,049,783.03</p><p> equity)</p><p>                                                                                      Person in charge of</p><p>        The chairman of the                          CFO of the Company:</p><p>                                                                                    Accounting Department:</p><p>   Company: HOU Juncheng                                 WANG Li</p><p>                                                                                          WANG Li</p><p>                                      Parent Company"s Balance Sheet</p><p>                                          As at December 31, 2022</p><p>Prepared by: Proya Cosmetics Co., Ltd.</p><p>                                                                                 Unit: Yuan     Currency: RMB</p><p>                                                                                      As at December 31,</p><p>              Item                      Notes        As at December 31, 2022</p><p> Current assets:</p><p>  Cash and cash equivalents                                     2,169,179,716.12              1,691,858,730.42</p><p>   Held-for-trading       financial</p><p> assets</p><p>   Derivative financial assets</p><p>   Notes receivable</p><p>   Accounts receivable                XVII. 1                    289,883,063.24                354,196,955.99</p><p>   Receivable financing                                                                          3,092,000.00</p><p>   Prepayments                                                    34,908,418.05                 24,580,460.37</p><p>   Other receivables                  XVII. 2                    141,574,549.59                222,452,930.42</p><p>   Including: Interest receivable</p><p>          Dividends receivable</p><p>   Inventories                                                   458,341,886.37                271,436,146.45</p><p>   Contract assets</p><p>   Held-for-sale assets</p><p>   Non-current assets due</p><p> within one year</p><p>   Other current assets                                            32,667,616.71                 33,270,945.69</p><p>     Total current assets                                       3,126,555,250.08              2,600,888,169.34</p><p> Non-current assets:</p><p>   Debt investments</p><p>                                             Annual Report 2022</p><p>  Other debt investments</p><p>  Long-term receivables</p><p>  Long-term             equity     XVII. 3                    394,321,950.41       350,003,540.49</p><p>investments</p><p>  Other equity        instrument                              110,580,000.00        20,580,000.00</p><p>investments</p><p>  Other non-current financial</p><p>assets</p><p>  Investment real estate                                      348,408,309.83       362,657,495.17</p><p>  Fixed assets                                                278,011,361.35       253,209,471.02</p><p>  Construction in progress                                    206,756,324.14       105,012,647.89</p><p>  Bearer biological assets</p><p>  Oil and gas assets</p><p>  Right-of-use assets                                              5,707,540.03</p><p>  Intangible assets                                           382,584,698.57       395,609,113.72</p><p>  Development expenditure</p><p>  Goodwill</p><p>  Long-term prepaid expenses                                      13,494,337.73     20,075,870.93</p><p>  Deferred income tax assets                                      11,372,733.52     22,968,793.93</p><p>  Other non-current Assets                                         4,916,417.58      4,493,322.95</p><p>    Total non-current assets                                 1,756,153,673.16     1,534,610,256.10</p><p>       Total assets                                          4,882,708,923.24     4,135,498,425.44</p><p>Current liabilities:</p><p>   Short-term borrowings                                      200,195,890.41       200,251,506.85</p><p>   Held-for-trading   financial</p><p>liabilities</p><p>   Derivative       financial</p><p>liabilities</p><p>   Notes payable                                               69,626,352.12        79,156,771.40</p><p>   Accounts payable                                           217,330,371.42       282,934,452.33</p><p>  Advance from customers</p><p>  Contract liabilities                                            68,099,041.17     28,108,787.35</p><p>  Employee        compensation                                    58,246,111.22     33,926,736.55</p><p>payable</p><p>  Taxes payable                                                69,952,710.78        66,893,331.24</p><p>  Other payables                                              167,125,433.78         8,546,397.66</p><p>  Including: Interest payable</p><p>          Dividends payable</p><p>  Held-for-sale liabilities</p><p>  Non-current liabilities due                                      2,210,449.03</p><p>within one year</p><p>  Other current liabilities</p><p>     Total current liabilities                                852,786,359.93       699,817,983.38</p><p>Non-current liabilities:</p><p>                                         Annual Report 2022</p><p>  Long-term borrowings</p><p>  Bonds payable                                            724,491,557.93            695,586,778.80</p><p>  Including: Preferred stock</p><p>          Perpetual bonds</p><p>  Lease liabilities                                            3,354,028.30</p><p>  Long-term payables</p><p>  Long-term         employee</p><p>compensation payable</p><p>  Provisions</p><p>  Deferred income                                              6,399,811.33            6,416,263.33</p><p>   Deferred     income      tax                               18,758,960.23            8,395,198.23</p><p>liabilities</p><p>   Other non-current liabilities</p><p>      Total        non-current                             753,004,357.79            710,398,240.36</p><p>liabilities</p><p>       Total liabilities                                  1,605,790,717.72         1,410,216,223.74</p><p>Owners" equity (or shareholders" equity):</p><p>  Paid-in capital (or share                                283,519,469.00            201,009,966.00</p><p>capital)</p><p>  Other equity instruments                                    50,903,510.12           50,956,622.11</p><p>  Including: Preferred stock</p><p>         Perpetual bonds</p><p>  Capital reserve                                          964,613,342.84            834,563,920.32</p><p>   Less: Treasury shares                                   164,976,000.00              5,628,128.21</p><p>   Other        comprehensive</p><p>income</p><p>  Special reserve</p><p>  Surplus reserve                                           141,759,734.50           100,634,780.00</p><p>  Retained profits                                        2,001,098,149.06         1,543,745,041.48</p><p>     Total owners" equity (or                             3,276,918,205.52         2,725,282,201.70</p><p>shareholders" equity)</p><p>        Total liabilities and                             4,882,708,923.24         4,135,498,425.44</p><p>owners" equity (or shareholders"</p><p>equity)</p><p>                                                                                Person in charge of</p><p>       The chairman of the                        CFO of the Company:</p><p>                                                                              Accounting Department:</p><p>  Company: HOU Juncheng                               WANG Li</p><p>                                                                                    WANG Li</p><p>                                   Consolidated Income Statement</p><p>                                      January - December 2022</p><p>                                                                            Unit: Yuan Currency: RMB</p><p>                Item                      Notes                   2022                  2021</p><p>I. Total operating revenue            VII. 61                  6,385,451,424.00     4,633,150,538.43</p><p>Including: Operating revenue          VII. 61                  6,385,451,424.00     4,633,150,538.43</p><p>                                             Annual Report 2022</p><p>         Interest income</p><p>         Premiums earned</p><p>         Fee and commission income</p><p>II. Total operating costs                                         5,191,391,396.39   3,892,457,794.07</p><p>Including: Operating costs                VII. 61                 1,934,850,203.65   1,554,155,646.61</p><p>         Interest expenses</p><p>         Fee      and      commission</p><p>expenses</p><p>         Surrenders</p><p>         Claims and policyholder</p><p>benefits (net of amounts recoverable</p><p>from reinsurers)</p><p>         Net provision for insurance</p><p>liability reserves</p><p>         Insurance         policyholder</p><p>dividends</p><p>         Expenses for reinsurance</p><p>accepted</p><p>         Taxes and surcharges             VII. 62                    56,394,508.94      40,680,295.80</p><p>         Selling expenses                 VII. 63                 2,785,837,352.95   1,991,534,076.73</p><p>         General and administrative       VII. 64</p><p>expenses</p><p>         Research and development         VII. 65</p><p>expenses</p><p>         Financial expenses               VII. 66                   -40,996,523.01     -7,484,395.13</p><p>         Including: Interest expenses                                13,019,503.91      9,759,260.83</p><p>                 Interest income                                     51,707,124.62     28,096,157.42</p><p>   Add: Other income                      VII. 67                    39,065,105.62     16,458,269.45</p><p>         Investment income ("-"           VII. 68</p><p>                                                                     -5,658,023.28      -7,337,735.84</p><p>refers to loss)</p><p>         Including: Income from</p><p>investments in associates and joint                                  -5,658,023.28      -7,337,735.84</p><p>ventures</p><p>                Income            from</p><p>derecognition of financial assets</p><p>measured at amortized cost</p><p>         Foreign exchange gains ("-"</p><p>refers to loss)</p><p>         Net gain on exposure</p><p>hedging ("-" refers to loss)</p><p>         Gains on changes in fair</p><p>value ("-" refers to loss)</p><p>         Credit impairment loss ("-"      VII. 71</p><p>                                                                     -5,057,425.43     -24,834,947.18</p><p>refers to loss)</p><p>                                           Annual Report 2022</p><p>         Asset impairment losses ("-" VII. 72</p><p>                                                                -164,884,555.28    -53,513,590.04</p><p>refers to losses)</p><p>         Gains from disposal of assets VII. 73</p><p>("-" refers to loss)</p><p>III. Operating profit ("-" refers to</p><p>loss)</p><p>   Add: Non-operating revenue            VII. 74                    1,178,886.33       249,852.89</p><p>   Less: Non-operating expenses          VII. 75                    4,613,645.24     3,801,835.06</p><p>IV. Total profits ("-" refers to total</p><p>losses)</p><p>   Less: Income tax expenses             VII. 76                 222,866,719.56    110,746,888.31</p><p>V. Net profits ("-" refers to net</p><p>losses)</p><p>(I) Classified by the nature of continuing operations</p><p>operations ("-" refers to net losses)</p><p>discontinued operations ("-" refers</p><p>to net losses)</p><p>(II) Classified by ownership</p><p>shareholders of the parent company                               817,400,223.93    576,119,025.56</p><p>("-" refers to net losses)</p><p>to minority interests ("-" refers to net                          13,883,582.44    -19,065,338.53</p><p>losses)</p><p>VI. Other comprehensive income,</p><p>                                                                    -670,928.97       -978,607.97</p><p>net of tax</p><p>   (I) Other comprehensive income</p><p>attributable to owners of the parent                                -670,928.97       -978,607.97</p><p>company, net of tax</p><p>income that cannot be reclassified to</p><p>profit or loss</p><p>   (1) Changes arising from the re-</p><p>measurement of net liabilities or net</p><p>assets of defined benefit plans</p><p>   (2) Other comprehensive income</p><p>that cannot be reclassified to profit</p><p>or loss under the equity method</p><p>   (3) Changes in fair value of other</p><p>equity instrument investments</p><p>   (4) Changes in fair value of</p><p>enterprises" own credit risks</p><p>                                          Annual Report 2022</p><p>  income that will be reclassified into                            -670,928.97            -978,607.97</p><p>  profit or loss</p><p>     (1) Other comprehensive income</p><p>  that will be reclassified to profit or</p><p>  loss under the equity method</p><p>     (2) Changes in fair value of other</p><p>  debt investments</p><p>     (3) Amounts of financial assets</p><p>  reclassified         into        other</p><p>  comprehensive income</p><p>     (4)     Provision      for   credit</p><p>  impairment       of     other     debt</p><p>  investments</p><p>     (5) Reserve for cash flow hedges</p><p>     (6) Translation differences of</p><p>  financial statements denominated in                              -670,928.97            -978,607.97</p><p>  foreign currencies</p><p>     (7) Others</p><p>     (II) Other comprehensive income</p><p>  attributable to minority interests, net</p><p>  of tax</p><p>  VII. Total comprehensive income                              830,612,877.40         556,075,079.06</p><p>     (I) Total comprehensive income</p><p>  attributable to owners of the parent                         816,729,294.96         575,140,417.59</p><p>  company</p><p>     (II) Total comprehensive income</p><p>  attributable to minority interests</p><p>  VIII. Earnings per share</p><p>     (I) Basic earnings per share</p><p>  (RMB/share)</p><p>     (II) Diluted earnings per share</p><p>  (RMB/share)</p><p>In case of business combination under common control, net profit realized by the combined party before</p><p>the combination in the current period was RMB0.00; net profit realized by the combined in the previous</p><p>period was RMB0.00.</p><p>   The chairman of the Company:          CFO of the Company: WANG     Person in charge of Accounting</p><p>           HOU Juncheng                              Li                   Department: WANG Li</p><p>                               Parent Company"s Income Statement</p><p>                                      January - December 2022</p><p>                                                                         Unit: Yuan      Currency: RMB</p><p>                  Item                     Notes                   2022                   2021</p><p> I. Operating revenue                   XVII. 4                3,081,136,936.75       2,273,848,366.50</p><p>                                              Annual Report 2022</p><p>    Less: Operating cost                     XVII. 4               1,424,725,111.00   1,076,826,259.92</p><p>         Taxes and surcharges                                         24,372,917.75      19,398,763.14</p><p>         Selling expenses                                            472,193,858.89     284,076,298.04</p><p>         General and administrative</p><p>expenses</p><p>         Research and development</p><p>expenses</p><p>         Financial expenses                                          -41,965,768.21     -9,534,296.78</p><p>         Including: Interest expenses                                 13,019,503.91      7,909,483.79</p><p>                 Interest income                                      42,503,905.91     23,839,106.03</p><p>    Add: Other income                                                 15,650,274.95      7,273,692.73</p><p>         Investment income ("-" refers       XVII. 5</p><p>                                                                      -4,161,437.71     -18,567,432.77</p><p>to loss)</p><p>         Including:      Income      from</p><p>investments in associates and joint                                   -5,149,438.13      -7,608,313.87</p><p>ventures</p><p>                Income               from</p><p>derecognition of financial assets</p><p>measured at amortized cost</p><p>         Net gain on exposure hedging</p><p>("-" refers to loss)</p><p>         Gains on changes in fair value</p><p>("-" refers to loss)</p><p>         Credit impairment loss ("-"</p><p>refers to loss)</p><p>         Asset impairment losses ("-"</p><p>                                                                   -126,987,703.77      -25,486,816.12</p><p>refers to losses)</p><p>         Gains from disposal of assets</p><p>("-" refers to loss)</p><p>II. Operating profit ("-" refers to loss)                           788,849,771.00     629,736,591.27</p><p>    Add: Non-operating revenue                                           22,010.99          25,856.69</p><p>    Less: Non-operating expenses                                      1,516,181.13       3,739,409.87</p><p>III. Total profits ("-" refers to total</p><p>losses)</p><p>       Less: Income tax expenses                                    116,008,968.02      72,463,653.90</p><p>IV. Net profits ("-" refers to net losses)                          671,346,632.84     553,559,384.19</p><p>    (I) Net profits from continuing</p><p>activities ("-" refers to net losses)</p><p>    (II) Net profits from discontinuing</p><p>activities ("-" refers to net losses)</p><p>V. Net amount of other comprehensive</p><p>income after tax</p><p>    (I) Other comprehensive income</p><p>that cannot be reclassified into profit</p><p>or loss</p><p>                                           Annual Report 2022</p><p>measurement of defined benefit plans</p><p>that cannot be reclassified to profit or</p><p>loss under the equity method</p><p>other equity instrument investments</p><p>enterprise"s own credit risk</p><p>   (II) Other comprehensive income to</p><p>be reclassified into profit or loss</p><p>that may be reclassified to profit or</p><p>loss under equity method</p><p>debt investments</p><p>comprehensive          income        on</p><p>reclassification of financial assets</p><p>of other debt investments</p><p>translation of financial statements</p><p>VI. Total comprehensive income                                  671,346,632.84           553,559,384.19</p><p>VII. Earnings per share:</p><p>      (I) Basic earnings per share</p><p>(RMB/share)</p><p>      (II) Diluted earnings per share</p><p>(RMB/share)</p><p> The chairman of the Company: HOU                  CFO of the Company:           Person in charge of</p><p>                Juncheng                               WANG Li                 Accounting Department:</p><p>                                                                                     WANG Li</p><p>                                  Consolidated Cash Flow Statement</p><p>                                      January - December 2022</p><p>                                                                           Unit: Yuan     Currency: RMB</p><p>                  Item                         Notes                2022                    2021</p><p>I. Cash flows from operating activities:</p><p>   Cash received from the sale of goods</p><p>and the rendering of services</p><p>   Net increase in customer deposits and</p><p>deposits from banks and other financial</p><p>institutions</p><p>                                       Annual Report 2022</p><p>   Net increase in loans from the central</p><p>bank</p><p>   Net increase in taking from other</p><p>financial institutions</p><p>   Cash received from premiums under</p><p>original insurance contract</p><p>   Net cash received from reinsurance</p><p>business</p><p>   Net cash received from policyholders"</p><p>deposits and investment contract</p><p>liabilities</p><p>   Cash received from interest, fees and</p><p>commissions</p><p>   Net increase in taking from banks and</p><p>other financial institutions</p><p>   Net increase in financial assets sold</p><p>under repurchase arrangements</p><p>   Net cash received from securities</p><p>trading agency</p><p>   Receipts of tax refunds                                                           80,005.56</p><p>   Other cash received related to VII. 78 (1)</p><p>operating activities</p><p>      Sub-total of cash inflows from</p><p>operating activities</p><p>   Cash paid for goods purchased and</p><p>services received</p><p>   Net increase in loans and advances to</p><p>customers</p><p>   Net increase in balance with the central</p><p>bank and due from banks and other</p><p>financial institution</p><p>   Cash paid for compensation payments</p><p>under original insurance contract</p><p>   Net increase in loans to banks and</p><p>other financial institutions</p><p>   Cash paid for interest, fees and</p><p>commissions</p><p>   Cash paid for insurance policyholder</p><p>dividends</p><p>   Cash paid to and on behalf of</p><p>employees</p><p>   Payments of various types of taxes                        660,096,624.31     432,668,333.55</p><p>   Other cash paid related to operating VII. 78 (2)</p><p>activities</p><p>                                         Annual Report 2022</p><p>     Sub-total of cash outflows from</p><p>operating activities</p><p>         Net cash flow from operating</p><p>activities</p><p>II. Cash flows from investing activities:</p><p>   Cash received from disposal and</p><p>recovery of investments</p><p>   Cash received from investment income</p><p>   Net cash received from disposal of</p><p>fixed assets, intangible assets and other                         3,751,463.96         47,622.98</p><p>long-term assets</p><p>   Net cash received from disposal of</p><p>subsidiaries and other business entities</p><p>   Other cash received related to</p><p>investing activities</p><p>     Sub-total of cash inflows from</p><p>investing activities</p><p>   Cash paid for acquisition or</p><p>construction of fixed assets, intangible                       170,963,405.43     194,102,666.70</p><p>assets and other long-term assets</p><p>   Cash paid for investments                                   131,003,609.10      70,029,200.00</p><p>   Net increase in pledged loans</p><p>receivables</p><p>   Net cash paid for acquiring</p><p>subsidiaries and other operating entities</p><p>   Other cash paid related to investing VII. 78 (4)</p><p>activities</p><p>     Sub-total of cash outflows from</p><p>investing activities</p><p>         Net cash flow from investing</p><p>                                                              -298,215,550.57    -341,823,618.60</p><p>activities</p><p>III. Cash flows from financing activities:</p><p>   Cash      received    from     capital</p><p>contributions</p><p>   Including: Cash received from capital</p><p>contributions from minority shareholders                           700,000.00         700,000.00</p><p>of subsidiaries</p><p>   Cash received from borrowings                               300,000,000.00     946,996,018.87</p><p>   Other cash received related to</p><p>financing activities</p><p>     Sub-total of cash inflows from</p><p>financing activities</p><p>   Cash repayments of borrowings                               300,000,000.00     299,000,000.00</p><p>                                          Annual Report 2022</p><p>   Cash paid for distribution of dividends</p><p>or profits or settlement of interest                            182,663,748.85      154,245,329.79</p><p>expenses</p><p>   Including: Payments for distribution of</p><p>dividends or profits to minority owners of</p><p>subsidiaries</p><p>   Other cash paid related to financing VII. 78 (6)</p><p>activities</p><p>     Sub-total of cash outflows from</p><p>financing activities</p><p>         Net cash flow from financing</p><p>                                                                 -65,251,320.73     489,615,295.96</p><p>activities</p><p>IV. Impact of foreign exchange rate</p><p>                                                                   -670,928.97         -978,607.97</p><p>changes on cash and cash equivalents</p><p>V. Net increase in cash and cash</p><p>equivalents</p><p>  Add: Opening balance of cash and cash</p><p>equivalents</p><p>VI. Closing balance of cash and cash</p><p>equivalents</p><p>                                                                             Person in charge of</p><p> The chairman of the Company: HOU                   CFO of the Company:</p><p>                                                                           Accounting Department:</p><p>             Juncheng                                   WANG Li</p><p>                                                                                 WANG Li</p><p>                             Parent Company"s Cash Flow Statement</p><p>                                     January - December 2022</p><p>                                                                           Unit: Yuan Currency: RMB</p><p>                      Item                          Notes          2022                 2021</p><p>I. Cash flows from operating activities:</p><p>   Cash received from the sale of goods and the</p><p>rendering of services</p><p>   Receipts of tax refunds</p><p>   Other cash received related to operating</p><p>activities</p><p>     Sub-total of cash inflows from operating</p><p>activities</p><p>   Cash paid for goods purchased and services</p><p>received</p><p>   Cash paid to and on behalf of employees                      265,940,955.35      180,867,131.86</p><p>   Payments of various types of taxes                           276,743,971.90      197,049,919.18</p><p>   Other cash paid related to operating</p><p>activities</p><p>     Sub-total of cash outflows from operating</p><p>activities</p><p>   Net cash flow from operating activities                     1,790,129,321.03     644,827,094.22</p><p>                                           Annual Report 2022</p><p>II. Cash flows from investing activities:</p><p>   Cash received from disposal and recovery of</p><p>investments</p><p>   Cash received from investment income</p><p>   Net cash received from disposal of fixed</p><p>assets, intangible assets and other long-term                       1,057,300.53</p><p>assets</p><p>   Net cash received from disposal of</p><p>subsidiaries and other business entities</p><p>   Other cash received related to investing</p><p>activities</p><p>     Sub-total of cash inflows from investing</p><p>activities</p><p>   Cash paid for acquisition or construction of</p><p>fixed assets, intangible assets and other long-                  163,990,474.83     135,132,853.40</p><p>term assets</p><p>   Cash paid for investments                                     179,238,922.10      36,338,783.21</p><p>   Net cash paid for acquisition of subsidiaries</p><p>and other business units</p><p>   Other cash paid related to investing</p><p>activities</p><p>     Sub-total of cash outflows from investing</p><p>activities</p><p>         Net cash flow from investing activities                -340,472,096.40      -34,093,079.88</p><p>III. Cash flows from financing activities:</p><p>   Cash received from capital contributions                      164,976,000.00</p><p>   Cash received from borrowings                                 300,000,000.00     946,996,018.87</p><p>   Other cash received related to financing</p><p>activities</p><p>     Sub-total of cash inflows from financing</p><p>activities</p><p>   Cash repayments of borrowings                                 300,000,000.00     200,000,000.00</p><p>   Cash paid for distribution of dividends or</p><p>profits or settlement of interest expenses</p><p>   Other cash paid related to financing</p><p>activities</p><p>     Sub-total of cash outflows from financing</p><p>activities</p><p>         Net cash flow from financing activities                  -18,454,612.37    589,812,011.86</p><p>IV. Impact of foreign exchange rate changes</p><p>on cash and cash equivalents</p><p>V. Net increase in cash and cash equivalents                    1,431,202,612.26   1,200,546,026.20</p><p>   Add: Opening balance of cash and cash</p><p>equivalents</p><p>                                Annual Report 2022</p><p>VI. Closing balance of cash and cash</p><p>equivalents</p><p>                                                                   Person in charge of</p><p> The chairman of the Company:          CFO of the Company:</p><p>                                                                 Accounting Department:</p><p>        HOU Juncheng                       WANG Li</p><p>                                                                       WANG Li</p><p>                                                                                                                   Annual Report 2022</p><p>                                                                                        Consolidated Statements of Changes in Owners" Equity</p><p>                                                                                                       January - December 2022</p><p>                                                                                                                                                                                                    Unit: Yuan           Currency: RMB</p><p>                                                                                             Equity attributable to owners of the parent company</p><p>                                                                                                                                                                                                                                               Total equity</p><p>     Item                                                                                                                                                                                                                      Minority</p><p>                    Paid-in capital          Other equity instruments                                                  Other                                         General                                                                  attributable to</p><p>                                                                                                 Less: Treasury                       Special                                                                                  interests</p><p>                      (or share                                                Capital reserve                     comprehensive                   Surplus reserve     risk    Retained profits   Other       Subtotal                            owners</p><p>                                      Preference   Perpetual                                         shares                           reserve</p><p>                       capital)                                    Other                                              income                                         reserve</p><p>                                        shares      bonds</p><p>I. Balance at</p><p>the end of the      201,009,966.00                             50,956,622.11   834,272,205.66      5,628,128.21      -1,247,674.10                 100,634,780.00              1,696,978,064.52           2,876,975,835.98    9,864,591.09   2,886,840,427.07</p><p>previous year</p><p>Add: Changes</p><p>in accounting</p><p>policies</p><p>      Correction</p><p>for     previous</p><p>errors</p><p>      Business</p><p>combination</p><p>under common</p><p>control</p><p>      Other</p><p>II. Balance at</p><p>the beginning</p><p>of the current</p><p>year</p><p>III. Increase of</p><p>the      current</p><p>period       ("-"    82,509,503.00                                -53,111.99    80,543,580.56    159,347,871.79       -670,928.97                   41,124,954.50               603,406,698.67             647,512,823.98     2,870,079.24    650,382,903.22</p><p>refers         to</p><p>decrease)</p><p>(I)        Total</p><p>comprehensive                                                                                                         -670,928.97                                               817,400,223.93             816,729,294.96    13,883,582.44    830,612,877.40</p><p>income</p><p>                                                                                   Annual Report 2022</p><p>(II)    Owners"</p><p>contribution</p><p>and       capital</p><p>reduction</p><p>shares</p><p>contributed by</p><p>the owners</p><p>contributions</p><p>by other equity</p><p>instrument</p><p>holders</p><p>share-based</p><p>payments                                          47,357,121.25                                                                            47,357,121.25               47,357,121.24</p><p>credited       to</p><p>owners" equity</p><p>(III)      Profit</p><p>distribution</p><p>of       surplus                                                                                        41,124,954.50    -41,124,954.50</p><p>reserve</p><p>of general risk</p><p>provision</p><p>to owners (or                                                                                                           -172,868,570.76   -172,868,570.76             -172,868,570.76</p><p>shareholders)</p><p>(IV) Internal</p><p>carry-forward</p><p>of       owners"</p><p>equity</p><p>capital reserve</p><p>to capital (or</p><p>share capital)</p><p>                                                                                                           Annual Report 2022</p><p>surplus reserve</p><p>to capital (or</p><p>share capital)</p><p>reserve to cover</p><p>loss</p><p>defined benefit</p><p>scheme carried</p><p>forward        to</p><p>retained</p><p>earnings</p><p>forward        of</p><p>other</p><p>comprehensive</p><p>income         to</p><p>retained</p><p>earnings</p><p>(V)      Special</p><p>reserve</p><p>for the period</p><p>for the period</p><p>(VI) Others                                                                                                                                                                                                           -</p><p>                                                                      -50,040,368.19                                                                                                     -50,040,368.19                     -61,753,871.38</p><p>IV. Balance at      283,519,469.00                                                                                                                          2,300,384,763.19</p><p>the end of the                                        50,903,510.12   914,815,786.22    164,976,000.00      -1,918,603.07                 141,759,734.50                               3,524,488,659.96   12,734,670.33   3,537,223,330.29</p><p>period</p><p>                                                                                    Equity attributable to owners of the parent company                                                                                     Total equity</p><p>      Item                                                                                                                                                                                                 Minority</p><p>                                                                                                                                                                                                                           attributable to</p><p>                                                                                                                                                                                                           interests</p><p>                                     Other equity instruments         Capital reserve                                                     Surplus reserve   Retained profits   Other      Subtotal                             owners</p><p>                                                                                                                Annual Report 2022</p><p>                    Paid-in capital                                                                Less:            Other       Special                    General</p><p>                                      Preference   Perpetual</p><p>                      (or share                                   Other                           Treasury      comprehensive   reserve                      risk</p><p>                                        shares      bonds</p><p>                       capital)                                                                    shares          income                                  reserve</p><p>I. Balance at</p><p>the end of the      201,116,925.00                                             837,034,836.69   12,653,905.25     -269,066.13             100,634,780.00             1,265,671,865.63   2,391,535,435.94   90,326,830.19   2,481,862,266.13</p><p>previous year</p><p>Add: Changes</p><p>in accounting</p><p>policies</p><p>      Correction</p><p>for     previous</p><p>errors</p><p>      Business</p><p>combination</p><p>under common</p><p>control</p><p>      Other</p><p>II. Balance at</p><p>the beginning       201,116,925.00                                             837,034,836.69   12,653,905.25     -269,066.13             100,634,780.00             1,265,671,865.63   2,391,535,435.94   90,326,830.19   2,481,862,266.13</p><p>of the year</p><p>III. Increase of</p><p>the      current</p><p>period       ("-"      -106,959.00                             50,956,622.11    -2,762,631.03   -7,025,777.04     -978,607.97                                         431,306,198.89     485,440,400.04                     404,978,160.94</p><p>refers         to</p><p>decrease)</p><p>(I)        Total</p><p>comprehensive                                                                                                     -978,607.97                                         576,119,025.56     575,140,417.59                     556,075,079.06</p><p>income</p><p>(II)    Owners"</p><p>contribution</p><p>                       -106,959.00                                              -1,999,494.15   -7,025,777.04                                                                               4,919,323.89     700,000.00        5,619,323.89</p><p>and       capital</p><p>reduction</p><p>shares</p><p>                       -106,959.00                                              -1,626,846.39   -7,025,777.04                                                                               5,291,971.65     700,000.00        5,991,971.65</p><p>contributed by</p><p>the owners</p><p>contributions</p><p>by other equity</p><p>                                  Annual Report 2022</p><p>instrument</p><p>holders</p><p>share-based</p><p>payments            -372,647.76                                             -372,647.76       -372,647.76</p><p>credited       to</p><p>owners" equity</p><p>(III)      Profit</p><p>                                                       -144,804,186.00   -144,804,186.00   -144,804,186.00</p><p>distribution</p><p>of       surplus</p><p>reserve</p><p>of general risk</p><p>provision</p><p>to owners (or                                          -144,804,186.00   -144,804,186.00   -144,804,186.00</p><p>shareholders)</p><p>(IV) Internal</p><p>carry-forward</p><p>of       owners"</p><p>equity</p><p>capital reserve</p><p>to capital (or</p><p>share capital)</p><p>surplus reserve</p><p>to capital (or</p><p>share capital)</p><p>reserve to cover</p><p>loss</p><p>defined benefit</p><p>scheme carried</p><p>forward        to</p><p>retained</p><p>                                                                                                                    Annual Report 2022</p><p>earnings</p><p>forward        of</p><p>other</p><p>comprehensive</p><p>income         to</p><p>retained</p><p>earnings</p><p>(V)      Special</p><p>reserve</p><p>for the period</p><p>for the period</p><p>(VI) Others                                                                                                                                                                                                                      -</p><p>IV. Balance at</p><p>the end of the      201,009,966.00                         50,956,622.11     834,272,205.66          5,628,128.21   -1,247,674.10             100,634,780.00             1,696,978,064.52        2,876,975,835.98     9,864,591.09   2,886,840,427.07</p><p>period</p><p>                    The chairman of the Company: HOU Juncheng                              CFO of the Company: WANG Li                          Person in charge of Accounting Department: WANG Li</p><p>                                                                                    Parent Company"s Statement of Changes in Owners" Equity</p><p>                                                                                                   January - December 2022</p><p>                                                                                                                                                                                              Unit: Yuan      Currency: RMB</p><p>                         Paid-in                 Other equity instruments                                                                         Other</p><p>         Item            capital     (or                                                                                  Less: Treasury         compre        Special                                                           Total equity</p><p>                                           Preference   Perpetual                                Capital reserve                                                          Surplus reserve         Retained profits</p><p>                         share                                             Other                                              shares             hensive       reserve                                                     attributable to owners</p><p>                                             shares      bonds</p><p>                         capital)                                                                                                                income</p><p>  I. Balance at the</p><p>  end     of    the                                                                                 834,563,920.32             5,628,128.21                                  100,634,780.00        1,543,745,041.48             2,725,282,201.70</p><p>  previous year</p><p>  Add: Changes</p><p>  in accounting</p><p>  policies</p><p>                                                              Annual Report 2022</p><p>      Correction</p><p>for     previous</p><p>errors</p><p>      Other</p><p>II. Balance at</p><p>the beginning of                                 834,563,920.32        5,628,128.21   100,634,780.00   1,543,745,041.48   2,725,282,201.70</p><p>the year</p><p>III. Increase of</p><p>the       current</p><p>period       ("-"                  -53,111.99    130,049,422.52      159,347,871.79    41,124,954.50    457,353,107.58     551,636,003.82</p><p>refers         to</p><p>decrease)</p><p>(I)         Total</p><p>comprehensive                                                                                           671,346,632.84     671,346,632.84</p><p>income</p><p>(II)     Owners"</p><p>contribution and</p><p>capital</p><p>reduction</p><p>shares</p><p>contributed by</p><p>the owners</p><p>contributions by</p><p>other      equity</p><p>instrument</p><p>holders</p><p>share-based</p><p>payments                                          47,357,121.24                                                             47,357,121.24</p><p>credited       to</p><p>owners" equity</p><p>                                                             Annual Report 2022</p><p>(III)      Profit</p><p>distribution</p><p>of        surplus                                                                 41,124,954.50    -41,124,954.50</p><p>reserve</p><p>to owners (or                                                                                     -172,868,570.76   -172,868,570.76</p><p>shareholders)</p><p>(IV)     Internal</p><p>carry-forward       80,403,986.0</p><p>                                                -80,403,986.00</p><p>of       owners"               0</p><p>equity</p><p>capital reserve     80,403,986.0</p><p>                                                -80,403,986.00</p><p>to capital (or                 0</p><p>share capital)</p><p>surplus reserve</p><p>to capital (or</p><p>share capital)</p><p>reserve to cover</p><p>loss</p><p>defined benefit</p><p>scheme carried</p><p>forward        to</p><p>retained</p><p>earnings</p><p>forward of other</p><p>                                                                                            Annual Report 2022</p><p>comprehensive</p><p>income         to</p><p>retained</p><p>earnings</p><p>(V)      Special</p><p>reserve</p><p>for the period</p><p>for the period</p><p>(VI) Others                                                                     -534,526.22                                                                                              -534,526.22</p><p>IV. Balance at</p><p>the end of the                                                               964,613,342.84        164,976,000.00                         141,759,734.50    2,001,098,149.06       3,276,918,205.52</p><p>period</p><p>                      Paid-up            Other equity instruments                                                    Other</p><p>      Item           capital (or                                                                 Less: Treasury     compre    Special                                                Total equity</p><p>                                   Preference   Perpetual                 Capital reserve                                               Surplus reserve    Retained profits</p><p>                       share                                   Other                                 shares         hensive   reserve                                          attributable to owners</p><p>                                     shares      bonds</p><p>                      capital)                                                                                      income</p><p>I. Balance at the</p><p>end     of    the                                                            837,075,425.32         12,653,905.25                         100,634,780.00    1,134,989,843.29       2,261,163,068.36</p><p>                            .00</p><p>previous year</p><p>Add: Changes</p><p>in accounting</p><p>policies</p><p>     Correction</p><p>for    previous</p><p>errors</p><p>     Other</p><p>                                                             Annual Report 2022</p><p>II. Balance at</p><p>the beginning of                                837,075,425.32       12,653,905.25   100,634,780.00   1,134,989,843.29   2,261,163,068.36</p><p>                            .00</p><p>the current year</p><p>III. Increase of</p><p>the       current</p><p>period       ("-"   -106,959.00                  -2,511,505.00       -7,025,777.04                     408,755,198.19     464,119,133.34</p><p>refers         to</p><p>decrease)</p><p>(I)      Total</p><p>comprehensive                                                                                          553,559,384.19     553,559,384.19</p><p>income</p><p>(II)    Owners"</p><p>contribution and</p><p>                    -106,959.00                  -1,999,494.15       -7,025,777.04                                          4,919,323.89</p><p>capital</p><p>reduction</p><p>shares</p><p>                    -106,959.00                  -1,626,846.39       -7,025,777.04                                          5,291,971.65</p><p>contributed by</p><p>the owners</p><p>contributions by</p><p>other     equity</p><p>instrument</p><p>holders</p><p>share-based</p><p>payments                                           -372,647.76                                                               -372,647.76</p><p>credited      to</p><p>owners" equity</p><p>(III)      Profit</p><p>                                                                                                      -144,804,186.00    -144,804,186.00</p><p>distribution</p><p>                    Annual Report 2022</p><p>of      surplus</p><p>reserve</p><p>to owners (or                            -144,804,186.00   -144,804,186.00</p><p>shareholders)</p><p>(IV)     Internal</p><p>carry-forward</p><p>of       owners"</p><p>equity</p><p>capital reserve</p><p>to capital (or</p><p>share capital)</p><p>surplus reserve</p><p>to capital (or</p><p>share capital)</p><p>reserve to cover</p><p>loss</p><p>defined benefit</p><p>scheme carried</p><p>forward     to</p><p>retained</p><p>earnings</p><p>forward of other</p><p>comprehensive</p><p>income        to</p><p>                                                                             Annual Report 2022</p><p>retained</p><p>earnings</p><p>(V)     Special</p><p>reserve</p><p>for the period</p><p>for the period</p><p>(VI) Others                                       50,956,622.</p><p>                                                                   -512,010.85                                                                            50,444,611.26</p><p>IV. Balance at</p><p>the end of the                                                  834,563,920.32        5,628,128.21            100,634,780.00     1,543,745,041.48   2,725,282,201.70</p><p>                            .00                           11</p><p>period</p><p>              The chairman of the Company: HOU Juncheng         CFO of the Company: WANG Li          Person in charge of Accounting Department: WANG Li</p><p>                                            Annual Report 2022</p><p>III. General Information about the Company</p><p>√ Applicable □ Not applicable</p><p>Proya Cosmetics Co., Ltd. (hereinafter referred to as "Company" or the "Company"), formerly known as</p><p>Proya (Huzhou) Cosmetics Co., Ltd., was registered in Wuxing Branch of Huzhou Municipal</p><p>Administration for Industry and Commerce on May 24, 2006. Headquartered in Hangzhou, Zhejiang, the</p><p>Company now holds the business license with the unified social credit code of 91330100789665033F.</p><p>Currently, the Company"s registered capital is RMB283,513,952.00, and the paid-in capital is</p><p>RMB283,519,469.00 (the paid-in capital is RMB5,517.00 higher than the registered capital due to the</p><p>conversion of convertible bonds without industrial and commercial change registration). The total number</p><p>of shares converted is 283,519,469 (with a par value of 1.00 RMB/per share), including 2,100,000</p><p>restricted circulating A shares and 281,419,469 unrestricted circulating A shares. which were listed for</p><p>trading on SSE on November 15, 2017.</p><p>The Company is a beauty and personal care company mainly engaged in cosmetics research and</p><p>development, production, and sales. The Company"s main products are cosmetics.</p><p>The financial statements were approved for external disclosure by the 11th meeting of the third session of</p><p>the Board of Directors of the Company on April 19, 2023.</p><p>√ Applicable □ Not applicable</p><p>The Company has incorporated 47 subsidiaries, including Hangzhou Proya Trade Co., Ltd., Anya (Huzhou)</p><p>Cosmetics Co., Ltd., Zhejiang Meiligu Electronic Commerce Co., Ltd., Huzhou Chuangdai E-commerce</p><p>Co., Ltd., Yueqing Laiya Trading Co., Ltd. and Hapsode (Hangzhou) Cosmetics Co., Ltd., into the</p><p>consolidated financial statements of the reporting period. For details, refer to the particulars contained in</p><p>notes "VIII. Change of Consolidation Scope" and "IX. Equity in Other Entities" in this report.</p><p>IV. Preparation Basis of Financial Statements</p><p>The financial statements of the Company are prepared based on going concern.</p><p>√ Applicable □ Not applicable</p><p>There are no matters or situations that may substantially affect the Company"s ability to continue as a</p><p>going concern within 12 months since the end of the Reporting Period.</p><p>V.   Significant Accounting Policies and Estimates</p><p>Notes to specific accounting policies and accounting estimates:</p><p>√ Applicable □ Not applicable</p><p>Refer to "44. Changes in Significant Accounting Policies and Estimates" in "V. Significant Accounting</p><p>Policies and Estimates" of "Section X Financial Report" for details.</p><p>The financial statements have been prepared by the Company in conformity with the China Accounting</p><p>                                               Annual Report 2022</p><p>Standards for Business Enterprises, and present truly and completely the Company"s financial position,</p><p>operating performance, changes in shareholders" equity, cash flow and other related information.</p><p>The accounting period of the Company is from January 1 to December 31 of each calendar year.</p><p>√ Applicable □ Not applicable</p><p>The operating cycle of the Company"s businesses is short; the Company adopts 12 months as the liquidity</p><p>classification criteria for assets and liabilities.</p><p>The functional currency of the Company is RMB. Overseas subsidiaries including Hapsode Co., Ltd.,</p><p>Hanna Cosmetics Co., Ltd., Korea Younimi Cosmetics Co., Ltd. and O&R Co., Ltd. adopt the currency in</p><p>their major econonmic environment of operation as their function currency.</p><p>√ Applicable □ Not applicable</p><p>The assets and liabilities acquired by the Company through business combination are measured at the</p><p>carrying value of the combined party in the consolidated financial statements of the ultimate controlling</p><p>party at the combination date. The Company adjusts the capital reserve in accordance with the difference</p><p>between the carrying value share of the owners" equity of the combined party in the consolidated financial</p><p>statements of the ultimate controlling party and the carrying value of the consideration paid for the</p><p>business combination or the total nominal value of the issued shares. If the capital reserve is not sufficient</p><p>to offset the difference, the retained earnings will be adjusted.</p><p>The difference by which the cost of combination is greater than the fair value of the net identifiable assets</p><p>of the acquiree is recognized by the Company as goodwill on the acquisition date; the difference by which</p><p>the combination cost is less than the fair value share of the net identifiable assets of the acquiree is recorded</p><p>into the profit or loss after the re-check of the measurement of the fair value of identifiable assets, liabilities</p><p>or contingent liabilities acquired from the acquiree, and the combination cost.</p><p>√ Applicable □ Not applicable</p><p>statements. The consolidated financial statements are based on the financial statements of the parent</p><p>company and its subsidiaries, and prepared by the parent company in accordance with the Accounting</p><p>Standards for Business Enterprises No. 33 - Consolidated Financial Statements.</p><p>same subsidiary in two consecutive fiscal years</p><p>The acquisition of the equity of the acquiree is to control its operating and financial policies and to obtain</p><p>long-term benefits from its operating activities. After the right to control the acquiree is acquired, the</p><p>acquiree is included in the consolidation scope of the consolidated financial statements. Due to changes</p><p>                                               Annual Report 2022</p><p>in the Company"s business plans and arrangements, if the equity of the acquiree is disposed of in the second</p><p>fiscal year to the point of losing control over it, the acquiree will be excluded from the consolidation scope</p><p>of the consolidated financial statements when the control is lost.</p><p>√ Applicable □ Not applicable</p><p>related to the share of interests in the joint operation:</p><p>(1) Assets solely held, and assets jointly held on proportion;</p><p>(2) Liabilities solely undertaken, and liabilities jointly undertaken on proportion;</p><p>(3) Income generated from selling the Company"s output share of the joint operation;</p><p>(4) Income of the joint operation generated from selling assets according to the Company"s holding share;</p><p>(5) Cost incurred alone, and cost incurred from the joint operation on proportion;</p><p>Cash presented in the cash flow statement refers to cash on hand and deposits that can be used for payment</p><p>at any time. Cash equivalents refer to the short-term (generally the expiration is within three months from</p><p>the date of purchase) and highly liquid investments that are readily convertible to known amounts of cash</p><p>and subject to an insignificant risk of change in value.</p><p>√ Applicable □ Not applicable</p><p>Foreign currency transactions are translated into RMB at the approximate rate of spot rate on the</p><p>transaction date during initial recognition. On the balance sheet date, the foreign-currency monetary items</p><p>are calculated based on the spot rate on the same date. The exchange difference arising from the different</p><p>exchange rates is included in the current profit or loss, except the exchange difference between the</p><p>principal and interest of the foreign currency loans specially borrowed for the purchase and construction</p><p>of assets eligible for capitalization. The foreign currency non-monetary items measured at historical cost</p><p>are still translated based on the approximate rate of the spot rate on the transaction date, and the RMB</p><p>amount is not changed. The foreign currency non-monetary items measured at fair value are translated</p><p>based on the spot rate on the determination date of the fair value, and the difference is included in the</p><p>current profit or loss or other comprehensive income.</p><p>Assets and liabilities items in the balance sheet are translated at the spot rates prevailing at the balance</p><p>sheet date. Owners" equity items other than "undistributed profits" are translated at the spot rates on the</p><p>transaction dates. Income and expense items in the income statement are translated at the approximate</p><p>rates of the spot rates on the transaction dates. Any balance incurred from the translation of foreign-</p><p>currency financial statements by the above method is included in other comprehensive income.</p><p>√ Applicable □ Not applicable</p><p>                                              Annual Report 2022</p><p>Financial assets are classified into the following three categories at initial recognition: (1) financial assets</p><p>measured at amortized cost; (2) financial assets measured at fair value through other comprehensive</p><p>income; (3) financial assets measured at fair value through profit or loss.</p><p>Financial liabilities are classified into the following four categories at initial recognition: (1) financial</p><p>liabilities measured at fair value through profit or loss; (2) financial liabilities arise when a transfer of a</p><p>financial asset does not qualify for derecognition or that are accounted for using the continuing-</p><p>involvement method; (3) loan commitments not belonging to the financial guarantee contracts mentioned</p><p>in item (1) or (2) above and those not belonging to item (1) above and given at a rate lower than market</p><p>interest rate; (4) financial liabilities measured at amortized cost.</p><p>(1) Recognition basis and initial measurement method for financial assets and liabilities</p><p>A financial asset or liability is recognized when the Company becomes a party to a financial instrument</p><p>contract. Financial assets and liabilities are measured at the fair value at initial recognition. For financial</p><p>assets and liabilities measured at fair value through profit or loss, relevant transaction expenses are directly</p><p>included in the current profit or loss; for other categories of financial assets or liabilities, relevant</p><p>transaction costs are recognized as expenses at initial recognition. However, where the accounts receivable</p><p>initially recognized by the Company do not contain a significant financing component or the Company</p><p>does not consider the financing component in the contract of less than one year, the initial measurement</p><p>is made according to the transaction price defined in the Accounting Standards for Business Enterprises</p><p>No. 14 – Revenue.</p><p>(2) Subsequent measurement of financial assets</p><p>Such financial assets are subsequently measured at amortized cost using the effective interest method. The</p><p>gains and losses incurred by the financial assets measured at amortized cost but not belonging to any</p><p>hedging relationship are included in the current profit or loss during derecognition, reclassification,</p><p>amortization according to the effective interest method or impairment recognition.</p><p>They are subsequently measured at fair value. The interest, impairment losses or gains and exchange gains</p><p>or losses calculated with the effective interest method are included in the current profit or loss, and other</p><p>gains or losses are included in other comprehensive income. At derecognition, the gains or losses</p><p>accumulated previously through comprehensive income are transferred from other comprehensive income</p><p>and included into the current profit or loss.</p><p>They are subsequently measured at fair value. The dividends obtained (except for the part from investment</p><p>cost recovery) are included in the current profit or loss, and other gains or losses are included in other</p><p>comprehensive income. At derecognition, the gains or losses accumulated previously through other</p><p>comprehensive income are transferred from other comprehensive income and included into retained</p><p>earnings.</p><p>They are subsequently measured at fair value. The generated gains or losses (including interest and</p><p>dividend income) are included in the current profit or loss, unless the financial assets belong to part of the</p><p>hedging relationship.</p><p>(3) Subsequent measurement of financial liabilities</p><p>Such financial liabilities include held-for-trading financial liabilities (including derivative instruments</p><p>belonging to financial liabilities) and those designated as financial liabilities measured at fair value through</p><p>                                              Annual Report 2022</p><p>profit or loss. Such financial liabilities are subsequently measured at fair value. Changes in the fair value</p><p>of financial liabilities measured at fair value through profit or loss due to changes in the Company"s own</p><p>credit risk are included in other comprehensive income, unless the treatment will cause or enlarge the</p><p>accounting mismatch in the profit or loss. Other gains or losses (including interest, except changes in the</p><p>fair value arising from the Company"s own credit risk) are included in the current profit or loss, unless the</p><p>financial liabilities belong to part of the hedging relationship. At derecognition, the gains or losses</p><p>accumulated previously through other comprehensive income are transferred from other comprehensive</p><p>income and included into retained earnings.</p><p>continued involvement in transferred financial assets</p><p>They are measured in accordance with the Accounting Standards for Business Enterprises No. 23 -</p><p>Transfer of Financial Assets.</p><p>and those not belonging to item 1) above and given at a rate lower than market interest rate</p><p>They are subsequently measured at the higher one of the following two amounts, after initial recognition:</p><p>① loss provisions determined according to regulations on impairment of financial instruments; ②</p><p>balance of the initially recognized amount after deducting cumulative amortization recognized in</p><p>accordance with the regulations set out in the Accounting Standards for Business Enterprises No. 14 –</p><p>Revenue.</p><p>They are measured at amortized cost using the effective interest method. The gains and losses incurred by</p><p>the financial liabilities measured at amortized cost but not belonging to any hedging relationship are</p><p>included in the current profit or loss during derecognition or amortization according to the effective interest</p><p>method.</p><p>(4) Derecognition of financial assets and liabilities</p><p>① The contract right to collect cash flow from the financial assets has terminated;</p><p>② The financial assets have been transferred and such transfer satisfies the provisions for derecognition</p><p>of financial assets in the Accounting Standards for Business Enterprises No. 23 - Transfer of Financial</p><p>Assets.</p><p>liabilities (or that part thereof) are derecognized.</p><p>If the Company has transferred almost all the risks and rewards related to the ownership of financial assets,</p><p>the financial assets are derecognized, and the rights and obligations resulting from or retained in the</p><p>transfer are separately recognized as the assets or liabilities. In case that almost all the risks and rewards</p><p>related to the ownership of the financial assets are retained, the recognition of the transferred financial</p><p>assets is continued. In case that almost all the risks and rewards related to the ownership of the financial</p><p>assets are neither transferred nor retained, disposal shall apply depending on the following circumstances:</p><p>(1) if the control over the financial assets is not retained, the financial assets shall be derecognized, and</p><p>the rights and obligations resulting from or retained in the transfer are separately recognized as the assets</p><p>or liabilities; (2) if the control over the financial assets is retained, the relevant financial assets are</p><p>recognized according to the degree of continued involvement in the transferred financial assets, and the</p><p>relevant liabilities are recognized accordingly.</p><p>If the transfer of an entire financial asset satisfies the conditions for derecognition, the difference between</p><p>                                              Annual Report 2022</p><p>the two amounts below shall be included in the current profit or loss: (1) Carrying value of the transferred</p><p>financial assets at the date of derecognition; (2) The sum of consideration received for the transfer of</p><p>financial asset, plus the corresponding derecognized portion of accumulated change in fair value</p><p>previously included in other comprehensive income (in cases where the transferred financial asset is debt</p><p>instrument investment measured at fair value with changes included in other comprehensive income). If</p><p>part of the financial assets is transferred and the transfer satisfies the conditions for derecognition, the</p><p>overall carrying value before the transfer of financial assets is apportioned according to their respective</p><p>relative fair value at the transfer date between the portion of derecognized part and the remaining part, and</p><p>the difference between the two amounts below is included in the current profit or loss: (1) carrying value</p><p>of the derecognized part; (2) the sum of consideration for the derecognized part, plus the corresponding</p><p>derecognized part of accumulated change in fair value previously included in other comprehensive income</p><p>(in cases where the transferred financial assets are debt instrument investment measured at fair value with</p><p>changes included in other comprehensive income).</p><p>The Company adopts valuation techniques appropriate to the prevailing circumstances with the support of</p><p>sufficient data and other information available, to determine the fair value of relevant financial assets and</p><p>liabilities. The Company divides the inputs for the estimation technique into the following levels and uses</p><p>them in turn:</p><p>(1) Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities that the</p><p>Company can access at the measurement date.</p><p>(2) Level 2 inputs are inputs other than quoted prices included within Level 1 that are observable, either</p><p>directly or indirectly, including: the quotation of similar assets or liabilities in an active market; the</p><p>quotation of the identical or similar assets or liabilities in an inactive market; other observable inputs other</p><p>than the quotation, such as the interest rate and yield curves that can be observed during the normal</p><p>quotation intervals; and the market validation inputs;</p><p>(3) Level 3 inputs are unobservable inputs of related assets or liabilities, including the interest rate, stock</p><p>volatility, future cash flow of retirement obligations borne during the business combination, and financial</p><p>forecasts made based on its own data, which cannot be observed directly or cannot be verified according</p><p>to observable market data.</p><p>(1) Impairment measurement and accounting treatment of financial instruments</p><p>Based on the expected credit loss, the Company carries out accounting treatment for impairment and</p><p>recognizes the loss provision for the financial assets measured at amortized cost, the debt instrument</p><p>investment measured at fair value through other comprehensive income, contract assets, lease receivables,</p><p>the loan commitment other than financial liabilities measured at fair value through profit or loss, and the</p><p>financial guarantee contracts of financial liabilities not measured at fair value through profit or loss or</p><p>financial liabilities not from failure of transfer of financial assets to meet the derecognition conditions or</p><p>continued involvement in transferred financial assets.</p><p>Expected credit loss refers to the weighted average of credit losses of financial instruments weighted by</p><p>the risk of default. Credit loss refers to the balance between all contractual cash flows discounted according</p><p>to the original effective interest rate and receivable under the contract by the Company and all cash flows</p><p>as expected, i.e. the present value of all cash shortages. The purchased or underlying financial assets of</p><p>the Company with credit impairment incurred are discounted according to their effective interest rates</p><p>upon credit adjustment.</p><p>                                              Annual Report 2022</p><p>For the purchased or underlying financial assets with credit impairment incurred, only the accumulative</p><p>changes in the expected credit loss in the whole duration after initial recognition are recognized by the</p><p>Company as loss provisions on the balance sheet date.</p><p>For the receivables and contract assets from transactions in accordance with the Accounting Standards for</p><p>Business Enterprises No. 14 – Revenue, excluding significant financing components or without</p><p>consideration, by the Company, to the financing components in the contract of no more than one year, the</p><p>Company measures the loss provision according to the amount equal to the expected credit loss in the</p><p>whole duration by applying simplified measurement method.</p><p>For the lease receivables as well as receivables and contract assets from transactions in accordance with</p><p>the Accounting Standards for Business Enterprises No. 14 – Revenue, including significant financing</p><p>components, the Company measures the loss provision according to the amount equal to the expected</p><p>credit loss in the whole duration by applying simplified measurement method.</p><p>For financial assets other than the above measurement methods, the Company shall, on each balance sheet</p><p>date, assess whether their credit risk has increased significantly since initial recognition. If the credit risk</p><p>has increased significantly since the initial recognition, the Company will measure the loss provision based</p><p>on the amount of expected credit loss in the whole duration; if the credit risk has not significantly increased</p><p>since the initial recognition, the Company will measure the loss provision based on the amount of expected</p><p>credit loss for the financial instruments in the next 12 months.</p><p>The Company determines whether the credit risk of financial instruments has increased significantly since</p><p>initial recognition by utilizing the available, reasonable and well-grounded information, including</p><p>forward-looking information, and comparing the default risks of the financial instruments on the balance</p><p>sheet date and on the initial recognition date.</p><p>If the Company determines that the financial instruments bear a low credit risk on the balance sheet date,</p><p>it assumes that the credit risk of the financial instruments has not increased significantly since initial</p><p>recognition.</p><p>The Company evaluates the expected credit risk and measures the expected credit loss based on single</p><p>financial instrument or portfolio of financial instruments. When based on the portfolio of financial</p><p>instruments, the Company divides financial instruments into different portfolios on the basis of the</p><p>common risk characteristics.</p><p>The Company re-measures the expected credit loss on each balance sheet date, and the increased or</p><p>reversed amount of the loss provision arising therefrom, as losses or gains from impairment, shall be</p><p>included in the current profit or loss. For financial assets measured at amortized cost, the loss provision</p><p>deducts the carrying value of the financial assets listed in the balance sheet; for the debt investment</p><p>measured at fair value with changes included in other comprehensive income, the Company recognizes its</p><p>loss provision in other comprehensive income without deducting the carrying value of the financial assets.</p><p>(2) Financial instruments of which expected credit risks are assessed by portfolio and expected credit</p><p>losses are measured with a three-stage model</p><p>                                     Basis for determining the Method for measuring the</p><p>     Item</p><p>                                     portfolio                          expected credit loss</p><p>                                                                        Calculating the expected credit</p><p>                                                                        loss by the default risk exposure</p><p>  Other receivables - account age                                       and the expected credit loss rate</p><p>                                     Account age</p><p>  portfolio                                                             in next 12 months or in the</p><p>                                                                        whole duration by referring to</p><p>                                                                        historical experience in credit</p><p>                                             Annual Report 2022</p><p>                                                                           loss and according to the</p><p>                                                                           current situation and the</p><p>                                                                           forecast on future economic</p><p>                                                                           conditions.</p><p>(3) Receivables and contract assets with expected credit losses measured by portfolio with a simplified</p><p>measurement method</p><p>                                      Basis for determining the Method for measuring the</p><p>    Item</p><p>                                      portfolio                            expected credit loss</p><p>                                                                           Calculating the expected credit</p><p>                                                                           loss by the default risk exposure</p><p>                                                                           and the expected credit loss rate</p><p>                                                                           in the whole duration by</p><p> Receivables financing - bank</p><p>                                      Bill type                            referring      to       historical</p><p> acceptance note</p><p>                                                                           experience in credit loss and</p><p>                                                                           according to the current</p><p>                                                                           situation and the forecast on</p><p>                                                                           future economic conditions</p><p>                                                                           Calculating the expected credit</p><p>                                                                           loss     by     preparing      the</p><p>                                                                           comparison table between</p><p>                                                                           account age of accounts</p><p>                                                                           receivable and expected credit</p><p> Accounts receivable - account</p><p>                                      Account age                          loss rate in the whole duration</p><p> age portfolio</p><p>                                                                           by referring to historical</p><p>                                                                           experience in credit loss and</p><p>                                                                           according to the current</p><p>                                                                           situation and the forecast on</p><p>                                                                           future economic conditions</p><p>loss rate in the whole duration</p><p>                                                            Accounts receivable</p><p> Account age</p><p>                                                            Expected credit loss rate (%)</p><p> Within 1 year (inclusive, same for below)                  5</p><p> Above 3 years                                              100</p><p>Financial assets and liabilities are resented in the balance sheet respectively without offsetting. However,</p><p>when the following conditions are met, the financial assets and liabilities are presented at the net amount</p><p>after mutual offset in the balance sheet: (1) the Company has the legal right of offsetting the recognized</p><p>amount and such legal right is currently executable; (2) the Company plans to settle by net amount or</p><p>simultaneously realize the financial assets and clear off the financial liabilities.</p><p>When the financial assets that do not meet the derecognition conditions are transferred, the Company does</p><p>not offset the transferred financial assets with the relevant liabilities.</p><p>                                            Annual Report 2022</p><p>Determination and accounting treatment of the expected credit loss of notes receivable</p><p>□ Applicable √ Not applicable</p><p>Determination and accounting treatment of the expected credit loss of accounts receivable</p><p>√ Applicable □ Not applicable</p><p>Refer to "10. Financial instruments" in "V. Significant Accounting Policies and Estimates" of "Section X</p><p>Financial Report" of this report.</p><p>√ Applicable □ Not applicable</p><p>Refer to "10. Financial instruments" in "V. Significant Accounting Policies and Estimates" of "Section X</p><p>Financial Report" of this report.</p><p>Determination and accounting treatment of the expected credit loss of other receivables</p><p>√ Applicable □ Not applicable</p><p>Refer to "10. Financial instruments" in "V. Significant Accounting Policies and Estimates" of "Section X</p><p>Financial Report" of this report.</p><p>√ Applicable □ Not applicable</p><p>Inventories include finished goods or commodities for sale in daily operations, goods in process during</p><p>the production, materials consumed during production or rendering of service.</p><p>Moving weighted average method is adopted for delivered inventories.</p><p>At the balance sheet date, inventories are measured at the lower of cost and net realizable value, and</p><p>provision for devaluation of inventories is made if the cost of a single inventory is higher than its net</p><p>realizable value. The net realizable value of inventories directly for sale is determined by the amount of</p><p>the estimated selling price after subtracting the estimated sales expenses and relevant taxes during the</p><p>normal production and operation; the net realizable value of inventories required to be processed is</p><p>determined by the amount of the estimated selling price of the finished products after subtracting the</p><p>estimated cost by the end of processing, the estimated sales expenses and relevant taxes during the normal</p><p>production and operation. On the balance sheet date, the net realizable value is determined separately for</p><p>the two parts of the same inventory with or without contract price, and is compared with the relevant costs</p><p>to separately determine the amount withdrawn or reversed for inventory falling price reserve.</p><p>The Company adopts a perpetual inventory system.</p><p>                                             Annual Report 2022</p><p>(1) Low-value consumables</p><p>Amortization is performed by the immediate write-off method.</p><p>(2) Packaging</p><p>Amortization is performed by the immediate write-off method.</p><p>(1). Recognition methods and standards of contract assets</p><p>√ Applicable □ Not applicable</p><p>The rights of the Company to collect consideration from the customer unconditionally (i.e. only depending</p><p>on time) are presented as receivables; the rights (depend on other factors than time) to collect consideration</p><p>for transferring goods to the customer are presented as contract assets.</p><p>(2). Determination and accounting treatment of the expected credit loss of contract assets</p><p>□ Applicable √ Not applicable</p><p>□ Applicable √ Not applicable</p><p>(1). Determination and accounting treatment of the expected credit loss of debt investments</p><p>□ Applicable √ Not applicable</p><p>(1). Determination and accounting treatment of the expected credit loss of other debt investments</p><p>□ Applicable √ Not applicable</p><p>(1). Determination and accounting treatment of the expected credit loss of long-term receivables</p><p>□ Applicable √ Not applicable</p><p>√ Applicable □ Not applicable</p><p>Joint control is the contractually agreed sharing of control of an arrangement. It exists only when decisions</p><p>about the relevant activities of the arrangement require the unanimous consent of the parties sharing</p><p>control. Significant influence refers to the power to participate in the decision-making process on the</p><p>financial and operating policies of the investee, but not to control or impose joint control together with</p><p>other parties over the formulation of these policies.</p><p>(1) For a long-term equity investment obtained from a business combination under common control: where</p><p>the combining party pays cash, transfers non-cash assets, bears debts or issues equity securities as</p><p>combination consideration, the initial investment cost is the share with reference to the carrying value of</p><p>                                              Annual Report 2022</p><p>the owners" equity of the combined party in the consolidated financial statements of the ultimate</p><p>controlling party on the combination date. The difference between the initial investment cost of the long-</p><p>term equity investment and the carrying value of the consideration paid for the business combination or</p><p>the total nominal value of the issued shares is adjusted to capital reserve. If the capital reserve is not</p><p>sufficient to offset the difference, the retained earnings are adjusted.</p><p>For a long-term equity investment obtained from a business combination under common control through</p><p>multiple transactions by step, the Company judges whether the transactions are a "package deal". If yes,</p><p>the transactions are subject to accounting treatment as one deal that has acquired control right. If no, the</p><p>initial investment cost is determined on the basis of the share with reference to the carrying value of the</p><p>net asset of the combined party in the consolidated financial statements of the ultimate controlling party</p><p>on the combination date. The difference between the initial investment cost of long-term equity investment</p><p>at the combination date and the sum of the carrying amount of long-term equity investment before business</p><p>combination and the carrying value of newly paid consideration for additional shares acquired on the</p><p>combination date is adjusted to the capital reserve. If the capital reserve is not sufficient to be offset, the</p><p>retained earnings are adjusted.</p><p>(2) For a long-term equity investment obtained from a business combination not under common control,</p><p>the fair value of consideration paid for business combination is regarded as the initial investment cost on</p><p>the acquisition date.</p><p>For the long-term equity investment achieved by the Company via a business combination not under</p><p>common control through multiple transactions by step, the relevant accounting treatment is based on</p><p>individual financial statements or consolidated financial statements:</p><p>sum of the carrying value of the equity investment originally held and the newly increased investment cost.</p><p>"package deal". If yes, the transactions are subject to accounting treatment as one deal that has acquired</p><p>control right. If no, the equity of the acquiree held before the acquisition date is re-measured at the fair</p><p>value of the equity on the acquisition date, and the difference between the fair value and its carrying value</p><p>is included in the current investment income. If the equity of the acquiree held before the acquisition date</p><p>is related to other comprehensive income under the equity method, the other related comprehensive</p><p>income is converted into the current income on the acquisition date, excluding the other comprehensive</p><p>income derived from changes in net liabilities or assets due to re-measurement on defined benefit plans</p><p>by the investee.</p><p>(3) For a long-term equity investment obtained by means other than business combination: If it is obtained</p><p>by cash, the initial investment cost is the actual payment; If it is obtained through issuing equity securities,</p><p>the initial investment cost is the fair value of the issued equity securities. If it is obtained through debt</p><p>restructuring, the initial investment cost is determined based on the Accounting Standards for Business</p><p>Enterprises No. 12 - Debt Restructuring. If it is obtained through the exchange of non-monetary assets,</p><p>the initial investment cost is determined based on the Accounting Standards for Business Enterprises No.</p><p>For a long-term equity investment controlled by the investee, the cost method is adopted for accounting.</p><p>For a long-term equity investment in associates and joint ventures, the equity method is adopted for</p><p>accounting.</p><p>multiple transactions</p><p>(1) Individual financial statements</p><p>                                             Annual Report 2022</p><p>For disposal of equity, the difference between the carrying value and the consideration actually received</p><p>is included in the current profit or loss. The accounting of remaining equity is completed by equity method</p><p>in case of significant influence on the investee or implementation of joint control with other parties.</p><p>However, in case of no control, joint control or significant influence on the investee, the accounting of</p><p>remaining equity must comply with the relevant provisions of the Accounting Standards for Business</p><p>Enterprises No.22 - Recognition and Measurement of Financial Instruments.</p><p>(2) Consolidated financial statement</p><p>belonging to a "package deal"</p><p>Before the loss of control, the difference between the price of disposal and the subsidiary"s net assets</p><p>entitled from the disposal of long-term equity investment cumulatively calculated from the acquisition</p><p>date or the combination date, is adjusted to capital reserve (capital premium). If the capital premium is</p><p>insufficient to offset the difference, the retained earnings are adjusted.</p><p>When the control over the original subsidiary is lost, the remaining equity is re-measured at fair value as</p><p>at the date on which the control is lost. The difference between the sum of the consideration received from</p><p>equity disposal and the fair value of the remaining equity and the net assets of the original subsidiary</p><p>proportionate to the original shareholding accumulated from the date of acquisition or business</p><p>combination is included in investment gains of the period during which the control is lost, and meanwhile,</p><p>the goodwill is offset. Other comprehensive income related to the equity investment in the original</p><p>subsidiary is transferred to investment gains of the period during which the control is lost.</p><p>belonging to a "package deal"</p><p>All transactions are regarded as one transaction disposing the subsidiaries and losing the control right for</p><p>accounting treatment. However, the difference between the amount received each time for disposal before</p><p>the control is lost and the net assets of such subsidiary corresponding to the disposal of investment is</p><p>recognized as other comprehensive income in the consolidated financial statements, and is transferred to</p><p>profit or loss of the period during which the control is lost upon loss of control.</p><p>(1). In case of a cost measurement model:</p><p>Depreciation or amortization method</p><p>and building leased-out.</p><p>depreciated or amortized with the same method as that for fixed assets and intangible assets.</p><p>(1). Conditions for recognition</p><p>√ Applicable □ Not applicable</p><p>Fixed assets are tangible assets that are held for use in the production or rendering of goods or services,</p><p>for rental to others, or for administrative purposes, and have a service life of more than one accounting</p><p>year. The fixed assets are recognized when the following conditions are satisfied at the same time: the</p><p>economic benefits are likely to inflow to the Company. The costs of such fixed assets can be measured</p><p>reliably.</p><p>                                              Annual Report 2022</p><p>(2). Depreciation method</p><p>√ Applicable □ Not applicable</p><p>                       Depreciation           Depreciation life                                 Annual</p><p>     Category                                                         Residual value</p><p>                          method                  (year)                                    depreciation rate</p><p> Houses        and     Straight-line</p><p> buildings                method</p><p> General               Straight-line</p><p> equipment                method</p><p> Dedicated             Straight-line</p><p> equipment                method</p><p> Means          of     Straight-line</p><p> transportation           method</p><p>(3). Recognition basis, valuation and depreciation of fixed assets under financial lease</p><p>□ Applicable √ Not applicable</p><p>√ Applicable □ Not applicable</p><p>economic benefits are likely to inflow to the Company; the costs of such construction in progress can be</p><p>measured reliably. Construction in progress is measured at the actual cost incurred to make the assets ready</p><p>for their intended use.</p><p>condition for service. When construction in progress has achieved serviceable conditions but final</p><p>settlement has not been finished yet, it is first transferred to fixed assets as per estimated value. After final</p><p>settlement is finished, the estimated value is adjusted based on actual cost, but the depreciated amount is</p><p>not adjusted.</p><p>√ Applicable □ Not applicable</p><p>Borrowing costs incurred by the Company, which are directly attributable to the purchase and construction</p><p>of assets eligible for capitalization, are capitalized and included in the costs of the related assets. Other</p><p>borrowing costs are recognized as expense in the period in which they incur and are included in the current</p><p>profit or loss.</p><p>(1) Capitalization of borrowing costs begins when the following three conditions are fully satisfied: 1)</p><p>expenditures for the assets have incurred; 2) borrowing costs have incurred; 3) acquisition and construction</p><p>or production that are necessary to enable the assets reach the intended usable or saleable conditions have</p><p>commenced.</p><p>(2) Where abnormal interruption of the assets eligible for capitalization occurs during the acquisition and</p><p>construction or production process and such interruption has lasted for more than 3 consecutive months,</p><p>the capitalization of borrowing costs is suspended; the borrowing costs during the interruption are</p><p>                                             Annual Report 2022</p><p>recognized as current expenses till resumption of purchasing or production of the assets.</p><p>(3) Capitalization of borrowing costs is suspended during periods in which the qualifying asset under</p><p>acquisition and construction or production is ready for the intended use or sale.</p><p>In case of special borrowing for the acquisition and construction or production of assets meeting the</p><p>capitalization conditions, interest amount to be capitalized is recognized after deducting the bank interests</p><p>for the unused portion or the investment income for temporary investment from the interest costs</p><p>(including recognized depreciation or amortization of premium under effective interest method) actually</p><p>incurred in the current period of specific borrowing; for general borrowing occupied for the acquisition</p><p>and construction or production of assets meeting the capitalization conditions, the interest amount to be</p><p>capitalized shall be determined by the result obtained by multiplying the capitalization rate of occupied</p><p>general borrowing with the weighted average value of the asset expenditure for the accumulated</p><p>expenditure exceeding the specific borrowing portion.</p><p>□ Applicable √ Not applicable</p><p>□ Applicable √ Not applicable</p><p>√ Applicable □ Not applicable</p><p>    Refer to "42. Lease" in "V. Significant Accounting Policies and Estimates" of "Section X Financial</p><p>Report" of this report for details.</p><p>(1). Valuation method, service life and impairment test</p><p>√ Applicable □ Not applicable</p><p>at the cost.</p><p>life in accordance with the expected realization method of the economic benefits related to the intangible</p><p>assets. If the expected realization method cannot be reliably determined, the straight-line method is used</p><p>for amortization. The specific year information is shown as below:</p><p>  Item                        Amortization period</p><p>                                     (year)</p><p>  Land use rights                   40 or 50</p><p>  Unpatented technology                  5</p><p>  Office software                     3 - 10</p><p>  Patent right                           5</p><p>  Customer resources                     3</p><p>  Trademark right                       10</p><p>                                              Annual Report 2022</p><p>(2). Accounting policy regarding the expenditure on the internal research and development</p><p>√ Applicable □ Not applicable</p><p>Expenditure incurred during the research phase of the internal research and development projects is</p><p>included in the current profit or loss when actually incurred. Expenditure incurred during the development</p><p>phase is recognized as an intangible asset when all of the following conditions are satisfied simultaneously.</p><p>(1) The technical feasibility of completing the intangible asset so that it will be available for use or sale.</p><p>(2) Its intention to complete the intangible asset so that it will be available for use or sale.</p><p>(3) How the intangible asset will generate probable future economic benefits. Amongst other things, the</p><p>Company can demonstrate the existence of a market for the output of the intangible asset or the intangible</p><p>asset itself or, if it is used internally, the usefulness of the intangible asset.</p><p>(4) The availability of adequate technical, financial and other resources to complete the development and</p><p>to use or sell the intangible asset.</p><p>(5) Its ability to reliably measure the expenditure attributable to the intangible asset during its development.</p><p>√ Applicable □ Not applicable</p><p>For such long-term assets as long-term equity investment, investment real estate measured with the cost</p><p>model, fixed assets, construction in progress and intangible assets with limited service life, in case that</p><p>there are signs indicating impairment on the balance sheet date, the recoverable amount should be</p><p>estimated. Whether there is a sign of impairment or not, the goodwill acquired through the business</p><p>combination and intangible assets with indefinite service life is tested for impairment each year. The</p><p>impairment test on goodwill is carried out in combination with its related asset group or asset group</p><p>portfolio.</p><p>In case the recoverable 

关键词:

为你推荐

Copyright   2015-2023 华夏家具网 版权所有  备案号:琼ICP备2022009675号-37   联系邮箱:435 227 67@qq.com